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This section provides a medium through which
Canadian surgeons can declare themselves,
briefly and informally, on the day-to-day affairs of surgery.

QUILL ON SCALPEL

n Adrenalin Rush
Nis Schmidt, MD, MSc, FRCSC
Member. Editorial Board. Canadian Journal o f Surgery. Clinical Professor, Department o f
Surgery, University o f British Columbia. St. Paul’s Hospital. Vancouver. BC

a surgical problem of
M anaging
the adrenal gland can get
one’s adrenalin going. The presen
tation, pathophysiology, pathologi
cal features, investigation and treat
ment of adrenal disease are fascinat
ing and challenging. Admittedly,
adrenal tumours are uncommon in
clinical practice — benign nonfunc
tioning tumours occur unexpected
ly in 0.6% of computed tomography
series1 and in only 1.4% to 8.7% of
autopsy series,2 and adrenocortical
carcinomas appear in 0.0006% to
0.00017% of annual cancer regis
tries.3-4 Certainly, these rates indi
cate that the numbers of cases will
be small.

In this issue (pages 51 to 55),
Bautista and colleagues describe
three cases of a fascinating adrenal
tumour that is benign, nonfunction
al and may be bilateral. Myelolipo
mas of the adrenal gland are real
tumours in that they are discovered
as an adrenal mass. Bautista and
colleagues present an interesting
debate regarding etiology in their
development as a tissue composed
of hematopoietic and fatty ele
ments. The real question for the
clinician on discovering a tumour of
the adrenal gland is what to do with
it; fortunately most adrenal tu
mours found incidentally are non
functional and benign. But these
Tel.; (613) 731-9331
Telex: 053-3152
Fax: (6 13)731-9013
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must be proven, and therein lies the
challenge.
The widespread use of ul
trasonography and computed to
mography has fortuitously uncov
ered many previously unsuspected
adrenal lesions and at the same time
eliminated the use of many invasive
and potentially harmful diagnostic
procedures. Gone are the days of
retroperitoneal air insufflation, and
the use of adrenal gland arteriogra
phy for tumour diagnosis is de
creasing. For patients who present
with a clinical syndrome of hyper
tension, Cushing’s syndrome or vi
rilization, and endocrinologic inves
tigation indicates a tumour, the
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treatment is clearly surgical. When
adrenal tumours are discovered in
the absence of clinical syndromes,
careful biochemical investigation is
necessary to uncover subclinical
pheochromocytoma or androgen/
estrogen-producing tumours sug
gesting malignancy.
Tests basic to this investigation
include measurement of plasma
concentrations of cortisol, aldoster
one, epinephrine, norepinephrine,
testosterone and estrogen, levels of
vanillylmandelic acid, catechola
mines, 17-hydroxycorticosteroids,
17-ketosteroids and dehydroepiandrosterone sulfate. Dexamethasone
and metyrapone suppression tests
are used to distinguish between
pituitary Cushing’s disease and
adrenal adenomas or carcinomas
causing Cushing’s syndrome. Col
laboration with an endocrinologist
is important because interpretation
of the results of these tests can be
confusing and subject to error. Ra
dionuclide scanning may also help
in locating and distinguishing pheochromocytomas and aldosteroneproducing Conn’s adenomas. Adre
nal venous samplings may be im
portant to discriminate between the
two glands, particularly in uncom
mon conditions of bilateral adrenal
adenomas associated with clinical
syndromes or in adrenal hyperplasia
and hyperfunction.
Because an adrenal tumour can
be malignant, its pathological fea
tures may be of more concern to
the surgeon than the presentation
and pathophysiology. Although ma
lignant adrenal tumours supposedly
start small and increase in size, few
adrenal tumours less than 6 cm in

4
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diameter are malignant. Adrenal tu
mours 4 cm or greater in diameter,
functioning or not, must be consid
ered for surgical removal. When the
tumour is less than 4 cm in diame
ter, has been carefully evaluated
and is clearly nonfunctional, it
should be followed up closely. If no
changes occur on ultrasonography
or computed tomography over 12
to 18 months, the tumour is proba
bly unimportant. A tissue diagnosis
will give the best assurance that it
is benign.
Fine-needle aspiration biopsy
with good radiologic control has
proven effective and safe. Simple
cysts can be aspirated; bloody fluid
indicates the need for surgical re
moval. Benign cytologic patterns
can be recognized and cortical ade
noma, nodular hyperplasia, myeloli
poma and pheochromocytoma diag
nosed. Biopsy of functioning adre
nal tumours associated with clinical
syndromes is usually not necessary.
Primary adrenocortical and second
ary carcinomas, functioning or not,
have been diagnosed and a few
fungal infections of the adrenal
glands identified using fine-needle
aspiration biopsy.
When the clinical picture, histo
ry, physical examination, biochemi
cal investigation and possible patho
logical findings are established, a
surgical approach can be formulat
ed, dictated mainly by the type of
syndrome and tumour suspected. I
prefer to approach Conn’s tumours
and benign unilateral nonfunction
ing tumours through the flank. A
bilateral flank or posterior approach
is used in bilateral adrenalectomy
for Cushing’s disease. Pheo-

chromocytomas need an anterior
approach to permit scrutiny for
multiple tumours and to eliminate
the possibility of a malignant tu
mour. Larger, more complex tu
mours and those that are likely
malignant may require extensive ex
posure and possible vascular by
pass; for these I prefer a long
midline laparotomy incision with
extension to a midline sternotomy.
Surgery in the investigation of
adrenal clinical syndromes and tu
mours can be challenging, particu
larly in the planning and perfor
mance of procedures that technical
ly may be demanding. What ap
peared to be potentially serious may
prove to be an innocent benign
nonfunctional tumour, like a myelo
lipoma, requiring simple removal,
much to the relief of surgeon and
patient. Results can be extremely
satisfying, since postoperative re
covery from these endocrine syn
dromes can be dramatic.
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QUILL ON SCALPEL

A Plea for Standard Methods of Reporting
Studies on Lower Extremity Ischemia
Nathan M. Sheiner, MD, FRCSC
Member. Editorial Board. Canadian Journal o f Surgery. Professor. Department o f Surgery.
McGill University. Surgeon-in-Chief. Sir Mortimer B. Davis-Jewish General Hospital. Montreal.
PQ

n this issue (pages 48 to 50) is
an article by my colleagues Laurendeau and Lassonde entitled
“Above-knee femoropopliteal recon
struction with polytetrafluoroethylene: a good alternative to sa
phenous vein bypass”. I do not
intend to criticize the article, debate
the selection of patients for surgery
or the conclusions of the authors,
but rather to point out that this and
most other reports in the vascular
surgery literature cannot be as
sessed appropriately because there
is a complete lack of standardized
reporting practices. For example, in
their article Laurendeau and Lass
onde claim that of the 64 femoropo
pliteal bypasses performed, 34 were
for ischemic problems with rest
pain and trophic changes and 30
for claudication alone. There is no
objective categorization of the se
verity of claudication as could be
achieved by treadmill testing in a
vascular laboratory, nor is there any
attempt to further categorize isch
emic rest pain or trophic changes.
As a result it is virtually impossible
to compare this group of patients
with others reported in the litera
ture.
In terms of outcome, the only
criterion noted in this article ap
pears to be graft patency, though it
is well known that patency does not
necessarily imply success. Further
more, there are instances in which
graft occlusion occurs but does not
result in limb loss, even when the

I

bypass grafting is performed for
so-called “limb salvage”. Conse
quently, it is essential that patients
be placed into standardized catego
ries and that success be gauged by
a shift into a higher category ac
companied by an improvement in
the ankle-brachial index. There
must be objective criteria for deter
mining patency, and a distinction
should be made between primary
and secondary patency rates. There
should also be a standardized tech
nique for identifying and grading
those features that modify outcome,
such as diabetes, smoking history,
hypertension, hyperlipidemia and
cardiac disease, in addition to a
standardized method of assessing
and reporting runoff. The reporting
of deaths and complications should
also be standardized as should re
sults by life-table analyses; this can
be done in either table or graph
form. In Laurendeau’s paper, re
sults are reported by life-table anal
ysis, but there is no notation of the
number of grafts at risk or the
standard deviation in each period.
Aware of the importance of stan
dardizing reporting methods, the
joint councils of the Society for
Vascular Surgery and the North
American Chapter of the Interna
tional Society for Cardiovascular
Surgery appointed an ad hoc com
mittee to deal with this issue. The
first report,1 issued by a subcommit
tee, deals with reporting in lower
extremity ischemia. In this report,

terms are defined and criteria pre
sented for uniformly gauging sever
ity of disease, the findings of diag
nostic studies, the types of thera
peutic intervention and their out
come. The authors conclude: “We
feel confident that most readers will
appreciate that precisely defined
and uniformly adopted reporting
practices will allow us to better
understand the data presented in
the articles we read, be able to
compare them with reliance, depend
more confidently on their conclu
sions, and base our practices on the
more solid foundations of fact and
the proper perspectives they will
provide.”
Although acceptance of the rec
ommendations in this report will
result in considerably more work
for vascular surgeons and necessi
tate the use of computers, the po
tential gains are enormous. Local,
regional and national vascular so
cieties should accept these recom
mendations, or at least their broad
principles and insist that they be
followed when presentations are
made at their meetings.

Reference
1. Suggested standards for reports dealing
with lower extremity ischemia. Prepared
by the Ad Hoc Committee on Reporting
Standards, Society for Vascular Surgery/
North American Chapter, International
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SESAP V Question

Item 218
The arteriogram of a 74-year-old man is shown above. Which of the following statements about this lesion is
NOT true?

(A) The incidence of bilaterality is 35% to 70%
(B) It may be associated with ischemic symptoms in the toe even in the presence of good pedal pulses
(C) Spontaneous rupture may occur
(D) Abdominal aortic aneurysms occur in 30% to 50% of cases
(E) This disease is seen with equal frequency in both sexes

For the critique of Item 218 see page 68.

(Reproduced by permission from SESAP V Syllabus: Surgical Education and Self-Assessment Program No. 5.
The Surgical Education and Self-Assessment Program No. 6 is now available. For further information and
enrolment in SESAP VI, please apply to the American College of Surgeons, 55 East Erie St., Chicago, IL
60611.)
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Primary Omental Torsion
To the editors. Primary torsion of
the greater omentum is a rare cause
of abdominal pain. Since it was first
described by Eitel1 in 1899, fewer
than 250 cases have been reported.2
It occurs when a segment of omen
tum twists on its vascular pedicle,
producing congestion, ischemia and
eventual necrosis of the distal seg
ment. Since the condition is rarely
diagnosed preoperatively, its pres
ence must be recognized at laparot
omy. It should be distinguished
from the more common secondary
omental torsion, caused by attach
ment of the free edge of the omen
tum to cysts, tumours, inflammato
ry foci, postoperative wounds or
scarring, and to internal or external
hernias.
We recently treated two such
patients. Both had tenderness and
guarding in the right lower quad
rant of the abdomen, diagnosed as
acute appendicitis preoperatively.
At laparotomy, the appendix ap
peared normal in both patients and
was removed. There was approxi
mately 250 ml of serosanguineous
fluid in the peritoneal cavity in one
patient, and further exploration re
vealed a 10 X 15-cm mass in the
right upper quadrant. The mass
comprised an edematous, cyanotic
piece of greater omentum with
areas of necrosis. By twisting on
itself, an attached pedicle caused
infarction of the distal segment
which was easily excised. Patholog
ical examination confirmed a nor
mal appendix and necrosis of omen
tum.
In the second case, a smaller 3 X
3.5-cm segment of infarcted omen
tum was found and excised. Again,
pathological examination confirmed
the diagnosis. Both patients made

smooth recoveries and were dis
charged after 5 days.
In an extensive review of primary
omental torsion by Mainzer and
Simoes,3 the commonest preopera
tive diagnosis was acute appendici
tis (82%), followed by acute chole
cystitis (12%). An abdominal mass
was palpable in approximately 50%
of the patients.
The finding of sterile serosan
guineous fluid in the peritoneal cav
ity is almost universal.34
The etiology of primary omental
torsion is unknown; however, in
1951, Leitner and colleagues5 clas
sified possible predisposing and pre
cipitating factors. The former in
cluded anatomical variations in the
omentum, obesity and redundancy
of omental veins leading to kinking
and twisting around the shorter,
more tense arteries. Precipitating
factors are those causing displace
ment of the omentum; they include
trauma, violent exercise and hy
perperistalsis with resultant in
creased passive movement of the
omentum.
Treatment is resection of the in
farcted segment; if it is not excised,
the mass becomes atrophied and
fibrotic and, on rare occasions, autoamputated. Associated morbidity
and mortality are extremely low.
James P. Appleby, MD
Resident VI.
Division o f General Surgery.
University o f British Columbia.
Vancouver. BC

William T. Simpson, MB, FRCSC,
FACS
T.E. Abraham, MD. FRCSC
Department o f Surgery,
Prince George Regional Hospital.
Prince George. BC

Contributions to the Correspondence section
are welcome. They should be typewritten
and double spaced.
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Immediate Thrombosis of
Carotid Endarterectomy
To the editors. In the September
1988 issue of the Journal (pages
368 to 371), Egan and Walker
documented symptomatic thrombo
sis of carotid endarterectomy in 5 of
325 procedures (1.5%). Four of the
five patients were symptomatic
within 2 hours and one within 9
hours after operation. Although
they indicated that the condition
will be recognized only in patients
with symptoms, the authors cited
one reference1 in which asymptom
atic postoperative thrombosis, doc
umented by digital subtraction angi
ography, was found in 1.2% of
patients.
In a series of 864 carotid endar
terectomies, in which all patients
were monitored in the recovery
room by ocular pneumoplethysmo
graphy (OPG-Gee), 26 patients were
considered to have early throm
boses, all of which were confirmed
by immediate reoperation without
interval arteriography.2 These
thromboses were symptomatic on
the side appropriate in 9 patients;
they were asymptomatic in 17 pa
tients.
Although direct testing and other
VOL. 32. NO. 1. JANUARY 1989
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NOTICE OF CHANGE OF ADDRESS/
AVIS DE CHANGEMENT D’ADRESSE
forms of indirect noninvasive test
ing are difficult to apply in the
recovery room, the OPG-Gee is a
simple, economical procedure for
identifying thrombosed carotid re
pairs, both symptomatic and asymp
tomatic.
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STATE OF THE ART

Dilatation and Curettage
Mark E. Boyd, MD, FRCSC
The most important role of dilatation and curettage is in the evacuation of retained
products of conception; its diagnostic value is mostly limited to the detection of
cancer of the endometrium. The procedure is associated with a number of
complications, the majority of which occur during dilatation of the cervix. Vabra
curettage is suggested as an alternative to diagnostic dilatation and curettage; it is
efficient, is associated with fewer complications and is less expensive. Hysteroscopy
is a useful supplement to Vabra curettage, especially in diagnosing focal lesions.

L’indication principale de la dilatation et du curetage est l’evacuation des restes des
produits de conception; son interet diagnostique se limite a la detection des cancers
de l’endometre. L’intervention est associee a un certain nombre de complications,
dont la majorite survient durant la dilatation du col. Le curetage par la methode
Vabra est recommande comme alternative a la dilatation et au curetage diagnostiques; il est efficace, comporte moins de complications et est moins couteux.
L’hysteroscopie complemente bien le curetage Vabra, surtout pour diagnostiquer les
lesions focales.

s a result of new understanding
of its diagnostic and therapeu
tic worth and concerns over its
cost, dilatation and curettage (D &
C) is no longer the mainstay of
gynecologic practice. In this review,
the value of D & C will be discussed
and the surgical technique de
scribed; the diagnosis and avoid
ance of complications will be em
phasized. Alternatives to D & C for
diagnosing gynecologic conditions
will be suggested.

A

Indications
The most important diagnostic
use of D & C is in cancer of the
endometrium, presenting as post
menopausal, intermenstrual or ex
cessive menstrual bleeding. The
only patients at high risk of har
bouring the disease are those with

postmenopausal bleeding (8%).12 It
is surprising, therefore, to find that
the majority of D & Cs are per
formed on women under 34 years of
age when cancer of the endometri
um is almost nonexistent.3 The pro
cedure is not a perfect diagnostic
tool; initial curettage fails to identi
fy 10% of endometrial cancers and
repeat curettage is often necessary
for a definitive diagnosis.3-4 Dilata
tion and curettage infrequently es
tablishes other causes of abnormal
bleeding.1 Information regarding
ovulation and its timing may be
important in the investigation of
infertility; although ovulation can
be confirmed by progesterone as
says, its timing depends on histo
logic examination of the endometri
um.
There are important, albeit limit
ed, therapeutic uses for curettage.
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It is curative when bleeding is
caused by retained products of con
ception or submucous polyps, but
unexpected discovery of the former
has declined as preoperative preg
nancy tests have become more sen
sitive.
Curettage may also be useful in
cases of acute vaginal bleeding not
associated with pregnancy. The he
morrhage is arrested by removing
endometrium, which is rich in pros
taglandins, and by causing throm
bosis of endometrial arterioles and
sinuses. Endometrial disease is
found in only one-third of such
cases.2
In all other circumstances, D & C
is unlikely to have any therapeutic
effect,1-5 particularly in patients who
complain of menorrhagia.6 In select
ed cases, medical curettage, using
progesterone to initiate withdrawal
bleeding, would be a more logical
alternative.

Surgical Technique
Preoperatively, routine perineal
shaving, catheterization and ene
mas are not necessary; detailed hor
mone studies are not worthwhile,
but pregnancy tests should be
done.1 The size and position of the
uterus and adnexa are confirmed by
pelvic examination. Local anesthe
sia is known to be safer than gener
al anesthesia, and efforts should be
made to use it in the operation.7
The anterior lip of the cervix is
grasped with a single-toothed tenac
ulum and downward tension is ex
erted; the degree of mobility deter
mines the feasibility of vaginal hys
terectomy and this should be re
corded.
If cancer of the endometrium is
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suspected, endocervical curettage is
indicated. The endocervix is first
sampled, using a Kevorkian curet,
care being taken to avoid the lower
uterine segment. Firm pressure on
the curet is necessary. The patholo
gist will wish to see endocervical
stroma in the specimen which is
collected on a separate Tulfa pad.
Although endocervical curettage is
done to diagnose extension of can
cer of the body of the uterus into
the cervix (thus marking the pro
gression of endometrial cancer from
stage I to stage II), the information
gathered is often unreliable. Tu
mour fragments in the endocervix
correlate best with a large tumour
in the body of the uterus or with
involvement of its lower segment
but not with cervical invasion. Onehalf of the cases diagnosed preoperatively as stage II on endocervical
curettage are found to be stage I
when the operative specimen is ex
amined.8 Conversely, 13% of cases
initially classified as stage I are
found to be stage II.8-10 The stage
of endometrial cancer is altered by
extension to the endocervix and
although this finding should
change the choice of therapy, it
seldom does.
The length of the uterine cavity,
used in staging endometrial cancer,
is estimated with a sound. The
procedure is made easier and safer
when the angle between the uterus
and cervix is obliterated by down
ward tension on the cervix. If it
catches in an endocervical crypt the
instrument may be impossible to
insert, in which case a slightly
larger probe, capable of bypassing
the crypt, should be used.
The cervix is then dilated. Most
complications associated with D &
C occur at this time. It is imperative
that there is minimal thrust on the
dilators which should be held by the
finger tips in a pencil grip. The
dilatation should allow the passage
of only the smallest curet — a no. 7
10
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Hegar — not nos. 10 to 12 Hegar
as advocated in the past.
It has been proposed that the
uterine cavity should now be ex
plored with Randall stone forceps to
remove any polypoid lesions pres
ent.11 Searching for polyps in this
manner is inefficient and is support
ed only by a single, uncontrolled
30-year-old paper.1213 In order to
pass stone forceps, the cervix must
be dilated to an inappropriate and
dangerous degree.
The curettage is done with a
sharp curet exploring the anterior
and posterior walls, the cornua and
the fundus. Despite the seeming
thoroughness of the curettage, later
examination will show that only
halt the endometrium has been
sampled.314 Accurate histologic di
agnosis cannot be made from gross
examination of the tissue, and even
frozen-section examination can be
misleading.1415 In 6% of cases the
sample of endometrium is such that
the pathologist is unable to give a
histologic diagnosis.1

there is seldom excessive intraperitoneal hemorrhage. When
perforation is diagnosed, the proce
dure is discontinued and the patient
closely observed for 3 to 4 hours.
The D & C can be repeated later.
Laceration of the whole thickness
of the cervix is caused by use of too
large a dilator and is diagnosed by
the sudden release of resistance to
the instrument. Substantial vaginal
or retroperitoneal hemorrhage may
follow; the injury is best managed
by laparotomy since vaginal mani
pulations are unsatisfactory.
There is some suggestion that D
& C contributes to infertility.18 A
long-term ill effect is cervical in
competence.19 An unusual compli
cation is obliteration of the en
dometrial cavity by postoperative
adhesions (Asherman’s syndrome),
most often a sequel to curettage of
a postpartum uterus.

Complements and Alternatives
to Dilatation and Curettage
Endometrial Cytologic Examination

Complications
The frequency of major complica
tions is similar to that with which
endometrial cancer is found.1-2 Per
foration is the most serious compli
cation, caused by improper dilata
tion of the cervix;18 this begins
when the proper axis between the
cervix and uterus is not found and a
false passage is created.
Perforation of the pregnant uter
us with a suction curet is particu
larly dangerous and necessitates
laparotomy.7 If the perforation is in
the cervix, the uterine artery may
be torn, and the ensuing hemorrh
age into the broad ligament can be
massive.17 If the fundus of the preg
nant uterus is perforated with a
dilator, the curettage may be com
pleted under laparoscopic control.
In the nonpregnant uterus, the
fundus is usually perforated and

Endometrial cytologic techniques
do not ensure a definitive diagnosis,
therefore they are not an alternative
to D & C. They can, however, be
used in screening when curettage is
not justified; for example, in highrisk asymptomatic women (estrogen
users) or symptomatic low-risk pa
tients (premenopausal women with
irregular bleeding).
The cytologic sample may be ob
tained directly by aspiration, lavage,
brush or direct smear tech
niques.20-21 Two appropriate instru
ments are the EndoPap and Endocyte.22-23 These techniques allow
endometrial cancer to be diagnosed
in 94% of cases with a false-positive
rate of 8%.24 In 10% of cases no
diagnosis was possible because the
specimen was too small and in 50%
there was failure to diagnose en
dometrial hyperplasia.24

DILATATION AND CURETTAGE

Endometrial Biopsy

Hysteroscopy

Definite determination of en
dometrial disease depends on direct
biopsy of the endometrium rather
than cytologic smears. Endometrial
biopsy is an incomplete curettage,
customarily done with a small curet
and without anesthesia. Since its
introduction some 40 years ago its
efficacy, compared with that of D &
C, has been questioned.25 Reported
series attest to its accuracy (91% to
92%) in diagnosing cancer of the
endometrium.25-26 However, these
studies have been criticized for fail
ing to indicate the percentage of
cases in which endometrial biopsy
was not possible and for failure to
perform control curettage.27
In recent years, the technologic
aspects of endometrial biopsy have
been refined, as exemplified by the
development of the Vabra curet
(Berkeley Medevices Inc., Berkeley,
Calif.). This disposable suction de
vice allows thorough curettage
without dilatation of the cervix. The
procedure is more expensive than
endometrial biopsy, but in a fairer
cost comparison with D & C it is
only 10% of the cost.29 Its diagnos
tic value has compared favourably
to D & C.3'28'29 The procedure is
96% to 98% accurate in diagnosing
cancer of the endometrium and 95%
in the diagnosis of benign disease.29
Also, it is associated with fewer
complications. Its main weakness is
a failure to diagnose endometrial
or fibroid polyps, a shortcoming
also noted with D & C.129-30
The sensitivity and specificity of
endometrial biopsy and Vabra curet
tage compared with D & C are
unavailable because information on
the true incidence of endometrial
cancer and the diagnostic error of
the D & C is lacking. A problem in
comparing Vabra curettage with D
& C is that the former may remove
the lesion and thus hinder the diag
nostic accuracy of the latter.3

Hysteroscopy is the definitive
method of diagnosing abnormal
uterine bleeding caused by focal
lesions, especially submucous fi
broids, but it is equally efficient in
diagnosing endometrial cancer.511
Hysteroscopy is done with disten
sion (panoramic hysteroscopy) or
without distension (contact hys
teroscopy) of the uterine cavity.
Both require expertise and are sub
ject to disruption because of techni
cal problems. It has been suggested
that hysteroscopy be used routinely
before endometrial biopsy to detect
lesions that may be missed by curet
tage and then to direct the curet
toward a lesion.31 Curettage is a
necessary supplement to hysteros
copy since a histologic diagnosis
cannot be made with this technique
and biopsy through the instrument
is unsatisfactory.5
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Dilatation and curettage has
changed from one of the most fre
quently used to one of the least
frequently used procedures in gyne
cology. It is a useful diagnostic tool
for detecting endometrial cancer
but its therapeutic value in control
ling uterine hemorrhage is limited.
Complications relate to dilatation of
the cervix. Under local anesthesia
Vabra curettage supplemented by
hysteroscopy is the most attractive
alternative to D & C.
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Fate of the Gallbladder With
Cholelithiasis After Endoscopic
Sphincterotomy for Choledocholithiasis
D. David Lamont, MD; Ronald B. Passi, MD, FACS, FRCSC
Endoscopic sphincterotomy is the treatment of choice for choledocholithiasis after
cholecystectomy. Its role has been expanded to treat choledocholithiasis in patients
with gallbladders still in place. The authors report their experience with endoscopic
sphincterotomy, with emphasis on the safety of the procedure, in high-operative-risk
patients with choledocholithiasis and gallbladder in situ. Stones were successfully
removed in 72 of 75 patients (96%); I required an emergency operation and 2 an
elective one. Complications included bleeding, pancreatitis and cholangitis; there
were no associated deaths. Follow-up of 54 of the patients, who had associated
cholelithiasis at the time of endoscopic sphincterotomy, showed that 14 died of
causes unrelated to the biliary tract. Of the others, 14 underwent cholecystectomy
for failure of endoscopic sphincterotomy (2), acute cholecystitis (4) or persistent
biliary tract symptoms (8). The other 26 patients were well after a mean follow-up of
30.4 months; 1 had mild biliary tract symptoms. Ultrasonography in 16 of the 26
patients showed persistent cholelithiasis in 12. Life-table analysis revealed a 15%
probability of acute cholecystitis within 5 years of endoscopic sphincterotomy.

La sphincterotomie endoscopique est le traitement de premier choix de la
choledocholithiase post-cholecystectomie. Son role s’est etendu au traitement de la
choledocholithiase chez les patients qui ont conserve leur vesicule biliaire. Les
auteurs commentent l’utilisation qu’ils ont faite de la sphincterotomie endoscopique
et ils soulignent l’innocuite de cette technique chez les patients a risque eleve
souffrant de choledocholithiase et ayant conserve leur vesicule. Des calculs purent
etre retires chez 72 patients sur 75 (96%); 1 necessita une operation d’urgence et 2,
une intervention differee. On compta parmi les complications une hemorragie, une
pancreatite et une cholangite; il n’y eut aucun deces relie a l'intervention. Suite
d’observation de 54 patients qui souffraient aussi de cholelithiase au moment de la
sphincterotomie endoscopique, revele que 14 sont decedes de causes etrangeres a
l'affection des voies biliaires. Parmi les autres, 14 ont subi une cholecystectomie,
soit apres echec de la sphincterotomie endoscopique (2), soit pour cholecystite aigue
(4) ou a cause de la persistance des symptomes biliaires (8). Apres un suivi moyen
de 30.4 mois, les 26 autres patients etaient en bonne sante; 1 presentait de legers
symptomes biliaires. Les analyses actuarielles revelent un risque de 15% de
cholecystite aigue dans les 5 ans qui suivent une sphincterotomie endoscopique.
Prom the Department o f Surgery. University Hospital, University o f Western Ontario, London,
Ont.

ndoscopic sphincterotomy (ES)
was introduced in 1974 as a
method of treating choledocholi
thiasis.1'2 Its success rate now ex
ceeds 90%, which is comparable to
that of choledochotomy.3 The com
plication and death rates are less
than 10% and 3% respectively,
which are superior to the rates for
choledochotom y.4-6 Endoscopic
sphincterotomy is now the treat
ment of choice for retained or re
current common-duct stones after
cholecystectomy. As a result of ex
perience, the role of endoscopic
sphincterotomy has expanded to in
clude the management of choledo
cholithiasis with gallbladders in
place. It is also used in patients
with ascending cholangitis and se
lectively in early gallstone pan
creatitis.7 Interest is now focused
on whether the gallbladder can
safely remain in situ after endoscop
ic sphincterotomy.812 This question
centres on two groups of patients
— those with primary common-duct
stones and no gallbladder disease
and those with both common-duct
stones and cholelithiasis. We report
on the clinical follow-up of 75 pa
tients with gallbladders in situ after
endoscopic sphincterotomy per
formed for choledocholithiasis; 54
had associated cholelithiasis.
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Patients and Methods
Between January 1981 and Au
gust 1987, 363 endoscopic sphincVOL. 32, NO. 1, JANUARY 1989
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terotomies were performed at Uni
versity Hospital, London, Ont., for
the management of choledocholithiasis or its complications. Seven
ty-five high-operative-risk patients
(48 men, 27 women) had their
gallbladders left in place. Coronary
artery disease and poor pulmonary
function were the most commonly
encountered risk factors (Table I).
The patients ranged in age from 32
to 98 years (mean 74.3 years). The
indications for endoscopic sphinc
terotomy were: obstructive jaundice
(38), cholangitis (24) and pancreati
tis (5). Eight sphincterotomies were
performed at the time of diagnostic
endoscopic retrograde cholangio
pancreatography when commonduct stones were identified. The
technique used in this study has
been described previously.13
Complete follow-up was obtained
for all 75 patients, either from their
referring physician or by direct per
sonal contact. The period from en
doscopic sphincterotomy to follow
up ranged from 5 to 68 months
(mean 31.8 months). The causes of
death were determined from death
certificates or autopsy.
Life-table analysis was performed
on the data from 52 patients in
Table 1. C o n d itio n s in 7 5 H ig h -R is k
P a tie n ts W h o U n d e rw e n t E n d o s c o p ic
S p h in c te ro to m y
Disease/condition
C o ro n a ry a rte ry d ise ase
C h ro n ic o b s tru c tiv e
p u lm o n a ry d is e a s e
M y o c a rd ia l in fa rc tio n
C e re b ro v a s c u la r a c c id e n t
M is c e lla n e o u s

Nc. of patients
29
20
3
3
20

whom cholelithiasis was document
ed at the time of endoscopic sphinc
terotomy and who underwent recent
ultrasonography.

Results
The common bile duct was suc
cessfully cleared in 72 patients
(96%). The procedure could not be
completed in one uncooperative pa
tient who was mentally retarded. He
underwent elective cholecystectomy
2 days later. One patient had large
common-duct stones that could not
be extracted and were removed sur
gically 1 week later. The third fail
ure was in a patient who had a
large stone impacted in the ampul
la; ascending cholangitis developed
after the procedure and he under
went emergency cholecystectomy
and duct decompression. This case
represents the only cholecystectomy
performed in a patient without doc
umented cholelithiasis.
In the 75 patients there were
three complications (4%): a minor
hemorrhage that did not require
transfusion, a mild pancreatitis and
an ascending cholangitis that re
quired cholecystectomy and duct
exploration. There were no associ
ated deaths.
The follow-up after endoscopic
sphincterotomy ranged from 2
weeks to 43 months (mean 16.7
months) in 16 patients who died.
No death was related to sphinc
terotomy or biliary sepsis. The
causes were myocardial infarction
(six patients), carcinoma of the lung

Table II. S u m m a ry o f O u tc o m e in 7 5 P a tie n ts W ith G a llb la d d e rs In S itu A fte r E n d o s c o p ic
S p h in c te ro to m y (E S )

With gallstones
(n = 54)

Outcome
D eath
C h o le c y s te c to m y
F o r fa ile d ES
F o r a cu te c h o le c y s titis
F o r p e rs is te n t s y m p to m s
A liv e and w e ll
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14
14
2
4
8
26

Without gallstones
(n = 2 1 )
2
1
1
18

(three), chronic obstructive lung
disease (two), carcinoma of the
prostate (one) and mesenteric in
farction (one). Although death was
reported as due to carcinoma of the
gallbladder in three, this was con
firmed in only one. All patients who
died had their gallbladders in situ.

Patients With Acalculous
Gallbladders

Of the 75 patients, 21 (mean age
73.9 years) had no documented
evidence of cholelithiasis at the time
of endoscopic sphincterotomy. Fol
low-up in this subgroup ranged
from 5 to 68 months (mean 33.6
months). Two of the 16 deaths
occurred in this group. One patient
underwent cholecystectomy for fail
ure of endoscopic sphincterotomy;
the remaining 18 are well with no
further biliary tract symptoms.
Patients With Cholelithiasis

Fifty-four patients (mean age 75
years) had documented cholelithia
sis at the time of endoscopic sphinc
terotomy. The follow-up in this sub
group ranged from 5 to 68 months
(mean 30.4 months). Fourteen of
the 16 patients who died were in
this subgroup. Of the remaining 40
patients, 14 (35%) underwent chole
cystectomy, in 2 cases, as noted
earlier, for failure of endoscopic
sphincterotomy. Four patients suf
fered from acute cholecystitis, an
average of 4 months after endo
scopic sphincterotomy. Eight pa
tients who had persistent biliary
tract symptoms were medically re
habilitated before elective cholecys
tectomy, which was performed a
mean of 3 months after the proce
dure (Table II). Twenty-six patients
with their gallbladders in situ re
main well and all but 1 are asymp
tomatic.
Ultrasonography in 16 of the 26

NEED FOR CHOLECYSTECTOMY AFTER SPHINCTEROTOMY

patients revealed persistent choleli
thiasis in 12, but no stones in 4;
these may represent false-negative
results, but the stones could have
passed from the gallbladder into the
duodenum through the sphinc
terotomy (Fig. 1).
By life-table analysis the probabil
ity of a patient having acute chole
cystitis within 5 years of endoscopic
sphincterotomy was found to be
15% (Fig. 2).

Discussion
Recent emphasis has been placed
on the fate of the gallbladder after
endoscopic sphincterotomy.8"12
Most patients who undergo the pro
cedure, leaving the gallbladder in
situ, are elderly and high operative
risks.
Because of altered gallbladder ki
netics and free intestinal reflux into
the biliary system, it has been sug
gested that there is an increased
risk of acute cholecystitis develop
ing after endoscopic sphincteroto

my, even without cholelithiasis.11
Tanaka and colleagues11 presented
a long-term follow-up report on 91
patients who underwent endoscopic
sphincterotomy with acalculous
gallbladders left in situ. None of
these patients suffered from acute
cholecystitis. This is in keeping
with an earlier study by Choi and
associates14 who reported on 271
patients with acalculous gallblad
ders followed up for 7 years after
endoscopic sphincterotomy; 2 suf
fered from cholecystitis. Our results
are in keeping with those in the
literature, and it is apparent that
endoscopic sphincterotomy is in
deed the treatment of choice for
primary common-duct stones. The
acalculous gallbladder can safely be
left in situ.
The management of the calcu
lous gallbladder is more controver
sial. Tanaka and colleagues11 re
ported 16 of 31 patients (51%) with
cholelithiasis who had acute chole
cystitis after endoscopic sphinc
terotomy and advocated cholecys
tectomy whenever feasible. Howev

er, the incidence of acute cholecys
titis after endoscopic sphincteroto
my in patients with gallstones has
been reported as 6.2%.s Rosseland
and Solhaug12 reported a follow-up
study of 77 patients, 10 (12.9%) of
whom had acute cholecystitis, but
only 7 required cholecystectomy.
They believed that the gallbladder
which contains stones can safely be
left in situ after endoscopic sphinc
terotomy in elderly high-risk pa
tients.

FIG. 2. Life-table analysis performed
on patients with associated cholelithia
sis, revealing probability of acute
cholecystitis in this group. GB = gall
bladder, E.S. = endoscopic sphinc
terotomy.

FIG. 1. Patient was 53-year-old man who had cirrhosis and previous placement of portacaval shunt. He underwent endoscopic
sphincterotomy for management of ascending cholangitis. Initial x-ray film at endoscopic sphincterotomy (A) reveals radiopaque
stones in gallbladder. X-ray film 5 days later (B) shows that stones had migrated to common duct alongside nasobiliary catheter.
Follow-up x-ray film 3 weeks later (C) shows no evidence of stones, suggesting that they had passed.
VOL. 32. NO. 1, JANUARY 1989
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Our results are in agreement with
those of Rosseland and Solhaug. In
our series, the common duct was
successfully cleared in 96% with a
4% rate of complications; only one
complication was serious and re
quired operative intervention.
Life-table analysis revealed a 15%
probability o f acute cholecystitis de
veloping within 5 years of endo
scopic sphincterotomy. This is
lower than the reported 29% death
rate with acute cholecystectomy
and duct exploration.15 Duron and
associates5 have shown that endo
scopic clearance of the bile duct
before cholecystectomy in the elder
ly reduces the operative mortality
associated with duct exploration
from 21% to 6%.
We believe that in elderly highrisk patients, endoscopic sphinc
terotomy is the treatment of choice
for common-duct stones or their
complications and that the calcu
lous gallbladder can safely be left in
situ. These patients are likely to die
of underlying medical conditions be
fore acute cholecystitis develops,
but should it do so, common-duct
exploration will not be required at
the time of cholecystectomy, thus
putting them in a lower-risk catego
ry.45
The unanswered question is
whether it is safe to manage youn
ger, healthy patients with choleli
thiasis in a similar manner. Further
studies are required in this area.
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Strictureplasty in Crohn’s Disease
Richard E. Silverman, MD, FRCSC; Robin S. McLeod, MD, FRCSC; Zane Cohen, MD, FRCSC
Strictureplasty may eliminate or decrease the extent of resection required in patients
who have obstructing Crohn’s disease of the small bowel. The authors performed 36
strictureplasties at 16 operations in 14 patients. Additional bowel resection was
carried out in 13 of the 16 procedures. Early complications included wound infection
in one patient, upper gastrointestinal bleeding in one and presumed suture-line
leak, treated conservatively, in a third patient. At the end of the follow-up period
(mean 16.1 months), 10 patients were asymptomatic and 4 had symptomatic
recurrences; 2 of these required reoperation. A number of preoperative factors and
operative techniques may have contributed to the favourable results.

La stricturoplastie peut eliminer ou reduire l’etendue de la resection que necessitent
les patients souffrant d’obstruction intestinale causee par la maladie de Crohn de
l’intestin grele. Les auteurs ont pratique 36 stricturoplasties au cours de 16
operations chez 14 patients. Des resections intestinales additionnelles ont ete
effectuees durant 13 de ces 16 interventions. Parmi les complications precoces, on
compte une infection de plaie chez un patient, une hemorragie gastrointestinale
haute chez un autre et une fuite presumee au point d’anastomose chez un troisieme,
laquelle fut traitee de fa?on conservatrice. A la fin de la periode de surveillance des
suites operatoires (16.1 mois en moyenne), 10 patients etaient asymptomatiques
alors que 4 presentaient une recidive des symptomes; 2 de ces derniers necessiterent
une deuxieme intervention. Un certain nombre de facteurs preoperatoires, de meme
que les techniques operatoires utilisees, peuvent avoir contribue a ces resultats
favorables.

of surgery for Crohn’s
G oals
disease are to treat complica
tions and relieve symptoms. After
an initial small-bowel resection or
subsequent ileocolic resection to re
move all visibly diseased bowel,
10-year rates of recurrence associ
ated with reoperation range from
30.5% to 53%.12 Indeed, there is
histologic evidence that Crohn’s
disease may affect the entire gas

trointestinal tract from the outset.34
These factors dampen any enthusi
asm for performing radical bowel
resection for cure. Conservative
surgery is especially applicable to
two groups of patients: those who
have previously undergone smallbowel resection and present with
recurrent disease of an obstructive
nature and those who have diffuse
disease and multiple small-bowel
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strictures. In these patients, remov
al of the involved areas of intestine
may lead to an iatrogenic shortbowel syndrome.
Strictureplasty for small-bowel
strictures was pioneered by sur
geons in India who successfully
used the technique in both tubercu
lous and Crohn’s lesions.5 Lee and
Papaioannou6 advocated stricture
plasty as a cornerstone of their
policy of minimal surgery in pa
tients having diffuse obstructive
Crohn’s disease. Their encouraging
preliminary results led to subse
quent recent reports7-9 attesting to
the safety and efficacy of the proce
dure. In this paper we review our
experience with strictureplasty be
tween October 1985 and March
1988 in the management of 14
patients who had Crohn’s disease.

Patients and Methods
The 14 patients (3 female, 11
male) underwent 16 operative pro
cedures in which 36 strictureplas
ties were performed. Their average
age was 28.1 years (range from 17
to 44 years). As a whole, they had a
relatively long history of Crohn’s
disease, with a mean time from
diagnosis of 9.7 years (range from 1
to 27 years). Ten patients had previ
ously undergone a total of 20 bowel
resections. The indication for stric
tureplasty in all cases was recurring
obstructive symptoms refractory to
medical therapy.
Thirty strictures were short (1 to
7 cm) and were treated by a Heineke-Mikulicz procedure using inter
rupted 3-0 Vicryl sutures (Fig. 1).
VOL. 32, NO. 1, JANUARY 1989
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The six longer strictures (7 to 12
cm) were treated by a Finney-type
strictureplasty and also sutured

with 3-0 Vicryl (Fig. 2). Only 3
operations consisted of stricture
plasty alone; the remaining 13 con
sisted of strictureplasty and smallbowel resections in 9, ileocolic
anastomotic resection in 2, proctec
tomy in 1 and small- and large-bow
el resection in 1. We used a Foley
catheter with the balloon inflated to
2 cm diameter to calibrate the
small-bowel lumen internally in
order to define strictures that were
not readily apparent. The catheter
was introduced into the first enterotomy site and passed proximally
and distally to evaluate the entire
small bowel.

Results

FIG. 1. Heineke-Mikulicz stricture
plasty. Strictured area is opened along
antimesenteric border with cautery (A).
Stay sutures are placed and incision is
oriented transversely (B). Interrupted
3-0 Vicryl is used to close stricture
plasty (C).
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The mean postoperative hospital
stay was 12.6 days (range from 9 to
24 days). Complications occurred
early after operation in three cases.
One patient had a wound infection.
Another, on coumadin therapy for
preoperative deep wound thrombo
sis, had an upper gastrointestinal
hemorrhage which responded to
conservative measures. The third
patient complained of localized
lower abdominal pain and tender
ness 9 days after five strictureplas
ties and a bowel resection were
performed; a presumptive diagnosis
of a suture-line leakage was made
and he was given broad-spectrum
antibiotics and total parenteral nu
trition infusion. His symptoms re
solved within 48 hours.
The follow-up ranged from 1 to
29 months (mean 16.1 months).
Nine patients had an excellent re
sult and were asymptomatic,
though five of them required main
tenance drug therapy to control
residual disease (Table I). Two pa
tients required reoperation for ob
structive symptoms, 3 and 8
months postoperatively. One had
extensive small-bowel and colonic
disease treated by resection and

strictureplasty. Three months later
a discrete stricture of the ileocecal
valve was resected; it had likely
been present but undiagnosed at
the time of the original operation.
The second patient had a resection
and strictureplasty for extensive jejunoileitis. Eight months later, at
laparotomy for recurrent obstruc
tive symptoms, a more proximal
stenosis was treated by stricture
plasty. Two, who had recurrent
symptoms due to active disease,
were being managed medically. The
remaining patient had no gastroin
testinal symptoms but remained
unwell due to unrelated medical
problems.
Eleven of the 14 patients gained
a substantial amount of weight
postoperatively (range from 3.2 to
22.7 kg, mean 9.8 kg); the others
had no change in weight or minimal
weight loss. Serum albumin levels
and total lymphocyte counts did not
change greatly after surgery (Table
II).

Discussion
Lee and Papaioannou6 delayed
publication of their results of stric
tureplasty in cases of Crohn’s dis
ease because of doubts about its
safety and long-term benefits. In
fact, on a follow-up of 8 to 42
months, none of their patients suf
fered a leak or other major compli
cation, and only one had recurrent
obstructive symptoms. In a recent
review, Alexander-Williams and
Haynes1" updated their results in 52
patients with 148 strictureplasties.
They found an 11% rate of “painful
episodes” suggestive of a contained
leak and a 6% rate of enterocutaneous fistula, which is comparable to
that seen after bowel resection for
Crohn's disease. In addition, 23% of
their patients required further sur
gery, usually for strictures develop
ing elsewhere in the alimentary

i

STRICTUREPLASTY

tract. Fazio and Galandiuk9 de
scribed three patients with exten
sive small-bowel Crohn’s disease
who underwent 12 strictureplasties.
There were no postoperative leaks
or symptom recurrences after 6
months’ follow-up. Whelan and col
leagues8 performed 15 strictureplas
ties on three patients. Two recov
ered without complications and re
mained well on follow-up. The third
had symptoms suggestive of a leak
which healed on conservative man
agement, but after 12 months this
patient needed reoperation for re
currence of an enterovesical fistula.
Kendal and associates11 reported
on nine patients who had 13 opera
tive procedures and 45 stricture
plasties. A high complication rate
was noted in those with diffuse
disease, including three who had
enterocutaneous fistulas and four
who required early reoperation (2 to
6 months postoperatively) for recur
rent obstructive symptoms.
Our experience is further evi
dence of the safety and utility of
strictureplasty. Of 16 operations,
only 1 was associated with a suture
line leak which responded to con
servative measures. At last follow
up, 10 of our patients were free of
symptoms. Two of four with recur
rent symptoms had improved on a
medical regimen and two had un

dergone reoperation at 3 and 8
months respectively. These latter
two continued to fare poorly, due to
diffuse small-bowel and gas
troduodenal Crohn’s disease in one
and to Crohn’s colitis in the other.
An additional benefit has been
the ability to maintain patient com
fort without using steroids. Only
one of nine patients who required
prednisone preoperatively needed it
postoperatively. Maintenance drugs
included Pentasa in five patients
and a course of azathioprine in
three patients with ongoing disease.
We used a Foley catheter to
identify stenotic areas not appreci
ated by external palpation. As in
one of our patients, the ileocecal
valve may be the site of an isolated
narrowing, so the entire small
T a b le 1. M a in te n a n c e D rug T h e ra p y
No. of p a tie n ts
Drug
P re d n iso n e
S a la z o p y rin e
P entasa
M e tro n id a z o le
A za th io p rin e

P reo p

Postop

9
2
3
9
0

1
0
5
1
3

bowel should be carefully evaluated.
In our opinion a number of thera
peutic maneuvers could have con
tributed to the effectiveness of stric
tureplasty in this series.
• An adequate trial of medical
therapy preoperatively may decrease
the number of strictureplasties per
formed because of resolution of
stenoses caused by inflammatory
edema.
• Many of these patients, initial
ly hospitalized with marked weight
loss and nutritional depletion, bene
fit from the use of total parenteral
nutrition or an elemental diet, as in
eight of our patients, for 10 to 14
days before surgery and thus may
have fewer complications.
• The use of a calibrating tech
nique is important for diagnosing
distal obstructing lesions which
might endanger healing of a stric
tureplasty or anastomotic suture
lines.
• It has been our practice to
resect extensively diseased seg
ments of bowel in addition to per
forming strictureplasty. An optimal
surgical procedure requires salvage

T a b le II. S e ru m A lb u m in L e v e ls and T o ta l L y m p h o c y te C o u n ts B e fo re a n d A fte r O p e ra tio n
(± SEM )
M e a s u re m e n t
S e ru m a lb u m in , g / L
T o ta l ly m p h o c y te s , x 1 0 9/ L

Preop

Postop

3 7 .8 ± 5 .8
1 .1 3 4 ± 0 . 4 9 3

4 4 .3 ± 4 .9
1 .1 0 6 ± 0 . 4 5 4

FIG. 2. Longer strictures are opened longitudinally and folded into two limbs. Back wall is closed with interrupted sutures (B),
followed by closure of anterior wall.
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of as much bowel as possible while
removing areas not amenable to
strictureplasty but which may com
promise the safety and outcome of
the procedure.
Symptomatic recurrence occurred
in four (28%) of our patients and
appeared to be due to progression
of disease in three. Based on the
experience of others,1011 a high
recurrence rate can be expected in
patients with extensive disease, and
it remains to be seen how many of
our patients will require repeated
operative procedures, including
strictureplasty, during long-term
follow-up.
Strictureplasty in our experience
has proven to be a safe method of
relieving obstructive symptoms in
patients with widespread small-bow
el Crohn’s disease. Major improve
ment in symptoms associated with

reversal of weight loss is the usual
result. An acceptable early rate of
symptomatic recurrence, usually
due to progression of disease, has
been seen associated with a 14%
reoperation rate.
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Identification and Importance of
Lymphocyte Subpopulations in the
Regional Lymph Nodes of Breast Cancer
Patients
N. Khuri, MD, FRCSC;* S.P. Jothy, MD, PhD, FRCPC;t H.R. Shibata, MD, MSc, FACS, FRCSC*
To determine whether the presence of metastatic cancer cells in lymph nodes is
accompanied by changes in lymphocyte subpopulations identified in tissue sections,
the authors studied metastatic and nonmetastatic lymph nodes from eight patients
with breast cancer and lymph nodes of three control patients. In all metastatic lymph
nodes, T cells were seen in close contact with infiltrating cancer cells; B cells tended
to accumulate focally, apart from cancer cell nests. In both metastatic and
nonmetastatic lymph nodes from breast cancer patients, the fractional areas occupied
by the T4 (helper) and T8 (suppressor/cytotoxic) lymphocytes were comparable. The
B-cell fractional area was significantly (p < 0.01) greater in nonmetastatic than in
metastatic nodes. The fractional area occupied by the T8 lymphocytes in the breast
cancer patients was significantly (p < 0.01) greater than in the normal lymph nodes,
but no difference was noted in the fractional area occupied by the T4 cells. These
findings indicate that all lymph nodes in breast cancer patients are characteristically
increased in suppressor/cytotoxic lymphocytes, and the presence of metastatic
cancer cells in the nodes is manifested by a depletion of B lymphocytes.

Les auteurs ont etudie des ganglions metastasies et non metastasies provenant de
huit patientes souffrant de cancer du sein, ainsi que les ganglions de trois patientes
temoins, afin de determiner si la presence de cellules cancereuses metastatiques dans
les ganglions s’accompagne de modifications des sous-populations lymphocytaires
identifies dans les coupes histologiques. Dans tous les ganglions metastasies, des
lymphocytes T ont ete vus en contact etroit avec les cellules tumorales infiltrantes;
les lymphocytes B avaient tendance a s’accumuler en foyers, a l’ecart des nids de
cellules cancereuses. Dans les ganglions metastasies et non metastasies, les surfaces
occupees par les lymphocytes T4 (helper) et T8 (suppresseurs/cytotoxiques) etaient
comparables. La surface des lymphocytes B etait significativement plus importante
(p < 0.01) dans les ganglions non metastasies que dans les ganglions metastasies.
Chez les patientes cancereuses, la surface occupee par les lymphocytes Tg etait
significativement plus grande (p < 0.01) que dans les ganglions normaux, mais
aucune difference significative n’a ete observee en ce qui a trait a la surface prise par
les lymphocytes T4. Ces resultats indiquent qu’il y a une augmentation caracteristique des lymphocytes suppresseurs/cytotoxiques dans tous les ganglions des
patientes atteintes de cancer du sein et que la presence de cellules tumorales
metastatiques dans les ganglions se manifeste par une depletion des lymphocytes B.
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here is circumstantial evidence
of a relationship between immunocompetence and the prognosis
of malignant disease .1-2 The discov
ery of monoclonal antibodies, which
are useful in identifying different
subsets of lymphocytes,3-4 has made
it possible to investigate some of
the complex aspects of the immune
mechanism as it relates to locoregional immunity.
One of the early clinical applica
tions of monoclonal antibodies was
determining lymphocyte subsets in
normal human lymphoid tissues ,5
and subsequent studies6 shed light
on the nature of lymphocytes in
solid tumour tissue. The pattern
and subtypes of these infiltrating
cells at the host-tumour interface
and the types of lymphocytes pres
ent in malignant and benign tissues
were identified.
No one has yet accurately identi
fied the lymphocytes in regional
lymph nodes or the difference, if
any, in the amount of T-cell subsets
in metastatic and nonmetastatic
lymph nodes and estimated their
relative distribution. In this study
we attempt to identify the distribu
tion of T and B cells in lymph nodes
of patients with breast cancer,
using the indirect immunoperoxidase technique with specific antihu
man T- and B-cell monoclonal anti
bodies. We also try to determine if
there is a difference in the T-cell
subsets in metastatic and nonmeta
static lymph nodes.

T
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number of lymph nodes with or
without metastases was determined
by routine histopathologic methods.

Patients and Methods
Eight patients operated on for
stage I or II breast cancer at the
Royal Victoria Hospital, Montreal,
between 1984 and 1985, served as
the study population. Six lymph
nodes from three patients who un
derwent surgery for non-neoplastic
or noninflammatory disease were
used as controls to quantitate the
surface area of different lymphocyte
subsets in normal lymphoid tissue.
For breast cancer patients, the

Tissue

Tissue blocks of 12 lymph nodes
from eight breast cancer patients
were studied as follows. After exci
sion, the lymph nodes were serially
sectioned and fixed in formalin for
histopathologic assessment. Adja
cent sections were snap-frozen in

liquid nitrogen and stored at
-8 0 °C until immunostaining of
the lymphocyte subpopulations was
done. Thick cryostat sections (5 /um
thick) were prepared and air dried
for 1 hour.
The functional characteristics of
the lymphocyte subpopulations de
fined by monoclonal antibodies is
listed in Table I (OKT from Ortho
Diagnostic Systems Inc., Raritan,
NJ; Bj from Coulter Electronics
Inc., Hialeah, Fla.)
Immunoperoxidase Staining

T a b le

1. Functional Characteristics of Lymphocyte Subsets as Defined by Monoclonal Antibodies

L y m p h o c y te s u b s e t

C D C la s s if ic a tio n *

S p e c ific ity

CD 2
CD 8
CD 4
CD 20

Pan T lymphocytes
Suppressor/cytotoxic T lymphocytes
Helper/inducer T lymphocytes
B lymphocytes

Antibody OKT,,
o kt8
o kt4

B,

*lnternational classification of clusters of differentiation (CD).
T a b le II.

Fractional Areas Occupied by Lymphocyte Subsets in Normal Lymph Nodes*
L y m p h o c y te s u b s e ts

n o.

T„

t

1

33(1)
22 ± 1.4 (2)
23 ± 2.8 (2)

11.4(1)
11.8 (1)
11.6(1)

25(1)
23.5 ± 0.7 (2)
19.5 ± 4 .9 (2)

17.5 (2)
14(2)
17.7(2)

26 ± 6.0

11.6 ± 8.4

22.6 ± 2.8

16.3

2
3
Mean

8

B,

T,

’ Numbers represent % fractional areas, expressed as ± 1 standard deviation, occupied by
lymphocyte subsets in total area of microscope fields. Numbers in parentheses refer to number of
lymph nodes examined.

T a b le I II .
C ancer
no.

N o. of nodes
r e s e c te d

1

2

2

11

3

10

4

18

5

17

6

4

7

19

8

10

1

Lymphocyte Subsets in Lymph Nodes of Breast Cancer Patients
No. of nodes
e x a m in e d

L y m p h o c y te s u b s e ts *
T„

T,

\

V rB

B,

1+
1 1+
3 0+
1 0+
1 0+

ND
ND
28
29.3

28
24
32
39.5

24
30.2
28
24.8

1.16
0.8
1.14
1.46

5.5
15.6
ND
19.4

ND

43

30

1.43

ND

ND

37

26

1.42

ND

-

1 -

ND

27

21

1.29

24

+

0+
1 0+
1 1+
0 -

ND

50

48

1.25

ND

ND
ND

54
ND

32
ND

1.69
ND

ND
4.2

1 +
1
10
1
9
0
18
0
17
0
4
0
19
1
9

Six sections (5 Aim thick) were
cut from each lymph node. Four
sections served for identification of
lymphocyte subsets, one as a nega
tive control and one for routine
staining with hematoxylin and eosin. The negative control section
included omission of the first layer
of monoclonal antibodies which was
replaced by normal mouse serum.
The staining procedure was per
formed at room temperature, as
previously described.7 Briefly, the
sections are handled as follows:
placed in pH 7.4, 0.01M TRIS
(tromethamine) buffer for 10 min
utes; incubated with saturating con
centrations of monoclonal antibod-

—

+
—
+
-

+
-

+

-

+
+
-

*% of fractional areas occupied by different lymphocyte subsets in metastatic and nonmetastatic lymph nodes. + = metastatic, - = nonmetastatic,
ND = not determined.
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ies at 37°C for 1 hour; washed in
TRIS buffer; incubated with peroxi
dase-conjugated rabbit antimouse
immunoglobulin (Dakopatts, A/S,
Glostrup, Denmark) for 20 minutes;
washed in TRIS buffer; incubated
with peroxidase-conjugated swine
antirabbit immunoglobulin (Dako
patts) for 20 minutes; rinsed with
TRIS buffer; the peroxidase reac
tion product developed with the
dimethylaminobenzidine chromo
gen, washed with tap water; count
er stained with hematoxylin;
washed, dehydrated and mounted.
For each lymph node, photomi
crographs of immunostained sec
tions representing different lympho
cyte subsets were analysed by quan
titative morphometry, using a mi
crocomputer and the Bioquant pro
gram (R and M Biometrics Inc.,
Nashville, Tenn.). The surface area
of one lymphocyte subset in each
section was calculated and related
to the surface area of the total
microscopic field. The lymphocytes
corresponding to the various sub
sets were found to be clustered in
discrete areas within the lymph
nodes, as previously documented by
studies of normal lymph nodes.8
The fractional area of each subset

was calculated as the ratio of its
surface area relative to the total
microscopic field. The mean frac
tional area of different lymphocyte
subsets was calculated as the mean
of at least six photomicrographs.
The calculated mean for all patients
in a given group was analysed using
Student’s f-test for unpaired data.

Results
Individual values of the nodes in
the control patients are shown in
Table II and results on the 12
lymph nodes from the eight cancer
patients in Table III. The mean
value for each lymphocyte subset in
control, nonmetastatic and meta
static lymph nodes is presented in
Table IV. Fractional areas occupied
by lymphocyte subsets in nonmeta
static lymph nodes from stage I and
stage II patients are summarized in
Table V.
When the different lymphocyte
subsets in nonmetastatic lymph
nodes of breast cancer patients were
quantitated and compared with
those of lymph nodes from normal
controls, the proportion of T4 cells
and B cells in the nodes of cancer

Table IV. Fractional Areas Occupied by Lymphocyte Subsets*
Lymphocyte subsets
Origin of node

T„
26
29.3
28.0

t8
1 1 .6

30.1t
2 6 .0 t

t4
22.6
40.8
30.0

B,
16
19.6
•H *
CO

Control
Nonmetastatic
Metastatic

‘ Numbers represent % area occupied by lymphocyte subsets in total area of microscope fields.
tStatistically significant (p < 0.01) compared with control nodes,
fStatistically significant (p < 0.01) compared with nonmetastatic and control nodes.

t

\
i

Table V. Fractional Areas of Lymphocyte Subsets T4and T8in Nonmetastatic Lymph Nodes in
Stage I and Stage II Patients
Lymphocyte subsets
Stage
I
_ ll ______

T4

T,

42.2(5)
31.4(5)
___________________ 31.75 (2)__________________ 27.5 (2)___________

Numbers represent % fractional areas occupied by lymphocyte subsets in total area of
microscopic field. Numbers in parentheses refer to number of patients.

patients was found to be slightly,
but not significantly, larger. How
ever, the mean of T8 lymphocytes
was 2.6-fold greater (p < 0.01) in
nonmetastatic nodes from breast
cancer patients than in the controls.
When the proportion of different
lymphocyte subsets in both non
metastatic and metastatic lymph
nodes was compared, there was no
significant difference in the mean
areas of T8 and T4 cells. However,
there were four times fewer B cells
in the metastatic than the nonmeta
static lymph nodes.
When the different lymphocyte
subsets in metastatic nodes were
compared with the control nodes,
the mean areas occupied by T4 cells
were not significantly different.
However, there was a marked deple
tion of B lymphocytes in the meta
static nodes and the proportion of
T8 cells was significantly (p < 0.01)
greater.
Comparison of different lympho
cyte subsets in nonmetastatic lymph
nodes from stage I and stage II
patients showed no significant dif
ference in the mean areas of T8 and
T4 cells.
This study also revealed that the
majority of lymphocytes infiltrating
cancer tissue were T cells, which
were often seen in intimate contact
with infiltrating cancer cells; how
ever, there was no predominant
pattern of the type of T-cell lym
phocyte subpopulation infiltrating
these cancers. Apart from cancer
cell nests, B cells tended to accumu
late focally.

Discussion
The importance of T and B cell
infiltrates in primary malignant tu
mour tissue has been examined in
both clinical and experimental mod
els. A discrepancy in the density of
T and B cell infiltrates in cancerous
and noncancerous breast tissue has
VOL. 32. NO. 1. JANUARY 1989
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been noted. Shimokawara and col
leagues9 reported that B cells were
predominant and T cells scanty in
noncancerous breast lesions, while
T cells predominated in cancerous
breast tissue. They also showed a
significant inverse correlation be
tween the intensity of the T-cell
infiltrate and the clinical stage. The
infiltrates were dense in breast can
cer without lymph-node metastases
but were scanty in advanced clinical
stages, suggesting that the infiltrat
ing T cells in cancerous tissue rep
resent host resistance. Berg10 also
reported fewer metastases and a
higher cure rate in breast cancer
with dense lymphocytic infiltrates.
Black and colleagues11 suggested
that patient survival is superior in
breast cancer with marked lympho
cytic infiltration. In contrast,
Schoorl and colleagues, 12 reporting
on T and B cells in human breast
cancer, indicated that T cells pre
dominated in benign breast tissue.
Giorno6 examined the microanatomic distribution of different lympho
cyte subsets in benign and malig
nant human breast tissue and found
that in malignant tissue most of the
T cells were of the T8 subset,
organized in single cells in the
tumour stroma or invading tumour
nests, while T4 cells predominated
in the lymphoid aggregates associ
ated with benign tissue. Rowe and
Beverley13 reported that T lympho
cytes existed in similar proportion
in benign and malignant breast tis
sue.
Our study demonstrated that the
lymph nodes of breast cancer pa
tients displayed marked changes in
their B and suppressor/cytotoxic T
cells. B-cell depletion was associat
ed with the presence of metastasis
in the lymph nodes. The increase in
suppressor/cytotoxic T cells was
associated with concomitant breast
cancer whether or not it had metas
tasized to the lymph nodes. No
marked difference was seen in
26
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nodes from stage I and stage II
patients, but the number in each
group did not allow a reliable statis
tical evaluation of possible changes
in lymphocyte subset populations.
The study also showed that the
amount of T lymphocytes and their
different subsets were present in
similar proportions in metastatic
and nonmetastatic lymph nodes of
breast cancer. However, B cells
were denser in nonmetastatic than
metastatic lymph nodes, suggesting
that an effector humoral response
might be depleted when metastasis
occurs. We also found that meta
static and nonmetastatic lymph
nodes of breast cancer patients con
tained more T8 (suppressor/cytotoxic) lymphocytes than did
normal lymph nodes from control
patients. It remains to be estab
lished whether the generation of
these suppressor/cytotoxic lym
phocytes is directly involved in the
host’s immune surveillance against
breast cancer.
It would appear that breast can
cer cells metastasizing to regional
lymph nodes cause an increase in
the number of T-cell subsets as well
as B cells.
In conclusion, breast cancer is
accompanied by marked changes in
lymphocyte subpopulations of asso
ciated axillary lymph nodes. Most
remarkably, the recruitment of sup
pressor/cytotoxic cells, even before
metastasis occurs, is consistent
with the notion that breast cancer
mounts an early cellular immune
response as a result of unidentified
factors associated with tumour
growth.
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Clinical Significance and Measurement of
the Length of the Right Main Bronchus
C.L.N. Robinson, MD, FRCS, FRCSC;* Nestor L. Muller, MD, FRCPC;f Cameron Essery, MD, FRCSC*
It is important for surgeons, pathologists, anesthetists and anatomists to know the
length of the right main bronchus. It extends from the carina of the trachea to the
origin of the right upper lobe bronchus, but an exact method for measuring it has
never been described.
Using bronchography, the authors measured the length of the right main
bronchus in 24 patients. The posteroanterior projection taken at a standard distance
(1.8 m) from the patient was used to minimize distortion due to the technique; if
present, the distortion would not be more than 5% and would be an increase rather
than a decrease in length.
The mean length of the right main bronchus was found to be 1.09 cm (range from
0 to 2.9 cm).
The clinical importance of this measurement is discussed. The authors conclude
that many anatomy textbooks err in describing the length of the right main
bronchus as 2.0 to 5.0 cm, but are correct in describing the left main bronchus as
being about 5 cm long.

II est important que les chirurgiens, pathologistes et anesthesistes connaissent bien
la longueur du tronc bronchique droit. II s’etend de l’eperon tracheal jusqu’a
l’origine de la bronche lobaire superieure droite. Toutefois, on n’a jamais decrit de
methode exacte de le mesurer.
A l’aide de la bronchographie, les auteurs ont mesure la longueur du tronc
bronchique droit de 24 patients. La projection postero-anterieure prise a distance
standard (1.8 m) du patient fut utilisee dans le but de minimiser la distorsion due a
la technique. Si elle etait presente, cette distorsion ne pourrait pas depasser 5%, et
elle aurait tendance a surevaluer la longueur plutot qu’a la minimiser.
La longueur moyenne mesuree du tronc bronchique droit a ete de 1.09 cm (avec
un ecart de 0 a 2.9 cm).
On commente l’importance clinique de cette mesure. Les auteurs concluent que
plusieurs ouvrages d’anatomie sont dans l’erreur quand ils decrivent la longueur du
tronc bronchique droit comme pouvant varier de 2.0 a 5.0 cm, mais qu’ils sont
exacts quand ils donnent environ 5 cm comme longueur du tronc bronchique
gauche.

he right main bronchus —
from the carina of the trachea
to the origin of the right upper lobe

T

bronchus — is easily seen during
bronchoscopy and at surgery, but is
often inaccurately described.
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The length of the right main
bronchus is of great importance to
pathologists, surgeons and anesthe
tists during resection of the right
lung or the upper lobe, or the upper
lobe with the “ sleeve” of the right
main bronchus, for example. There
is minimal clearance proximally
so it is of practical importance
to know the length of the main
bronchus.
The established rule for resection
of bowel cancer is to take at least 5
cm of macroscopically healthy
bowel on either side of the malig
nant lesion. The necessary clear
ance with respect to the lung or a
lobe is usually given as 1.5 to 2.0
cm.
For endobronchial anesthesia, a
double-lumen tube or an endobron
chial balloon on the right side
might cause encroachment on the
right upper lobe bronchus.
The surgical pathologist must
carefully examine the proximal re
section lines of right-sided bron
chial specimens, even more so than
those from other areas.
The purpose of this study was to
re-examine the tracheobronchial
tree in order to identify accurately
the take-off point of the right upper
lobe bronchus.

Methods and Results
The literature does not describe a
standard technique for consistently
and accurately measuring distances
in the tracheobronchial tree. In this
study, to determine the length of
the right main bronchus, the carina
VOL. 32. NO. 1. J A N U A R Y 1989
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FIG. 1. Method of measuring right
main bronchus (vertical distance from
carina to origin of right upper lobe
bronchus), which was done from lifesize bronchograms (adapted from cast
of bronchial tree by R.C. [Lord] Brock
depicted in Gray’s Anatom y1).

was identified and the vertical dis
tance between it and the upper
border of the right upper lobe bron
chus measured (Fig. 1).
Such measurements were made
from the bronchograms of 24 pa
tients, in whom “good filling” was
obtained. Bronchography was done
in the posteroanterior projection at
a standard distance (1.8 m) from
the patient to minimize distortion
which, if present, was not more
than 5% and was an increase rather
than a decrease in length (Fig. 2).
The results are tabulated in Table
I. The take-off point ranged from 0
to 2.9 cm below the carina (mean
1.09 cm, median 1.10 cm).

Discussion

FIG. 2. Anteroposterior bronchogram.
T a b l e 1. D is ta n c e o f t h e R ig h t U p p e r L o b e
B r o n c h u s f r o m C a rin a in 2 4 P a tie n ts

D is ta n c e , c m
0

N o . o f p a t ie n t s

-0 .5

6

0 .6 -1 .0

6

1 .1 - 1 . 5

7

1 .6 -2 .0

3

2 .1 - 2 . 5

1

2 .6 -3 .0

1

Many anatomy books, including
Gray’s and Cunningham’s1-3 de
scribe the right main bronchus and
give its length as about 2.5 cm
(Table II1-10). Grant’s Method of
Anatomy* states that the right
upper lobe bronchus arises 2 to 5
cm from the tracheal bifurcation.
However, Boyden,8 in an excellent
work on the segmental anatomy of
the lung, states that the right upper
lobe bronchus arises almost at the
bifurcation of the trachea, that is,
opposite the carina. He remarked:
“Unfortunately, it has not been pos
sible to provide bronchograms, but
this has been partially compensated
for by lateral views of a pair of
lungs that have been injected with
vinyl acetate and then dissected.”

T a b l e II . L e n g th o f R ig h t M a in B r o n c h u s R e p o r te d b y V a r io u s A u th o r s
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In another text9 the main bron
chus appeared to have been taken
from the measurement of one cast
only of an injected bronchial tree.
The relationship between the
right upper lobe bronchus and the
carina can be assessed in a variety
of ways — during surgery or endos
copy, by radiologic or imaging tech
niques, in the cadaver by direct
inspection or from a cast of the
bronchial tree. No one method is
ideal, but bronchography gives
quite accurate reproductions, is eas
ily performed and avoids the distor
tion of postmortem changes. More
over, the bronchogram gives almost
life-size definition. Using this meth
od, we found the mean length of
the right main bronchus in our 24
patients to be 1.09 cm, somewhat
shorter than the length noted in
most textbooks.
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A cute Scrotal Pain in Children:
Prospective Study of Diagnosis and
Management
P.A.M. Anderson, MD;* J.M. Giacomantonio, MD, FRCSC;* R.D. Schwarz, MD, FRCSCf

Forty-eight boys were assessed for an acutely painful scrotum. Thirty-six (75%) of
them underwent radionuclide scanning of the scrotum; the average age of this group
was 11 years. The scan revealed epididymitis in 19 cases, spermatic cord torsion in
9, appendix testis torsion in 7 and acute hernia-hydrocele in 1. The diagnosis was
confirmed at operation in all nine cases of spermatic cord torsion. Boys who had
epididymitis received antibiotics only; all were available for short-term follow-up,
and 16 were also assessed at a mean of 6 months after infection. Only one boy had
testicular atrophy; he had undergone repair of an inguinal hernia, which could not
be ruled out as a cause. Bacteriuric epididymitis occurred in three boys; two had
known predisposing genitourinary anomalies, the third had no abnormalities. Boys
who had nonbacteriuric epididymitis were investigated by renal and pelvic
ultrasonography or voiding cystourethrography; no important abnormalities were
detected. This prospective study indicates that radionuclide scanning can reliably
differentiate spermatic cord torsion from other acute scrotal disease.

Quarante-huit gar^ons souffrant d’une douleur aigue au scrotum ont fait l’objet de
cette evaluation. Trente-six (75%) d’entre-eux ont subi une scintigraphie isotopique
du scrotum; l’age moyen chez ce groupe etait de 11 ans. La scintigraphie a revele
une epididymite dans 19 cas, une torsion du cordon spermatique dans 9, une torsion
de l’appendice testiculaire dans 7 et une hernie hydrocele aigue dans 1. Le
diagnostique ete confirme lors de l’operation dans les neuf cas de la torsion du
cordon spermatique. Les garfons souffrant d’epididymite ont re?u des antibiotiques
seulement; tous ont pu etre revu a court terme pour des examens de controle et 16
ont aussi ete evalue 6 mois, en moyenne, apres l’infection. Un seule gargon a
presente une atrophie testiculaire. II avait subi la reparation d’une hernie inguinale,
intervention qui ne peut pas etre mise hors de cause. Trois gar?ons ont eu une
epididymite avec bacteriurie; deux avaient des anomalies genito-urinaires predisposantes connues, alors que le troisieme en etait exempt. Les gargons ayant eu une
epididymite sans bacteriurie ont fait l’objet d’examens par echographie renale et
pelvienne ou par cysto-uretrographie permictionnelle; aucune anomalie importante
ne fut decelee. Cette etude prospective montre que la scintigraphie isotopique peut
differencier avec certitude les torsions du cordon spermatique des autres lesions
aigues du scrotum.
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n acutely painful scrotum in a
child is of concern to parents
and physicians, not only because of
the discomfort it causes, but also
because of possible impairment of
fertility. Numerous studies 1" 4 have
shown that in torsion of the sper
matic cord the time between onset
of symptoms and surgical correc
tion is inversely related to the sub
sequent viability of the testicle.
Since the problem was traditionally
believed to account for most cases
of acutely painful scrotum in chil
dren, immediate surgical explora
tion was advocated .2-4-6 However,
recent studies , 1 J -8 including one
carried out at our institution , 7 have
indicated that nonsurgical condi
tions such as acute epididymitis are
much more common in boys than
was previously thought. Moreover,
new imaging techniques provide a
more accurate diagnosis so that, in
many cases, surgery can be avoid
ed .9 With the advent of radionuclide
scanning of the scrotum, we decid
ed to institute a prospective study
to determine the reliability of this
investigation in diagnosing acute
scrotal conditions in boys.
Because epididymitis in boys is
considered bacterial in origin and
secondary to underlying genitouri
nary anomalies, standard manage
ment has been antibiotic therapy
followed by appropriate investiga
tions for conditions that result in
obstruction of the lower urinary
tract or involve abnormal connec-
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tions between the reproductive and
urinary tracts. However, several
studies1011 have indicated that most
episodes of epididymitis occur in
boys with normal genitourinary
tracts and are not associated with
bacteriuria. In this study we at
tempted to answer three questions.
• Is radionuclide scanning a reli
able means of differentiating epi
didymitis from spermatic cord tor
sion?
• What is the frequency of bacteriuric epididymitis in boys?
• What is the incidence of un
derlying genitourinary anomalies in
boys with epididymitis?

Patients and Methods
All 48 boys less than 16 years old
who presented to the emergency
department of the Izaak Walton
Killam Hospital for Children in Hali
fax between September 1985 and
September 1987, suffering from an
acutely painful scrotum were en
tered into the study. Those suffer
ing trauma to the genitalia were
excluded, as were neonates, who
were cared for at another institu
tion. In addition to a routine analy
sis, the urine specimen was subject
ed to culture and sensitivity exami
nation. Whenever the clinical diag
nosis was in doubt, radionuclide
scanning of the scrotum was per
formed. We intended to operate
without the delay of scanning if
testicular torsion was the most like
ly diagnosis. However, in practice,
there was no case in which scan
ning did delay surgery; therefore,
all boys who had an equivocal diag
nosis underwent radionuclide scan
ning.
The scanning procedure usually
took less than 15 minutes. A bolus
of technetium-99m pertechnetate
was injected intravenously, then se
rial images of the scrotum were
obtained.12 Patients with a diagno30
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sis of epididymitis were not treated
surgically but were given a course
of antibiotics effective against most
enteric pathogens. Repeat physical
examinations were carried out sev
eral days after presentation and
following convalescence, at which
time the boys were investigated for
underlying genitourinary anomalies.

Results
Epididymitis
Epididymitis was diagnosed in 19
boys (Table I), who ranged in age
from 4 months to 15 years (mean
10.7 years). All underwent radionu
clide scanning (Fig. 1). They were
not explored surgically but were
given a course of antibiotics effec
tive against most enteric pathogens.
Because they did not have surgical
confirmation of the diagnosis, they
were followed up closely by clinical
examination within 2 weeks of the
onset of their symptoms. If a diag
nosis of torsion was missed, the
child would be expected to have
severe pain over several days, unre
sponsive to antibiotic therapy, and
subsequently testicular atrophy
would develop. However, at 2-week
follow-up all the children in this
group were convalescing without
problems. Three boys were then
lost to follow-up.
The remaining 16 boys under
went another clinical examination
at a mean of 6 months after the
acute episode (range from 1 to 20
months). Testicular size and sym

metry were judged to be normal for
age in all but one boy in whom the
testis on the side previously in
volved by epididymitis was half the
size of the contralateral testis. He
had had an inguinal hernia repaired
2 years before and no postoperative
record was available to indicate if
the atrophy was secondary to his
surgery.
Urinalysis was performed for 16
boys in this group. In 13 the find
ings were normal. The other three
had pyuria; Staphylococcus pyo
genes was cultured from one speci
men, that of a 9-year-old boy who
had undergone repair for hypos
padias and was known to have a
penile urethral fistula; Pseudomo
nas aeruginosa was cultured from
another specimen, that of an
11-year-old boy whose history in
cluded numerous urinary tract in
fections secondary to imperforate
anus, sacral agenesis and a neuro
genic bladder; the third culture was
sterile. Culture of the urine from
one boy whose urinalysis was nor
mal grew Escherichia coli. Voiding
cystourethrography and renal ul
trasonography in this 4-month-old
child did not reveal any anomalies.
All other cultures were sterile. Two
15-year-old boys gave a history of
sexual activity, but urine cultures
showed no growth of Chlamydia.
Two boys who had normal urina
lyses and negative cultures received
no antibiotics; both recovered
promptly. The others received 7-day
courses of appropriate antibiotics,
most commonly co-trimoxazole
orally, followed by amoxicillin and

Table 1. Diagnosis and Radionuclide Scan in 48 Boys
Diagnosis

Total no. (% )

Scan

Acute epididymitis
Torsion spermatic cord
Torsion appendages
Hernia/hydrocele
Idiopathic scrotal edema
Tumour

19 (40)
11 (23)
13 (27)
3 (6)
1 (2)
1 (2)

19
9
7
1
0
0

Totals, no. (%)

48 (100)

36 (75)

No scan

0
2
6
2
1
1
12 (25)

SCROTAL PAIN IN CHILDREN

tetracycline in dosages appropriate
for size and age. Two boys who had
fevers were treated parenterally
with gentamicin.
Nine of the 13 boys with negative
urine cultures were investigated to
rule out predisposing factors for
epididymitis. Radiologic investiga
tions were omitted in four boys (in
two at the parents’ request and in
the two who had possible sexual
exposure). Voiding cystourethrog
raphy and renal ultrasonography
were carried out in five cases, pelvic
and renal ultrasonography in three
and voiding cystourethrography
and intravenous urography in one.
None of these studies indicated any
abnormalities.

2) and all underwent surgery to
confirm the diagnosis. Four boys
who delayed seeking medical atten
tion for more than 24 hours had
infarcted testes which were re
moved. In no instance did scanning
delay operation or lead to misdiag
nosis.

Eight boys in this group under
went excision of the infarcted ap
pendage to relieve the pain, the
other four were managed conserva
tively.

Torsion o f the Appendix Testis

Previous studies have indicated
that spermatic cord torsion is the
most common cause of an acutely
painful scrotum in boys.245 Howev
er, other reviews18 have noted the
increasing frequency of nonsurgical
conditions, especially epididymitis.
Only 23% of boys in this study had
spermatic cord torsion compared
with 40% who had epididymitis and
27% who had torsion of the appen
dix testis. The age distribution was
of little diagnostic value. Other
studies47 have also noted this fact
and the considerable overlap of clin
ical findings in these conditions.
Since spermatic cord torsion is
often difficult to rule out clinically,
many authors24-6 have advocated
immediate surgical exploration.
However, since epididymitis is no
longer considered a rare cause of
acute scrotal pain, this policy may
lead to unnecessary operation. The
development of radionuclide scrotal
scanning, therefore, has been a
major advance in the diagnosis of
these often clinically confusing con
ditions.
Because none of the boys with
epididymitis in this study was surgi
cally explored, follow-up examina
tion was essential to rule out the
possibility of spermatic cord torsion
being misdiagnosed as epididymitis.
We reviewed all patients with epi
didymitis within 2 weeks of their
acute episodes and none had find
ings suggestive of a missed torsion.
At repeat examination, a mean of 6
months later, all but one boy had a
palpably normal testis. The technetium-99m pertechnetate scrotal
scan is a sensitive and selective

In 11 boys a diagnosis of sper
matic cord torsion was made. These
boys ranged in age from 7 to 16
years (mean 12.5 years). Nine un
derwent radionuclide scanning (Fig.

Appendix testis torsion was diag
nosed in 13 boys, who ranged in
age from 3 to 14 years (mean 10.1
years). Seven underwent radionu
clide scanning. In one of these the
scan was equivocal; spermatic cord
torsion could not be ruled out until
operation was performed. In the
other cases, the radiologist could
confidently rule out spermatic cord
torsion but could not always make
the diagnosis of appendix testis
torsion. However, clinical examina
tion (the “blue dot sign” or point
tenderness at the appendix) was
usually diagnostic.

FIG. 1. Technetium-99m pertechnetate
scrotal scan from 15-year-old boy with
24-hour history of right scrotal pain
and swelling. There was recent sexual
exposure. Urinalysis was normal and
subsequent routine culture and culture
for Chlamydia were negative. Scan
shows increased activity of right hemiscrotum and along cord, in keeping
with epididymitis. Three days after
initiating course of tetracycline, swell
ing and pain had markedly decreased.

FIG. 2. Technetium-99m pertechnetate
scrotal scan from 15-year-old boy with
24-hour history of left scrotal pain and
swelling. Urinalysis was normal. Scan
shows ring of increased activity sur
rounding photopenic defect in middle
of left hemiscrotum. Diagnosis of sper
matic cord torsion was made and con
firmed at surgery. Testicle was not
viable and orchiectomy and contralat
eral orchiopexy were carried out.

Torsion o f the Spermatic Cord

Discussion
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diagnostic tool in evaluating the
acutely painful scrotum and at our
institution has obviated the need for
surgical exploration in many cases.
Other studies1-9 have reported simi
lar encouraging results, so it is
likely that this imaging technique
will become common in assessing
acute scrotal pain in children. How
ever, when the scan cannot be ob
tained without delaying patient
management or if the scan is equiv
ocal, emergency scrotal exploration
remains the diagnostic procedure of
choice.
We found that most boys with
epididymitis had normal urinalysis
and sterile urine. This “nonspecific
epididymitis” is reported1011 to be
the most common type in boys, and
our inability to identify any underly
ing genitourinary anomalies is in
agreement with these studies. It has
been postulated that these infec
tions are of viral origin or are sterile
inflammation secondary to reflux of
urine into the genital tract, but
neither theory has been proven. It is
important to note that boys with
epididymitis and sterile urine do not
have underlying anomalies and

therefore do not require extensive
genitourinary investigations. Al
though most of these boys are
treated with antibiotics, their recov
ery may be just as successful with
rest and analgesics, as in two of our
cases.
Conversely, of the three boys
with positive urine cultures, two
had known genitourinary abnormal
ities, so a positive urine culture
does appear to warrant a diligent
search for underlying anomalies.
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infection occurs, therapy should be discontinued and appropriate measures taken.
Although CLAFORAN rarely produces alterations in kidney function, evaluation
of renal status is recommended, especially in severely ill patients receiving high
doses.

In vitro studies indicate that the bacterial action of CLAFORAN (cefotaxime sodium)
a semi-synthetic cephalosporin antibiotic, results from inhibition of cell wall
synthesis.

Patients with markedly impaired renal function should be placed on the special
dosage schedule recommended under Dosage and Administration, because nor
mal dosage in these individuals is likely to produce excessive and prolonged serum
antibiotic concentrations.
Positive direct Coomb’s test is known to develop in individuals during treatment
with the cephalosporin group of antibiotics, including cefotaxime sodium.
In laboratory tests a false positive reaction to glucose may occur with reducing
substances but not with the use of specific glucose oxidase methods.

Prescribing
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Claforan
cefotaxime
sodium

Action

Indications and Clinical Uses
Treatm ent: CLAFORAN (cefotaxime sodium) may be indicated for the treatment
of infections caused by susceptible strains of the designated micro organisms
in the diseases listed below.
Lower respiratory tra ct in fe c tio n s: pneumonia and lung abscess caused by
Streptococcus pneumoniae (formerly Diplococcus pneumoniae), other streptococci
(excluding enterocci, e.g. S. faecalis), Straphylococcus aureus (penicillinase and
non-penicillinase producing), Escherichia coli, Hemophilus influenzae, (including
ampicillin resistant strains) and unspecified Klebsiella species.
U rinary tract in fe c tio n s : caused by Escherichia coli, unspecified Klebsiella
species (including K. pneumoniae), Proteus mirabilis, indole positive Proteus, Ser
b ia marcescens and Staphylococcus epidermidis. Also, uncomplicated gonor
rhea caused by N. gonorrhoeae including penicillin resistant strains.
B a c te re m ia /S e p tice m ia : caused by Escherichia coli, unspecified Klebsiella
strains and Serratia marcescens.
Skin in fe c tio n s: caused by Staphylococcus aureus (penicillinase and non
penicillinase producing, S. epidermidis, Group A streptococci, Escherichia coli,
Proteus mirabilis and indole positive Pmteus.
Intra-abdominal infections: caused by Escherichia coli, and unspecified Kleb
siella species.
Gynecological in fe c tio n s: including pelvic inflammatory disease, endometritis
and pelvic cellulitis caused by E. coli, Group A streptococci and Staphylococcus
epidermidis, anaerobic bacteria including unspecified Peptococcus and Peptostreptococcus strains and some strains of Bacteroides Iragilis. In several cases, although
clinical cures were achieved, bacteriological follow-up was not available.
Clinical experience with CLAFORAN in anaerobic infections is limited. CLAFORAN
has been used with some success in wound and intra-abdominal infections against
some strains of unidentified Bacteroides and anaerobic cocci.
CLAFORAN has been shown to be active against some strains of Pseudomonas.
In the treatment of infections encountered in immunosuppressed and granulo
cytopenic patients, results of therapy with CLAFORAN have not been impressive.
CLAFORAN should not be considered in the treatment of enterococcal infections,
i.e. Streptococcus faecalis.
Specimens for bacteriologic culture should be obtained prior to therapy in order
to isolate and identify the causative organisms and to determine their suscep
tibilities to CLAFORAN. Therapy may be instituted before results of susceptibility
studies are known; antibiotic treatment should be re evaluated once these results
become available.
Prophylactic U se : The administration of CLAFORAN perioperatively (preoperative
ly, intraoperatively and postoperatively) may reduce the incidence of certain infec
tions in patients undergoing elective surgical procedures (e.g. abdominal or vaginal
hysterectomy, gastrointestinal and genitourinary tract surgery) that may be classified
as contaminated or potentially contaminated.
In patients undergoing caesarian section who are considered to be at increased
risk of infection, intraoperative (after clamping the umbilical cord) and postoperative
use of CLAFORAN may also reduce the incidence of certain postoperative infections
Effective use for elective surgery depends on the time of administration (see Dosage
and Administration).
For patients undergoing gastrointestinal surgery, preoperative bowel preparation
by mechanical cleansing as vrell as with a non absorbable antibiotic (e.g. neomycin)
is recommended
If there are signs of infection, specimens for culture should be obtained for iden
tification of the causative organism so that appropriate therapy may be instituted.

Contraindications
CLAFORAN is contraindicated in patients who have shown hypersensitivity to
cefotaxime sodium, the cephalosporin or the penicillin groups of antibiotics.

Warnings
Before therapy with CLAFORAN is instituted, it must be carefully determined whether
the patient has had previous hypersensitivity reactions to cefotaxime,
cephalosporins, penicillins or other drugs. CLAFORAN should be given with caution
to patients with Type 1 hypersensitivity reactions to penicillin. Antibiotics, including
CLAFORAN should be administered with caution to any patient who has
demonstrated some form of allergy, particularly to drugs. If an allergic reaction
to CLAFORAN occurs, the drug should be discontinued and the patient treated
with the usual agents (e.g. epinephrine, antihistamine, pressor-amines or
corticosteroids).
Pseudomembranous colitis has been reported with the use of cephalosporins
(and other broad spectrum antibiotics); therefore, it is important to consider its
diagnosis in patients who develop diarrhea during the administration of CLAFORAN.
This colitis can range from mild to life-threatening in severity.
Treatment with broad spectrum antibiotics, such as CLAFORAN, alters the nor
mal flora of the colon and may permit overgrowth of Clostridium difficile or other
Clostridia. It has been established that a toxin produced by Clostridium difficile
is one primary cause of antibiotic-associated colitis.
Mild cases of colitis may respond to discontinuation of CLAFORAN and replace
ment with a suitable specific antibiotic. Moderate to severe cases should be manag
ed with fluid, electrolyte and protein supplementation as indicated. When the colitis
is not relieved by discontinuance of CLAFORAN administration or when it is severe,
an antibiotic specifically effective in antibiotic-associated pseudomembranous colitis
(e.g. vancomycin) or other suitable therapy may be indicated. Other possible causes
of colitis should also be considered (see Adverse Reactions).

Adverse Reactions
The most frequent adverse reactions with their frequency of occurrence are:
Hypersensitivity (1.8%): Rash, pruritus, fever. Local (5%): Injection site inflam
mation with intravenous administration. Pain, induration and tenderness after in
tramuscular injection. Gastrointestinal (1.7%): Colitis, diarrhea, nausea and
vomiting. Symptoms of pseudomembranous colitis can appear during or after
CLAFORAN treatment. H em ic and Lymphatic System (< 1 % ): Mild, reversi
ble leukopenia, granulocytopenia and thrombocytopenia have been reported. Some
patients developed positive direct Coomb’s test during treatment with CLAFORAN.
Genitourinary System ( < 1%): Moniliasis, vaginitis. Liver ( < 1%): Transient
elevations in SGOT, SGPT, serum LDH and serum alkaline phosphatase levels
have been reported. Kidney ( < 1%): Increased serum creatinine and BUN have
occasionally been observed. Central Nervous System (0.2%): Headache.

Symptoms and Treatment of Overdosage
Since no case of overdosage has been reported to date with CLAFORAN, no
specific information on symptoms or treatment is available. Treatment of over
dosage should be symptomatic.

Dosage and Administration
CLAFORAN (cefotaxime sodium) may be administered intramuscularly or in
travenously after reconstitution (see Table with recommended mode of reconstitution
according to route of administration).

large muscle such as the upper outer quadrant of the buttock (i.e. gluteus maximus); aspiration is necessary to avoid inadvertent injection into a blood vessel.
Intravenous: The intravenous route is preferable for patients with bacteremia,
bacterial septicemia, or other severe or life-threatening infections, or for patients
who may be poor risks because of lowered resistance resulting from such
debilitating conditions as malnutrition, trauma, surgery, diabetes, heart failure,
or malignancy, particularly if shock is present or impending.
For bolus administration a solution containing 1 or 2 g of CLAFORAN can be
injected over a period of 3 to 5 minutes. Using an infusion system, it may also
be given over a longer period of time through the tubing system by which the
patient may be receiving other intravenous solutions. Butterfly* or scalp vein type
needles are preferred for this type of infusion. However, during infusion of the
solution containing CLAFORAN, it is advisable to discontinue temporarily the ad
ministration of other solutions at the same site.
Reg’d TM of Abbott Laboratories.

Reconstitution
For Intramuscular U se ; CLAFORAN should be reconstituted with Sterile Water
for Injection or Bacteriostatic Water for Injection in accordance with the volumes
recommended in the following table.

Reconstitution Table

Intramuscular

Guidelines for Dosage of CLAFORAN (cefotaxime sodium)

Type of Infection

Daily Dose
(g)

Uncomplicated
Gonorrhea
Uncomplicated
infections
Moderately
severe to severe
infections
Very severe
infections (e.g.
septicemia)
Life-threatening
infections

Frequency and Route

1

1 g IM (single dose)

2

1 g every 12 hours
IM or IV
1-2 g every
8 hours IM or IV

3-6

6-8

up to 12

2g every
6-8 hours IV
2 g every
4 hours IV

To prevent postoperative infection in contaminated or potentially contaminated
surgery, recommended doses are as follows.
(a) 1g IM or IV administered Vz to 1Vz hours prior to the initial surgical incision
to ensure that adequate antibiotic levels are present in the serum and tissues
at the start of surgery
(b) 1 g IM or IV administered 1Vz to 2 hours following the first dose; for lengthy
operative procedures, additional intraoperative doses may be administered, if
necessary, at appropriate intervals (1V2 to 2 hours) during surgery
(c) 1 g IM or IV administered within 2 hours following completion of surgery
The total cumulative prophylactic dose should not exceed 6 g in a 12 hour period.

Caesarian Section Patients
The first dose of 1g is administered IV as soon as the umbilical cord is clamped.
The second and third doses should be given as 1 g IM or IV at 6 and 12 hours
after the first dose.

Neonates, Infants, and Children
The following dosage schedule is recommended:
Neonates.
0-1 week of age
50 mg / kg IV q 12 h
1-4 weeks of age
50 mg / kg IV q 8 h
Infants and children (1 month to 12 years): For body weights less than 50 kg,
the recommended daily dose is 50 to 100 mg / kg IM or IV of body weight divid
ed into 4 to 6 equal doses, or up to 180 m g/kg/day for severe infections.
For body weights 50 kg or more, the usual adult dosage should be used.
The maximum daily dosage should not exceed 12 grams.
Administration of CLAFORAN should be continued for a minimum of 48 to 72
hours after the patient defervesces or after evidence of bacterial eradication has
been obtained; a minimum of 10 days of treatment is recommended for infec
tions caused by Group A beta-hemolytic streptococci in order to guard against
the risk of rheumatic fever or glomerulonephritis; frequent bacteriologic and clinical
appraisal is necessary during therapy of chronic urinary tract infections and may
be required for several months after therapy has been completed, persistent in
fections may require prolonged treatment. Doses less than those recommended
should not be employed.

Precautions

Dosage for Patients with Impaired Renal Function

CLAFORAN (cefotaxime sodium) should be prescribed with caution in individuals
with a history of lower gastrointestinal disease particularly colitis.
The safety of CLAFORAN in pregnancy has not been established. Consequently,
use of the drug in pregnant women requires that the likely benefit from the drug
be weighed against the possible risk to the mother and fetus.
Use of CLAFORAN in women of child-bearing potential requires that the anticipated
benefits be weighed against the possible risks.
Cefotaxime is excreted in human milk in low concentrations. Caution should be
exercised when the drug is administered to nursing mothers.
Prolonged use of CLAFORAN may result in the overgrowth of nonsusceptible
organisms. Constant evaluation of the patient’s condition is essential. If super

In patients with estimated creatinine clearance of less than 20 mL / min / 1.73m2
the dose of CLAFORAN should be halved (see Precautions).
If serum creatinine values alone are available, the following formula (based on
sex, weight, and age of the patient) may be used to convert these values into
creatinine clearance.
Males: Weight (kg) x (140 - age) Females: 0.85 x above value
72 x serum creatinine

Administration
Intram uscular: CLAFORAN should be injected well within the body of a relatively

Approximate
Available
Vol. (mL)

Approx. Average
Concentration
(mg/mL)

2
3
5

2.2
3.4

230
300
330

500 mg vial
1 g vial
2 g vial

6.0

'shake to dissolve.
For direct intravenous injection (bolus) a n d /o r continuous intravenous
in fu s io n : 500 mg, 1 and 2 g vials should be reconstituted with at least 10 mL
of Sterile Water for Injection. Reconstituted solution may be further diluted with
50 to 1000 mL of the fluids recommended for IV infusion.

Reconstitution Table

Dosage
Adults
The dosage of CLAFORAN should be determined by susceptibility of the causative
organisms, severity of the infection and condition of the patient.

Volume to be
Added to
Vial (mL)'

Intravenous
500 mg vial10
1 g vial
2 g vial

Volume to be
Added to
Vial (mL)*

Approximate
Available
Vol. (mL)

Approx. Average
Concentration
(mg/mL)

10.2
10
10

50
10.4
11.0

95
180

'shake to dissolve.
Solutions fo r IV In fu s io n : CLAFORAN is compatible with the following infu
sion fluids:
- Sterile Water for Injection
- 0.9% NaCI injection
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Diurnal Variation in Admission to
Hospital of Women in Labour
William D. Fraser, MD;*$ Frances H. McLean, BScN;t Robert H. Usher, MD|
In women having spontaneous labour or premature rupture of the membranes there
is a marked diurnal variation in times of admission to hospital.
Analysis of 4755 nulliparous women with single pregnancies in cephalic
presentation at term, indicated that they presented in labour or with premature
rupture of the membranes nearly twice as frequently during the night as during the
evening. The peak hours for delivery were late morning and afternoon.
The authors discuss previously published reports of similar findings and of a
diurnal variation in maternal hormone levels in humans and experimental animals.
The potential clinical importance of this phenomenon is considered.

On constate une variation diurne importante quant au moment d’admission a
l’hopital pour les femmes qui entrent en travail spontanement ou pour celles qui
subissent une rupture prematuree des membranes.
L’analyse de 4755 nullipares ayant eu une grossesse simple avec presentation
cephalique a terme, revele qu’elles arriverent en travail ou apres rupture prematuree
des membranes pres de deux fois plus souvent durant la nuit que durant la veillee.
Les periodes de pointe sur l’accouchement furent la fin de la matinee et l’apres-midi.
Les auteurs commentent les publications anterieures signalant des resultats
similaires ainsi que les rapports d’une variation diurne des taux d’hormones
maternelles chez l’humain et chez l’animal d’experience. Ils considerent l’importance
clinique que pourrait avoir ce phenomene.

n this study we review a seren
dipitous observation made during
investigation of the variation in la
bour outcomes by time of day
among nulliparous patients.1 A
marked diurnal variation was noted
in the times of admission to hospi
tal of nulliparous women at term
who had diagnoses of either sponta
neous labour or spontaneous rup
ture of membranes. The tendency
for labour to begin at certain times

I

of day has been described previous
ly,2 but, as with the regulation of
labour onset in general, it is not
well understood. The purpose of
this report is to emphasize the
importance of this clinical finding.

Population and Methods
This study was conducted at the
Royal Victoria Hospital, Montreal.
A computerized database was used
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to record data from all pregnant
women.3 The time of admission, the
time of delivery, the duration of
rupture of membranes, the duration
of labour, parity and method of
delivery were among the variables
entered on the computer.
Between January 1978 and
March 1984, 4228 pregnant women
admitted in labour (group 1) and
527 admitted with ruptured mem
branes but not in labour (group 2)
were included in the study. The
following criteria were necessary:
nulliparity, gestation period of 37
or more weeks, singleton pregnan
cy, cephalic presentation, labour
not induced. The time of admission
to hospital was analysed for both
groups and time of delivery for
group 1. Rates of admission by time
of day were compared using the x 2
goodness of fit test (Ryan BF, Jouer
BL, Ryan TA: Minitab, Duxbury
Press, Boston, Mass., 1985).

Findings
The number of admissions during
the night (24:00 to 08:00 hours)
was significantly greater (p <
0.001) in group 1 than that during
the day (08:00 to 16:00 hours) or
evening (16:00 to 24:00 hours) (Ta
ble I, Fig. 1). The mean interval
from admission to delivery did not
vary by time of admission. Delivery
rates peaked in the late morning
and afternoon.
The same pattern of admissions
was evident in group 2 women as in
group 1. The actual time of labour
onset or membrane rupture was less
accurate because these events ocVOL. 32, NO. 1, JANUARY 1989
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curred at home and the timing was
noted from the patient’s recollec
tion. Women admitted in labour
stated it had started, on average,
3.6 hours before. The others
claimed the membranes ruptured,
on average, 2.4 hours before admis
sion. If these intervals are taken
into account, the peak period for
onset of labour or rupture of mem
branes at home would be between
20:00 and 02:00 hours.

Discussion
Standard obstetric texts, in dis
cussing the initiation of parturition,
make no mention of a circadian
pattern to labour onset.4-6 Malek,7
in a series of 70 000 women, dem
onstrated that labour began more
frequently between 22:00 and
04:00 hours; Shettles,2 in a series
of more than 4000 patients, also
reported that labour onset was
more common at night. Glattre and
Bjerkedal8 reviewed all births in
Norway over a 10-year period and
found a cyclicity in the timing of
delivery. As was observed in our
study, nulliparous patients with
spontaneous onset of labour more
commonly delivered during daytime
hours. They concluded that diurnal
variation in rate of delivery is proba
bly mediated by factors that regu
late the time of labour onset.
How is the rhythmicity of labour
onset controlled? Ducsay and asso
ciates9 have described a circadian
pattern in uterine activity near term
in the rhesus monkey, a species
also known to initiate labour at
night. Peak uterine activity occurs
between 22:00 and 02:00 hours.
Further study10 confirmed this cy
clic uterine activity and demonstrat
ed a circadian pattern to fetal plas
ma progesterone and dehydroepiandrosterone sulfate levels, with peak
steroid concentrations correspond
ing to periods of peak uterine activi
ty. This suggests that fetal adrenal
34

Both progesterone and estriol dem
onstrate a circadian pattern before
term. However, estriol loses its cir
cadian pattern as term approach
es.11 While the interactions between

glands control the diurnal rhythm
in uterine contractility.
In the human, maternal plasma
steroid concentrations have been
monitored in the third trimester.1112

T a b le 1. N u m b e r o f A d m is s io n s
R u p tu re d m e m b ra n e s ,

H our of onset
In la b o u r

o r ru p tu re

N ig h t

n o t in la b o u r

( 1938)

(254)

2 4 :0 0

221

0 1 :0 0
0 2 :0 0

229

30

256

36

37

0 3 :0 0

252

32

0 4 :0 0
0 5 :0 0

282

27

250
255

33

0 6 :0 0
0 7 :0 0

193

D ay

37

22
(143)

( 1288)

0 8 :0 0

211

12

0 9 :0 0

218

1 0 :0 0
1 1 :0 0
1 2 :0 0

180

19
25
27

156
160
135

1 3 :0 0
1 4 :0 0
1 5 :0 0

22
15
15

116

112
(1 0 0 2 )

E ve n in g
1 6 :0 0
1 7 :0 0
1 8 :0 0
1 9 :0 0

2 0 :0 0
2 1 :0 0
2 2 :0 0
2 3 :0 0

T o ta ls
x

8
( 130)

115
93

14
14

103
116

18
18

148
133
134

11
13
17

160

25

4228

527

2 = 3 2 6 .5

p < 0.001

X

2 = 5 2 .9

p < 0.001

FIG. 1. Time of admission of term, primiparous patients in spontaneous labour
(circles) or with premature rupture of membranes (squares).
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fetal and maternal steroid rhythms
and their role in regulating labour
onset remain to be defined, they
may provide the basis for an expla
nation of its rhythmicity.
Further studies are needed to
determine whether the same diurnal
variation in labour onset or prema
ture rupture of membranes exists
before term. The following ques
tions need clarification: Should in
fusion rates for tocolytic agents be
increased during late evening and
night hours? Would induction of
labour be more successful if initiat
ed in the evening? Does the identi
cal diurnal variation in onset of
labour and premature rupture of
the membranes imply that the latter
is also the result of increased uter
ine activity, albeit imperceptible?
Fundamental knowledge regard
ing the onset of labour, as well as

practical clinical considerations,
provides incentives to increase our
understanding of the significance of
nature’s choice as to when labour
begins.

6. P ritchard JA, MacD onald PC, G ant

7.

8.
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Surgical Treatment of Post-traumatic
Kyphosis: a Report of 16 Cases
Alain Jodoin, MD, FRCSC;* Philippe Gillet, MD;f Pierre R. Dupuis, MD, FRCSC;t
Gilles Maurais, MD, FRCSC§
Thoracic and lumbar spine fractures may lead to symptomatic progressive kyphosis
for which surgery remains a controversial treatment. Sixteen patients with kyphosis
were treated surgically at the Sacre-Coeur Hospital in Montreal between 1979 and
1985. The mean follow-up was 38 months.
Initially, treatment of the fractures varied. On average the post-traumatic
kyphosis was surgically corrected 34 months later.
The corrective procedure consisted of staged anterior and posterior fusion with
instrumentation (six patients), posterior fusion with instrumentation (five), staged
anterior fusion, posterior osteotomy and fusion with instrumentation (four),
posterior osteotomy and fusion with Harrington instrumentation (one). Anterior
decompression was also performed in 5 of the 10 patients who had anterior fusion.
There was no major perioperative complication.
Pain was relieved in 13 patients and 9 of 11 had substantial neurologic
improvement. Two patients had nonunion of posterior grafts, but these united after
revision. The mean loss of correction in the early postoperative period was 3.5°.
The authors conclude that surgical treatment of post-traumatic symptomatic
progressive kyphosis is effective and safe.

Les fractures des colonnes thoracique et lombaire peuvent mener a une cyphose
evolutive symptomatique pour laquelle le traitement chirurgical demeure discutable.
Entre 1979 et 1985, 16 patients souffrant de cyphose ont ete operes a l’Hopital du
Sacre-Coeur de Montreal. Le suivi s’etend en moyenne sur 38 mois.
Initialement, le traitement des fractures a varie. En moyenne, les cyphoses
post-traumatiques furent corrigees chirurgicalement au bout de 34 mois.
Les techniques correctives employees furent les suivantes: fusions anterieure et
posterieure en deux temps avec instruments (six patients), fusion posterieure avec
instruments (cinq), fusion anterieure en deux temps, osteotomie posterieure et
fusion avec instruments (quatre), osteotomie posterieure et fusion avec instrument
de Harrington (un). Une decompression anterieure a aussi ete pratiquee chez 5 des
10 patients qui eurent une fusion anterieure. Aucune complication peroperatoire
importante n’a ete enregistree.
La douleur fut soulagee chez 13 patients et une amelioration neurologique
importante fut obtenue chez 9 patients sur 11. Dans deux cas, il y eut absence de
soudure d’une greffe posterieure, mais la fusion fut obtenue apres revision. Pendant
la periode postoperatoire immediate, la perte de correction moyenne etait de 3.5°.
Les auteurs concluent que le traitement chirurgical des cyphoses post-traumati
ques evolutives symptomatiques est efficace et sur.

vative or surgical, there is no doubt
that failure to correct and stabi
lize acute post-traumatic kyphosis
increases the likelihood that the
deformity will progress . 1 ' 3 -5 -8' 10-13
Post-injury laminectomy is especial
ly deleterious. 2-3-8-14' 22
Post-traum atic kyphosis can
cause disabling pain or progressive
neurologic impairment, due to tent
ing of the cord over the apex of the
curve or by direct compression by a
bony fragment in the neural can a ]_2,3.8.10.11.14-24

This condition has recently been
treated surgically by an anterior,
posterior or even combined approach . 3-7 -1 1 -18-22-25-26 Our study was
undertaken to establish the indica-
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ractures of the thoracic and
lumbar spines can lead to pro
gressive symptomatic kyphosis , 1 ' 8
which frequently is a result of in

F
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adequate initial management. 2 3 -7 ' 12
Although there is controversy over
whether the initial treatment of a
fractured spine should be conser
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tions, results and complications of
this type of surgery.

Patients and Methods
We reviewed the charts of 16
patients (12 men, 4 women) who
had progressive, symptomatic, posttraumatic kyphosis and were treat
ed at Sacre-Coeur Hospital in Mon
treal between 1979 and 1985. Medi
cal records, preoperative, immediate
postoperative and follow-up x-ray
films were reviewed. All patients
were examined personally, except
one who was assessed by question
naire and had x-ray films taken
elsewhere.
Initial management of the frac
tures was carefully correlated with
the patient’s clinical status at cor
rective surgery, the indications for
and techniques of which were re
viewed. The last follow-up consid
ered pain, curve correction, neuro
logic deficit and complications.

Findings
The mean age of the 16 patients
was 33 years (range from 17 to 56
years).
Fractures involved the thoracic
spine in five patients, the thoraco
lumbar junction in eight and the
lumbar spine in three. Patients were
treated initially as shown in Table I.
Eleven received their initial treat
ment in other medical centres.
Table 1. In itia l T re a tm e n t o f 1 6 P atie n ts
Procedure

►

►

Bed re s t + b o d y c a s t o r b ra c in g
P o s te rio r H a rrin g to n ro d s +
fu s io n
L a m in e c to m y + bed re s t
+ H a rrin g to n ro d s
A n te rio r d e c o m p re s s io n + rib
s tru t g ra ftin g
R o y -C a m ille p la te s + p o s te rio r
fu s io n

No. of
patients
9
3
1
1
1
1

Results o f Initial Management
All nine patients treated by bed
rest or orthosis subsequently had
back pain, six (nos. 1, 6, 7, 8, 10,
16 in Table II) suffered neurologic
irritation or deficit; patient 1 had
anesthesia at T4 with motor loss in
the left leg. Eight patients (nos. 1,
6, 7, 8, 9, 10, 12, 16) had increas
ing deformity. In four (nos. 1, 6, 7,
16), an incomplete myelographic
block and a central spinal stenosis
were demonstrated on lateral to
mography. Computed tomography
demonstrated a central spinal steno
sis in patients 9 and 15; the latter
suffered transient paraplegia.
Of the patients managed by pos
terior instrumentation and fusion,
patient 2 had an ataxic gait and a
pyramidal tract irritation syndrome,
thought to be caused by dislodgement of the Harrington rods. Pa
tient 3 had pain and increasing
kyphosis as did patient 13 who also
had spasticity; both these patients
had dislodgement of their Harring
ton rods.
Patient 15, managed by RoyCamille plates and posterior fusion
had a decreased lumbar lordosis.
Because of the resulting anterior
projection of the trunk, this patient
needed crutches to stand and walk,
even with bilateral long leg ortho
sis. Patient 16 had anterior im
pingement of the spinal canal by
the posterior aspect of L4, docu
mented by computed tomography.
Delayed posterior fusion in pa
tient 14 did not prevent increasing
kyphosis or improve his parapare
sis.
Patient 5, who underwent ante
rior decompression and rib strut
grafting, had neurologic improve
ment initially, but 5 months later he
experienced a loss of correction
with recurrence of his neurologic
deficit.
The mean time between the ini
tial injury and surgical correction of

the kyphosis was 34 months (range
from 5 months to 14 years). Indica
tions for corrective surgery were
back pain, neurologic impairment
or progression of the curve, or a
combination of these.
Surgical Procedures Used to Treat
the Kyphosis (Table II)
The surgical technique used de
pended on the initial treatment, the
radiologic findings in patients with
neurologic symptoms and configu
ration of the deformity.
Posterior Harrington instrumen
tation and fusion were required in
five patients; three (nos. 3, 5 and 8)
required compression Harrington
rods and two (nos. 9 and 11) dis
traction rods.
Posterior osteotomy, Harrington
instrumentation and fusion were re
quired for patient 2.
Staged anterior and posterior fu
sion with instrumentation, with or
without anterior decompression
were carried out in six patients
(nos. 1, 4, 6, 7, 12 and 16). Patient
6 required anterior release and fibular strut and intersomatic grafting
followed by posterior instrumenta
tion with Harrington distraction
rods and fusion. In patient 7, an
anterior release, fibular and rib
strut grafting were followed by Har
rington instrumentation and fusion;
patient 12 required multilevel re
lease with intersomatic grafting. In
patient 4, posterior distraction in
strumentation and fusion resulted
in posterior nonunion, so 2 years
later anterior fusion and instrumen
tation were necessary.
Finally, staged anterior decom
pression, fibular strut grafting or
iliac strut grafting and anterior Har
rington instrumentation, followed
by posterior osteotomy with instru
mentation and fusion were carried
out on patients 10, 13, 14 and 15.
In patient 15 the Roy-Camille

►
►
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plates, initially applied, were removed.
Postoperatively, each patient was
nursed on a Stryker frame. On
postoperative day 7 a Cotrel brace
or cast was applied until solid fu
sion was demonstrated radiologically, usually after 6 months.

Complications

Five patients had problems post
operatively. In patient 2 the Har
rington rods became dislodged after
6 months, but he resumed full
work, even though the correction
achieved by the rods was lost.

Patient 4 had a serious urinary
tract infection. Her posterior fusion
did not unite and she required an
anterior fusion 2 years later. Patient
12 had a pressure sore under a
Cotrel cast; the sore resolved after
10 days of bed rest on a Stryker
frame and another cast was applied

T a b le II. D ata on 16 P a tie n ts W ith P o s t-T ra u m a tic K yp h o sis

No.

S ex

Age,
yr

F ra ctu re
le v el

1

M

31

T4

H a rris —T a y lo r
brace

2

M

34

L1

HD ro d s and p o s t,
fu s io n

3

M

17

T9

HD ro d s and p o s t,
fu s io n 1 5 °

4

F

42

L2

Bed re s t
L a m in e c to m y L 2 ,
L3

5

M

53

T12

A n t.
d e c o m p re s s io n
and rib s tr u t
g ra ft

6

F

32

T12

Brace

7

F

23

T12

In itia l
tre a tm e n t

C a st

T im e fro m
in ju ry to
c o rre c tio n ,
mo
10

P re o p
s ta tu s

S urgical
technique

Postop
cu rve, °

1. A n t. d e c o m p re s s io n
T 3 .T 4
Ilia c s tru t g ra ft
2. HD ro d s
P o s t, fu s io n

32

3 0 ° c u rv e
B ro w n -S e q u a rd
s y n d ro m e
S p a s tic p a ra p a re s is o f
T4
W a lk s w ith 1 cane
M y e lo g ra p h ic b lo c k
In c o m p le te
d e c o m p re s s io n ?

48

5

3 0 ° curve
R od lo o s e n in g
B ack pain
S p a s tic ity
A ta x ic g a it

P o s t, o s te o to m y
HD ro d s
P o s t, fu s io n

17

3 4 ° c u rv e
M o rn in g s tiffn e s s
No n e u ro lo g ic d e fic it
R e su m e d w o rk
(fire m a n )

36

6

2 5 ° curve
R od lo o s e n in g
Incre a sed p a in

C o m p re s s io n ro d s
P o s t, fu s io n

26

2 7 ° c u rv e
N o pain

21

2 5 ° curve
Pain
L im p
P o s to p n o n u n io n
Incre a sed p ain

HD ro d s
P o s t, fu s io n
A n t. fu s io n w ith ant.
D w y e r co m p re s s io n
in s tru m e n ta tio n

20

2 0 ° c u rv e
P ain a t s c a r s ite

60

3 0 ° curve
M u s c le w e a k n e s s and
h y p o e s th e s ia a fte r
in itia l re c o v e ry

HC ro d s
P o s t, fu s io n

25

2 5 ° c u rv e
W a lk s w ith 1 cane
No pain

42

5 2 ° curve
B ac k pain
P ares th e sia
Im pa ire d v o id in g

1. A n t. s tr u t g ra ft
2. HD ro d s
P o s t, fu s io n

45

3 0 ° c u rv e
N o pain
B la d d e r n o rm a l
R e su m ed w o rk

32

3 4 ° curve
B ac k pain
H yp o e sth e sia
M ye lo g ra m +
T o m o g ra m +

1. A n t. s tr u t g ra ft
2. HD ro d s
P o s t, fu s io n

17

1 5 ° c u rv e
No pain
R e su m ed w o rk

72

1 1 ° c u rv e
No pain
R e su m ed w o rk

60

1 5 ° cu rve
N o pain
R e su m ed w o rk and
s p o rts

46

144

7

36

12

22

8

8

M

22

L3

C ast

15

1 0 ° curve
B ac k pain
R a d icu la r p a in ,
Lasegue
s ig n +

HC ro d s
P o s t, fu s io n

7

9

M

28

L1

B race

18

1 5 ° curve
B ack pain
S p in a l s te n o s is

HD ro d s
P o s t, fu s io n

13
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Follow -up,
mo

3 0 ° curve
B ack pain
M u s c le w e a k n e s s
S p a s tic ity
H y p o e s th e s ia
B la d d e r im p a irm e n t

HD = H a rrin g to n d is tra c tio n , HC = H a rrin g to n c o m p re s s io n , ant. = a n te rio r, p o s t = p o s te rio r, + = p o s itiv e .

38

Postop
status
a t la s t
fo llo w -u p
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until solid fusion occurred without
further problems. Posterior fusion
also failed in patient 13 who needed
revision with Harrington instrumen
tation 2 years later; successful
union resulted. Patient 14 had a
voiding problem early postoperatively and required catheterization.

C linical Outcom e

The mean follow-up was 38
months (range from 19 to 72
months). Pain improved or disap
peared in 10 patients, 3 showed
slight improvement but 1 did not
show any improvement (Table II).

T a b le II (C o n tin u e d ).

A ge,

»
►
►

Fracture
level

In itia l
tre a tm e n t

In patients with kyphosis of the
thoracic spine, the curve was re
duced from a mean of 38° to 27°
(range from 20° to 35°). In the
thoracolumbar spine, the improve
ment was from a mean of 39° to
27° (range from 8° to 34°). In the
lumbar spine, the reduction was

T im e from
in ju ry to
c o rre c tio n ,
mo

Data on 16 Patients With Post-Traumatic Kyphosis

P reop
status

S u rg ic a l
te c h n iq u e

P ostop
c u rv e , °

Postop
status
a t la s t
fo llo w -u p

F o llo w -u p ,
mo

No.

Sex

yr

10

M

31

T8-9
10-11

Brace

10

40° curve
Spastic paraparesis
Hypoesthesia
Ataxic gait
Bladder and bowel
problems
Myelogram +

1. Ant. decompression
Fibular strut graft
2. Post, osteotomy
HC rods and fusion

25

25° curve
Still increased reflexes
Resumed work and
sports

36

11

M

56

T7

Brace

22

20° curve
Back pain

HD rods
Post, fusion

20

20° curve
Solid fusion but pain

19

12

M

18

T6-7

Brace

15

75° curve
Back pain
Unable to work or run

1. Ant. release and graft
2. HC rods
Post, fusion

35

35° curve
Pain at upper hooks
Resumed work

33

13

M

24

T12

HD rods
Post, fusion

22

40° curve
Paresthesia
Back pain
Bladder impairment
Spasticity

1. Ant. decompression
T12
Fibular strut graft
T11-L1
2. Post, osteotomy
HC rods and fusion

15

32° curve
Light pain

30

14

M

18

L1

1. Laminectomy
and 1 HD rod
without fusion
2. Post, fusion

52

45° curve
Paresis for 3 mo
(needed crutches)
Sphincter hypotonia
Anesthesia of heels
Back pain

1. Ant. decompression
L1
Iliac strut graft
T12-L2
Ant. Harrington
instrumentation
2. Post, osteotomy
HC rods and fusion

34

34° curve
No pain
Muscle improvement
by 4 mo
Sensibility improved
Sphincter tone
unchanged
Removed orthosis 2
mo postop without
permission

24

15

M

17

L4

Post, fusion and
instrumentation
by Roy-Camilie
plates without
correction of
kyphosis

22

Loss of lumbar
lordosis with ant.
projection of trunk
and instability
without crutches
Muscle weakness
below L3
Sphincter hypotonia
Need for orthosis of
both legs
Low back pain

1. Ant. decompression
L4
Iliac strut graft
L3-L5
2. Removal of plates
and screws
Post, osteotomy
HC rods and fusion

-1 0

Restoration of normal
lordosis with ability
to stand without
crutches and
improved gait

25

16

F

30

L1

Bed rest and
orthosis

40° curve (5° in 1 yr)
Back pain
Hypoesthesia ant.
aspects of thighs
No muscle weakness
Slight stenosis

1. Ant. release and iliac
strut graft T12-L2
Ant. Harrington rods
2. Posterior
Harrington-Luque
instrumentation with
fusion

Pain improved
Back to normal
activities

24

14

8

HD = Harrington distraction, HC = Harrington compression, ant. = anterior, post. = posterior, + = positive.

►
►
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from a mean of 12° to 7° (range
from —10° to 20°).
Postoperatively, there was an av
erage loss of correction of 3.5°
(range from 0° to 17°).
In patient 15, lumbar lordosis
was restored which greatly im
proved his trunk balance.
Neurologically, the paresthesia
and hypoesthesia disappeared or
was greatly diminished soon after
the operation in the seven patients
noted to have these problems. Ra
dicular pain and a positive Lasegue
sign disappeared in patient 8. Pyra
midal syndrome disappeared in pa
tient 2 and was markedly improved
in patients 10 and 13, but it re
mained unchanged in patient 1.
Muscle strength returned to nor
mal in patient 10 and improved in
three others; it was unchanged in
patient 1. Ataxic gait resolved in
patients 2 and 10. Sphincter func
tion returned to normal in two
patients (6 and 10) but was un
changed in patients 1, 13, 14 and
15.
Eight patients returned to work.
Patient 11, who complained of pain,
would not return to work even

though he had a solid fusion, nor
mal spinal curve and no neurologic
symptoms. As a result, his eligibili
ty for sought-after compensation
has been difficult to assess.
Four patients were still too dis
abled to resume physical activities
and were not expected to improve.
Two patients (nos. 4 and 13) re
sumed light work.

phy (Fig. 2) demonstrated only
slight stenosis at the fracture level.
An anterior release and iliac strut
grafting from T12 to L2 with ante
rior Kostuik-Harrington instrumen
tation was carried out. The kypho
sis was reduced to 8° (Fig. 3), and
no late loss of correction was ob
served at follow-up 24 months later.

Discussion
Case Report
The following case report is a
representative example of our 16
patients who suffered post-traumatic kyphosis.
A 30-year-old woman (patient 16)
sustained a fracture of LI in a car
accident. The fracture was first
treated by bed rest and application
of a body jacket. Fourteen months
later she was referred to our institu
tion. She complained of back pain
and hypoesthesia over the anterior
aspect of both thighs. Preoperative
assessment revealed a sharp 40°
kyphosis from T12 to L2 (Fig. 1).
This deformity had increased 5°
over the previous year. Myelogra

FIG. 1. Anteroposterior and lateral views showing kyphosis of 40° from T12-L2.

Three main factors contribute to
the progression of post-traumatic
kyphosis:27 failure of the anterior
elements under compressive load
ing, failure of the posterior ele
ments under tensile loading and
increased physiological load after
“healing” because of increased mo
ment arm proportional to the mag
nitude of the kyphosis.
These factors make burst frac
tures particularly prone to a pro
gressive kyphotic deformity,9 espe
cially if the initial angulation is
more than 30°;2 multiple-level frac
tures are even more susceptible.2-7
Laminectomy, done initially in
patients 4 and 14, further destabil-

FIG. 2. Myelogram demonstrates slight
stenosis at LI.
4

40
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izes the spine and is ineffective in
decompressing neural elements, ex
cept in rare instances when the
fractured laminae have moved ante
riorly, compressing the neural ele
ments. 2- 4-6.8.1(U2.M,15.17-19.21-24
Posterior instrumentation and fu
sion to stabilize the curve is some
times the only procedure required;
when pain is the sole complaint and
the curve is slight, it has proven
effective.3
We believe that a solid fusion
should be the ultimate aim in most
cases of post-traumatic kyphosis.
For example, in case 2 correction
was entirely lost when the upper
hooks dislodged 4 months after
surgery. However, this patient had
complete neurologic recovery and
was able to resume work when
fusion was finally achieved 2
months later. This phenomenon has
been attributed to correction of
microinstability.1
To demonstrate spinal canal en
croachment and the need for de
compression it is important to ob
tain a laminagram,3 myelogram2-3
and computed tom ogram .21017
Compression is anterior, due to

a bony fragment at the apex of the
curve, so decompression must be
anterior.2-3-8-10-11-14-15-17-18-21-24-28 Mild
er deformities can be corrected with
posterior instrumentation and fu
sion.10-16 In patients previously op
erated on, who have severe deformi
ty, a posterior osteotomy is helpful.
In patients not previously operat
ed on, distraction rods using the
three-pressure-point method are ef
fective.2 Distraction must be mini
mal to prevent overstretching the
cord2-8 and the rods should be con
toured; square-ended rods are used
in the lumbar area.10 Compressive
devices are more effective but carry
the risk of pushing bony elements
into the spinal canal; these devices
should be used only if an anterior
decompression was performed ini
tially.
Anterior grafting is essential in
severe kyphosis for biomechanical
reasons.8-9-17"20-22-25-27-28 A rib strut
graft is mechanically weak, hence
fibular or iliac strut grafting with
anterior instrumentation is suggest
ed.
The anterior approach provides
the best exposure for decompres

sion2-3-14-19-21-23-24 and anterior strut
grafting. The posterolateral ap
proach is inadequate.11-21
Solid fusion is imperative. For
example, our patient 5 was treated
initially by anterior decompression
and rib strut grafting. Because the
fusion was not solid, the correction
obtained at surgery was lost and
the original neurologic deficit reap
peared. Subsequent use of Harring
ton compression rods and posterior
fusion resulted in partial neurologic
recovery.
We agree with the recommenda
tion of others2-3-18-24 that a posterior
fusion be performed in all cases,
including those who have an anteri
or fusion.
In the future, anterior decom
pression and fusion may be safe
enough and strong enough to pre
clude the use of the posterior m eth
od in the treatment of post-traum at
ic kyphosis, but at present this is
not the case.
When neurologic improvement is
not achieved by anterior decompres
sion, myelography or computed to 
mography, or both, should be re
peated.
No major surgically related com
plication occurred in this series and
most patients returned to their pre
vious employment. Even some of
the very disabled with ataxic gait,
muscle weakness and spasticity, re
turned to full work and sports 1
year after the procedure.
Effective correction of symptom
atic post-traumatic kyphosis is pos
sible, even when a neurologic defi
cit has been present for several
m onths.2-3-11 14-19-23-24-28 Corrective
surgery should be considered when
a deformity progresses after a spi
nal fracture, whatever the initial
treatment. This is especially true if
there is concomitant progressive
neurologic deficit.

FIG. 3. Anteroposterior and lateral views show kyphosis reduced to 8° with
anterior and posterior instrumentation and posterior fusion.

We thank Doctor Guy Paiement for his
help in reviewing this paper.
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Perioperative Chemotherapy for Primary
Sarcoma of Bone
Ka Wah Chan, MB, FRCPC;* M. Knowling, MD, FRCPC;t C.P. Beauchamp, MD, FRCSCJ
Preoperative chemotherapy for primary osteosarcoma has usually been accompanied
by a prolonged delay between withdrawal before operation and resumption after.
This is because animal studies showed impaired wound healing associated with
perioperative chemotherapy. Clinical studies, however, have not shown this to be
the case. The authors describe their experience in eight patients who had
osteosarcoma and Ewing’s sarcoma of the extremities and received one to three
cycles of chemotherapy preoperatively. Chemotherapy consisted of Adriamycin,
cis-platinum and vincristine. Definitive surgery on the primary tumour was done 1
to 4 days after the last dose. Amputation was performed on seven patients and
tumour resection for limb salvage on one. No wound healing or infectious
complications were encountered. The ensuing course of chemotherapy was not
delayed by the surgical procedure. The authors conclude that it is feasible to
combine neoadjuvant chemotherapy and early surgery in the management of
high-grade primary bone sarcoma.
La chimiotherapie preoperatoire des osteosarcomes primitifs est habituellement
accompagnee d’un delai prolonge entre l’interruption medicamenteuse avant l’operation et la reprise du traitement apres. Ceci decoule d’etudes animales qui ont montre
une alteration du mecanisme de cicatrisation de plaie reliee a la chimiotherapie
preoperatoire. Toutefois, les etudes cliniques n’ont rien revele de similaire. Les
auteurs decrivent le traitement de huit patients souffrant d’osteosarcome ou de
sarcome d’Ewing des extremites, qui re?urent de un a trois cycles de chimiotherapie
preoperatoire. Le traitement etait compose d’Adriamycine, de cis-platine et de
vincristine. L’operation definitive eut lieu de 1 a 4 jours apres la derniere dose. Une
amputation fut pratiquee chez sept patients, alors que le dernier subissait une
resection tumorale visant a sauvegarder le membre. Aucune complication infectieuse
ou de cicatrisation ne fut observee. La poursuite du traitement de chimiotherapie ne
fut pas retardee par l’intervention chirurgicale. Les auteurs concluent que, dans le
traitement des osteosarcomes primitifs au stade avance, il est possible d’associer
chimiotherapie “neoadjuvante” et chirurgie precoce.
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before definitive
C hemotherapy
treatment of a primary malig

nant tumour has become popular in
the past decade. The advantages of
this “neoadjuvant” approach in
clude early eradication of systemic
micrometastases and in-vivo sensi
tivity testing of tumour cells to
specific antineoplastic agents, thus
allowing early modification of che
motherapy regimens.1 This ap
proach has been used successfully
to treat osteosarcoma and has been
proposed for the management of
operable Ewing’s sarcoma.23 Sur
gery on the primary tumour usually
is performed 3 to 4 weeks from the
last course of chemotherapy to
allow recovery from its side effects.
Chemotherapy is seldom resumed
for another 2 to 3 weeks, until the
surgical wound has healed com
pletely. The patient, therefore, may
not receive systemic therapy for 6
or more weeks during the early,
critical period of antineoplastic
therapy. This delay was considered
inevitable because animal experi
ments4-5 showed that perioperative
chemotherapy significantly impaired
wound healing. On the other hand,
most clinical studies6-7 have shown
little effect of adjuvant chemothera
py on postsurgical recovery. In this
report we describe our experience in
carrying out surgery on primary
bone tumours immediately after
chemotherapy without deleterious
effect on wound healing.

►

►
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Patients and Materials
Between May 1985 and August
1987, eight patients with primary
bone sarcoma of the extremities
were given chemotherapy before de
finitive surgery (Table I). Chemo
therapy was administered over 2
days. One to three courses were
given and surgery was scheduled
within 1 to 4 days of the last dose
of cytotoxic therapy. The choice of
surgical procedure was not affected
by perioperative chemotherapy.
Postoperative chemotherapy was
scheduled to resume 3 weeks from
the start of the last course before
surgery, provided blood counts had
returned to a satisfactory level (ab
solute neutrophil count of 1.0 X
109/ L and platelets of 100 X
109/L ) and the surgical wound ap
peared healed. All patients were
followed up regularly to assess
complications at the surgical sites.

Findings
The median age of patients at the
time of diagnosis was 16.5 years
and all were male. Five patients
with osteosarcoma received one to
three cycles of cis-platinumAdriamycin preoperatively. Two
boys (nos. 4 and 5) received one
cycle of high-dose methotrexate a
week earlier, followed by cisplatinum-Adriamycin. The man

with Ewing’s sarcoma received vin
cristine and Adriamycin immediately
before tumour resection and inser
tion of a prosthesis. He had re
ceived one course each of vincristine-Adriamycin and vincristinecyclophosphamide previously. The
median time to surgery from the
last dose of chemotherapy was 2.2
days. No immediate postoperative
complication was encountered. No
wound infection, fever or hematoma
was noted. All patients were dis
charged 5 to 10 days (median 7
days) after surgery. Moderate neu
tropenia (absolute neutrophil count
between 0.2 and 0.5 X 109/L ) was
encountered in all patients, but
thrombocytopenia of less than 100
X 109/L was found in only one.
Chemotherapy was resumed 3
weeks from the last treatment in all
patients except no. 3, whose treat
ment was delayed for 1 week be
cause of neutropenia. No wound
dehiscence or impairment of healing
was found and the mean follow-up
was 28 months (range from 5 to 45
months).

Discussion
The effects of antineoplastic
agents on wound healing have been
investigated extensively. Controver
sy exists as to the importance of
findings in animal experiments and
their applicability to clinical prac
T a b le

P atie n t
no.

1

2
3
4
5
6
7
8

yr

Tum our
ty p e *

16
21
17
13
8
13
23
23

OS
OS
OS
OS
OS
ES
OS
OS

Age,

tice. Devereux and colleagues45 ad
ministered Adriamycin 6.0 m g/kg
intravenously to rats at various
times before and after surgery. Seri
ous impairment of wound tensile
strength resulted because of defec
tive collagen synthesis. The most
deleterious effect was observed
when treatment was given preopera
tively or intraoperatively, and the
addition of local radiotherapy po
tentiated the impairment.8 Lawrence
and associates9 reported a similar
finding and postulated that
Adriamycin-induced myelosuppression resulted in a decreased amount
of local chemotactic and growth
factors normally derived from gra
nulocytes and platelets. This in turn
led to decreased wound cellularity
and collagen accumulation. In con
trast, an earlier study10 showed that
Adriamycin up to a dose of 10
m g/kg had no adverse effect on
wound healing regardless of the
time of treatment in relation to the
time of injury. Cis-platinum, when
given at 5.0 m g/kg, impaired
wound healing,11 but studies1213
using one-third to one-half of this
dosage showed no noticeable effect
on healing of skin wounds or intes
tinal anastomoses in animals.
The clinical effects of adjuvant
chemotherapy on wound healing
were more acceptable. Patients with
advanced breast cancer received
several courses of Adriamycin and
cyclophosphamide before mastecto-

1. Clinical Characteristics of Patients

L ocation

Fibula
Femur
Tibia
Femur
Femur
Humerus
Tibia
Tibia

P erio p e ra tiv e
c h e m o th e ra p y t

In te rv al to
su rg ery,
d

S u rg ic a l
p rocedure

CA
CA
CA
M/CA
M/CA
VA/VC/VA
CA X 3
CA X 3

1
3
4
2
3
2
2
1

Above-knee amputation
High thigh amputation
Above-knee amputation
Above-knee amputation
Above-knee amputation
Limb salvage
Above-knee amputation
Above-knee amputation

*0S = osteosarcoma, ES = Ewing’s sarcoma.
tC A = cis-platinum, 100 m g/m 2, d 1, Adriamycin, 35.0 m g/m 2, d 1 and 2; M = methotrexate 8.0 g/m 2, d 1 with folinic acid rescue; VA = vincristine,
1.5 m g/m 2, d 1, Adriamycin, 75 m g/m 2, d 2; VC = vincristine, 1.5 mg/m2, d 1, cyclophosphamide 1.4 g/m 2, d 2 . _________________________________
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my and had no increase in wound
complications.6 However, surgery
was not usually performed until 3
or more weeks after the end of
chemotherapy. Nissen-Meyer and
associates7 administered a single
course of cyclophosphamide (5.0
m g/kg daily for 6 days) within
several days of mastectomy and
found no increase in the wound
complication rate compared with
control patients who underwent
surgery only. The effect of preoper
ative chemotherapy on wound heal
ing in skeletal tumours has been
reported. Bertermann and col
leagues14 summarized the experi
ence of the T4, T7 and T10 proto
cols from New York’s Memorial
Hospital, where high-dose metho
trexate and Adriamycin were given
to osteosarcoma patients, the last
dose being given 1 to 2 weeks
before limb-salvage surgery. No in
crease in wound complications was
seen, but 6% of the patients re
quired amputation because of
wound infection.
The addition of radiotherapy to
preoperative chemotherapy seems
to increase the risk of wound com
plications. Denton and associates15
administered Adriamycin intra
arterially and local radiotherapy
preoperatively to 30 patients with
bone and soft-tissue sarcoma. Poor
wound healing necessitated amputa
tion in two patients. Two others
had wound necrosis requiring
debridement and skin grafting. A
randomized trial of perioperative
brachytherapy showed a substantial
increase in wound complication rate
compared with control patients.
The addition of Adriamycin at 60.0
m g/m 2 did not increase the wound
problems, but most patients re
ceived chemotherapy more than 2
weeks after surgery.16 Similarly,
preoperative cis-platinum therapy
and radiotherapy in patients with
head and neck tumours led to a
25% increase in hospital stay be

cause of slow wound healing, but
only 1 of the 28 patients suffered
wound dehiscence.17
The present study showed no
deleterious effect on wound healing
when Adriamycin, cis-platinum and
vincristine were administered in
standard doses several days before
surgery. It is, therefore, possible to
continue neoadjuvant chemothera
py without interruption to treat
micrometastases and also to include
surgery for local disease control.
This is especially important in the
case of highly proliferative tu
mours; Goldie and Coldman18 illus
trated a steep quantitative relation
between tumour size and the likeli
hood of cure. We used a similar
approach to treat one child with a
large malignant sacrococcygeal ter
atoma obstructing the rectum. The
child received cis-platinum 120
m g/m 2, VP-16 (etoposide) 360
m g/m 2, vincristine 2.0 m g/m 2 and
bleomycin 50 m g/m 2 2 days before
tumour resection and no complica
tions developed. Similarly, if the
primary tumour has progressed
during preoperative chemotherapy
with other cytotoxic agents (such
as high-dose methotrexate for os
teosarcoma), alternative treatment
with Adriamycin and cis-platinum
may be given immediately without
awaiting recovery from surgery. An
other advantage of administering
chemotherapy before surgery is the
avoidance of treatment in the early
postoperative period, when compli
cations such as atelectasis and mal
nutrition are frequently present and
drains and catheters are in place.19
However, one must be careful in
extrapolating the results of this
small series to other chemothera
peutic agents and surgical proce
dures used in the treatment of dif
ferent neoplastic diseases. The
problem of wound healing with pe
rioperative chemotherapy may be
more frequent when complicated
surgical procedures are performed.

Our patients were healthy without
other adverse factors such as sep
sis, steroid use and local irradiation
during chemotherapy and surgery.
Further clinical observations and
comparative trials are necessary to
evaluate the effect of perioperative
chemotherapy in other malignant
tumours.
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Bacteroides fragilis
MEFOXIN® may also be appropriate for the
treatment of infections involving susceptible
strains of both aerobic and anaerobic bacteria.
MEFOXIN® is not active against Pseudomonas,
most strains of enterococci, many strains of
Enterobacter cloacae, and methicillin-resistant
staphylococci and Listeria monocytogenes.
Clinical experience has demonstrated that
MEFOXIN® can be administered to patients who
are also receiving carbenicillin, gentamicin,
tobramycin, or amikacin (see PRECAUTIONS
and ADMINISTRATION).
Intravenous Administration

The intravenous route is preferable for patients
with bacteremia, bacterial septicemia, or other
severe or life-threatening infections, or for
patients who may be poor risks because of
lowered resistance resulting from such debili
tating conditions as m alnu tritio n , trauma,
surgery, diabetes, heart failure, or malignancy,
particularly if shock is present or impending.
PROPHYLACTIC USE

MEFOXIN® may be administered perioperatively (preoperatively, intraoperatively and postoperatively) to patients undergoing vaginal or
abdom inal h y ste re cto m y and abdom inal
surgery when there is a significant risk of
postoperative infection or where the occurrence
of postoperative infection is considered to be
especially serious.
In patients undergoing cesarean section, intra
operative (after clamping the umbilical cord)
and postoperative use of MEFOXIN® may
reduce the incidence of surgery related post
operative infections.
Effective prophylactic use depends on the time
of administration. MEFOXIN® usually should be
iven one-half to one hour before the operation,
rophylactic administration should usually be
stopped within 12 hours. It has been generally

reported that continuing administration of any
antibiotic beyond 24 hours following surgery
increases the possibility of adverse reactions
but, in the majority of surgical procedures, does
not reduce the incidence of subsequent
infection.
If signs of postsurgical infection should appear,
specimens for culture should be obtained for
identification of the causative organism(s) so
that appropriate therapy may be instituted.

CONTRAINDICATIONS
MEFOXIN® is contraindicated in persons who
have shown hypersensitivity to cefoxitin or to
the cephalosporin group of antibiotics.

WARNINGS
Before therapy with MEFOXIN® is instituted,
careful inquiry should be made to determine
whether the patient has had previous hyper
sensitivity reactions to MEFOXIN®, cephalo
sporins, penicillins or other drugs. MEFOXIN®
should be given with caution to penicillinsensitive patients.
There is some clinical and laboratory evidence
of pa rtial c ro s s -a lle rg e n ic ity between
cephamycins and the other beta-lactam anti
biotics, penicillins and cephalosporins. Severe
reactions (including anaphylaxis) have been
reported with most beta-lactam antibiotics.
Pseudomembranous colitis has been reported
with virtually all antibiotics. This colitis can
range from mild to life threatening in severity.
Antibiotics should therefore be prescribed with
caution in individuals with a history of gastro
intestinal disease, particularly colitis. It is
important to consider a diagnosis of pseudo
membranous colitis in patients who develop
diarrhea in association with antibiotic use. While
studies indicate that a toxin produced by
Clostridium difficile is one primary cause of
antibiotic-associated colitis, other causes
should also be considered.
Any patient who has demonstrated some form of
allergy, particularly to drugs, should receive
antibiotics including MEFOXIN® with caution.
If an allergic reaction to MEFOXIN® occurs,
administration of the drug should be discon
tinued. Serious hypersensitivity reactions may
require treatment with epinephrine and other
emergency measures.

PRECAUTIONS
The total daily dosage should be reduced when
MEFOXIN® is administered to patients with
transient or persistent reduction of urinary
output due to renal insufficiency (see DOSAGE
AND ADMINISTRATION) because high and
prolonged serum antibiotic concentrations can
occur from usual doses.
In patients treated with MEFOXIN® a false
positive reaction to glucose in the urine may
occur with Benedict’s or Fehling's solutions but
not with the use of specific glucose oxidase
methods.
Using the Jaffe Method, falsely high creatinine
values in serum may occur if serum concen
trations of cefoxitin exceed 100/zg/mL. Serum
samples from patients treated with MEFOXIN®
should not be analyzed for creatinine if with
drawn within two hours of drug administration.
Increased nephrotoxicity has been reported
following concomitant administration of
cephalosporins and aminoglycoside antibiotics.
The safety of MEFOXIN® in the treatment of
infections during pregnancy has not been
established. If the administration of MEFOXIN®
to pregnant patients is considered necessary, its
use requires that the anticipated benefits be
weighed against possible hazards to the fetus.
Reproductive and teratogenic studies have been
performed in mice and rats and have revealed no
evidence of impaired fertility or harm to the fetus
due to MEFOXIN®.
Cefoxitin has been observed in the milk of
nursing mothers receiving the drug.
Prolonged use of MEFOXIN® may result in the
overgrowth of non-susceptible organisms.
Repeated evaluation of the patient’s condition is
essential and if superinfection occurs during
therapy, appropriate measures should be taken.
Should an organism become resistant during
antibiotic therapy, another antibiotic should be
substituted.
In children 3 months of age or older, higher
doses of MEFOXIN® (100 mg/kg/day and

above) have been associated with an increased
incidence of eosinophilia and elevated SGOT.

ADVERSE REACTIONS
MEFOXIN® is generally well tolerated. Adverse
reactions rarely required cessation of treatment
and usually have been mild and transient.

should be employed and it is advisable to
monitor serum levels in patients with severe
impairment.
In adults with renal insufficiency, an initial
loading dose of 1 g to 2 g should be given. After
a loading dose, the following recommendations
for maintenance dosage may be used as a guide:

Local Reactions

Thrombophlebitis has occurred with intra
venous administration. Some degree of pain and
tenderness is usually experienced after intra
muscular injections using water. Induration has
occasionally been reported.
Allergic

Maculopapular rash, urticaria, pruritus, eosino
philia, fever and other allergic reactions have
been noted.
Gastrointestinal

Symptoms of pseudomembranous colitis can
appear during or after antibiotic treatment.
Nausea and vomiting have been reported rarely.
Blood

Transient eosinophilia, leukopenia, neutropenia,
hemolytic anemia, and thrombocytopenia have
been reported. Some individuals, particularly
those with azotemia, may develop positive direct
Coombs tests during therapy with MEFOXIN®.

R ENAL
F U N C T IO N

C R E A T IN IN E
CLEARANCE
m L / m ln

M ild
im p a irm e n t
M o d e ra te
im p a irm e n t
Severe
im p a irm e n t
E s s e n tia lly
n o fu n c tio n

DOSE

FREQUENCY

5 0 -3 0

1-2 g

e v e ry 8 -1 2 h

2 9 -1 0

1 -2 g

e v e ry 1 2 -2 4 h

9 -5

0 .5-1 g

e v e ry 1 2 -2 4 h

<5

0 .5-1 g

e v e ry 2 4 -4 8 h

In the patient undergoing hemodialysis, the
loading dose of 1 - 2 g should be given aftereach
hemodialysis, and the maintenance dose should
be given as indicated in the Table above.
Neonates (Including Premature Infants), Infants
and Children (See WARNINGS for Neonates

under ADMINISTRATION in the complete
monograph.)

Liver Function

Transient elevations in SGOT, SGPT, serum
LDFf, and serum alkaline phosphatase have
been reported.
Kidney

Elevations in serum creatinine and/or blood
urea nitrogen levels have been observed. As
with the cephalosporins, acute renal failure has
been reported rarely. The role of MEFOXIN® in
changes in renal function tests is difficult to
assess, since factors predisposing to prerenal
azotemia or to impaired renal function have
often been present.

P r e m a tu r e In fa n ts
w ith B o d y W e ig h ts
A bove 1500 g

2 0 -4 0 m g /k g e v e ry 12 h I.V.

N e o n a te s

01 w e e k o f a ge
1- 4 w e e ks o f a g e
In fa n ts

1 m o n th to 2 y e a rs
o f age

2 0 -4 0 m g /k g e v e ry 6 h o r
e v e ry 8 h I.M . o r I.V.

C h ild r e n

2 0 -4 0 m g /k g e v e ry 6 h o r
e v e ry 8 h I.M . o r I.V.

TREATMENT OF OVERDOSE
Other than general supportive treatment, no
specific antidote is known. MEFOXIN® can be
eliminated by dialysis in patients with renal
insufficiency.

DOSAGE AND ADMINISTRATION
MEFOXIN® may be administered intravenously
or intramuscularly when required. (See
complete monograph on ADMINISTRATION
and RECONSTITUTION.)
TREATMENT DOSAGE
Adults

The usual adult dosage is 1 g or 2 g of
MEFOXIN® every 6 to 8 hours. Dosage and route
of administration should be determined by
severity of infection, susceptibility of the
causative organisms, and condition of the
patient. The usual adult dosages are shown in
the Table below.
Usual Adult Dosage
T yp e of
in fe c t io n

D a ily
Dosage

In severe infections, the total daily dosage in
infants and children may be increased to
200mg/kg, but not to exceed 12 g per day.
MEFOXIN® is not recommended for the therapy
of meningitis. If meningitis is suspectecf, an
appropriate antibiotic should be used.
At present there is insufficient data to
recommend a specific dosage for children with
impaired renal function. However, if the
administration of MEFOXIN® is deemed to be
essential the dosage should be modified
consistent with the recommendations for adults
(see Table above).
PROPHYLACTIC USE

For prophylactic use, a three-dose regimen of
MEFOXIN® is recommended as follows:
Vaginal or abdominal hysterectomy and
abdominal surgery

2g administered intramuscularly or intra
venously just prior to surgery (approximately
one-half to one hour before initial incision).
The second and third 2 g doses should be
administered at 2-6 hour intervals after the initial
dose.

F req u en cy
a n d R o u te

U n c o m p lic a te d
fo rm s * o f in 
fe c tio n s s u c h as
p n e u m o n ia ,
u rin a ry tra c t
in fe c tio n , s o ft
tis s u e in fe c tio n

3 -4 g

M o d e ra te ly
se ve re o r se ve re
in fe c tio n s

6 -8 g

1 g e v e ry 4 h
or
2 g e v e ry 6 -8 h I.V.

In fe c tio n s
c o m m o n ly
n e e d in g a n ti
b io tic s in h ig h e r
d o s a g e (e.g . gas
g a n g re n e )

129

2 g e v e ry 4 h
or
3 g e v e ry 6 h I.V .

• I n c l u d i n g p a t ie n t s
a b s e n t o r u n lik e ly

2 0 -4 0 m g /k g e v e ry 12 h I.V.
2 0 -4 0 m g /k g e v e ry 8 h I.V.

1 g e v e ry 6 -8 h
I.V . o r I.M .

Cesarean Section

in

whom

b a c t e r e m ia

is

Therapy may be started while awaiting the
results of susceptibility testing.
Antibiotic therapy for group A beta-hemolytic
streptococcal infections should be maintained
for at least 10 days to guard against the risk of
rheumatic fever or glomerulonephritis. In
staphylococcal and other infections involving a
collection of pus, surgical drainage should be
carried out where indicated.
Adults with Impaired Renal Function

MEFOXIN® may be used in patients with
reduced renal function but a reduced dosage

The first dose of 2g should be administered
intravenously as soon as the umbilical cord has
been clamped. The second and third 2g doses
should be given intravenously o r in tra 
muscularly four hours and eight hours after the
first dose.

AVAILABILITY
MEFOXIN® is supplied as sterile powder in
boxes of 10 vials:
3356 Ca - 1 g cefoxitin as sodium salt
3357 Ca - 2 g cefoxitin as sodium salt
Storage

MEFOXIN® in the dry state should be stored
below 30° C.
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Above-Knee Femoropopliteal
Reconstruction With
Polytetrafluoroethylene: a Good
Alternative to Saphenous Vein Bypass
F. Laurendeau, MD, FRCSC;* J. Lassonde, MD, FRCSCt
Over 6Vi years, 64 femoropopliteal bypasses were done on 55 patients, using
polytetrafluoroethylene (PTFE). The PTFE was chosen because previous surgery or
small diameter prohibited the use of saphenous vein. The distal anastomoses were
always placed above the knee. Patency rates were 92% at 1 month, 76% at 1 year,
72% at 2 years and 59% at 3 years, and then reached a plateau of 55% at 4 years.
When autogenous vein is not available, PTFE is the material of choice for
femoropopliteal reconstruction. The results compare favourably with those using
saphenous vein in an above-knee situation.

gery, or of inferior quality. In this
context, it is suggested that polytet
rafluoroethylene (PTFE) may func
tion as well as the saphenous vein
in above-knee reconstruction. We
report our experience with PTFE
over a 78-month period.

Sur une periode de 6V2 ans, 64 derivations femoro-poplitees ont ete pratiquees chez
55 patients a l’aide de tubulures de polytetrafluoroethylene (PTFE). Le PTFE etait
choisi quand une chirurgie anterieure ou le petit calibre des vaisseaux interdisait
l’emploi d’une veine saphene. Les anastomoses distales ont toujours ete faites
au-dessus du genou. Les taux de permeabilite ont ete de 92% a 1 mois, de 76% a 1
an, de 72% a 2 ans et de 59% a 3 ans, pour ensuite atteindre un plateau de 55%
apres 4 ans. Quand il est impossible d’utiliser une veine autogene, le PTFE est le
materiau de premier choix pour la reconstruction femoro-poplitee. Les resultats se
comparent favorablement a ceux des saphenes dans les obliterations au-dessus du
genou.

Patients and Methods

I

t is generally agreed that autolo
gous saphenous vein is the best
material to use for reconstruction in
femoropopliteal disease, especially

when the distal anastomosis is
below the knee joint. However, in a
number of patients, the vein is
either absent, due to previous sur

The records of patients who un
derwent femoropopliteal bypass
grafting for arterial occlusive dis
ease at the Hopital MaisonneuveRosemont between Jan. 1, 1979
and July 1, 1985 were reviewed.
Sixty-four above-knee PTFE grafts
were placed in 55 patients (48 men
and 7 women) who ranged in age
from 45 to 86 years (mean age 62
years) (Fig. 1). In all patients, the
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FEMOROPOPLITEAL RECONSTRUCTION WITH PTFE

saphenous vein was either absent or
of insufficient diameter (less than 4
mm). The operations were per
formed for ischemic problems with
rest pain or trophic changes, or
both (34), and for claudication
alone (30). This inordinately high
frequency of patients operated on
for claudication alone was due to a
more liberal use of the procedure in
the early part of the study. We are
more conservative now. Preoperatively, all patients underwent aortofemoral angiography and noninvasive hemodynamic assessment
with segmental pressure and pulse
volume recordings. Follow-up, com
plete for all but two patients,
ranged from 12 to 84 months. Graft
occlusion was determined by clini
cal, noninvasive or angiographic
methods.
Fifteen patients were diabetic,
but only 5 were insulin dependent.
A previous vascular procedure had
been performed on 17 patients, 10
of whom had a thrombosed venous
femoropopliteal graft (Table I).
The PTFE grafts measured 6 mm
in diameter in 27 patients, 8 mm in
32 and 10 mm in 5. Use of the
10-mm graft has been discontinued.

claudication or ischemic rest pain.
There were five early thromboses
(within 30 days). In all of these
cases, the surgery was performed
for ischemic rest pain and with an
outflow tract of poor quality, that is
with only one patent vessel distally.
Three of the distal anastomoses had
been placed on an isolated popliteal
artery. Only one of these graft
failures was followed by amputa
tion.
There were three late throm
boses, at 2, 5 and 24 months
respectively; they were successfully
thrombectomized, and the grafts
remained patent thereafter. Three
other late thromboses, at 4, 7 and
60 months were followed by a
major amputation.
There were no operative deaths.
Eight patients died between 2
months and 6 years postoperatively,
five of myocardial infarction and
three of lung carcinoma. Late mor
tality was 15%.
One patient presented with a
graft infection and was found to
have a false aneurysm which
prompted removal of the graft with
out loss of the limb.

Discussion
Results
By life-table analysis the cumula
tive patency rates were 92% at 30
days, 76% at 1 year, 72% at 2 years
and 59% at 3 years; they reached a
plateau of 55% at 4 years. There
was no statistical difference wheth
er the bypass was performed for
Table I. Previous Vascular Procedures
Procedure
Failed venous femoropopliteal
bypass
Aorto-bifemoral bypass
Aorto—bi-iliac bypass
Aortic endarterectomy
Common femoral
endarterectomy

No. of
patients
10
4
1
1
1

The PTFE graft was first used in
1974,1 and other reports detailed
early and intermediate patency
rates.2-3 Aneurysmal dilatation was
noted early in the initial series4 and
corrected by an additional layer
around the graft. Since then, the
material has been used extensively.
However, application of the findings
from previous reports has been hin
dered by differences in patient selec
tion and reporting methodology. It
is generally agreed that the ideal
conduit for leg revascularization
should have an adequate diameter,
compliance characteristics similar
to the recipient arteries, a perma
nent nonthrombogenic surface and

resistance to biodegradation by ath
erosclerosis.5
There is clear evidence that the
saphenous vein provides the best
results when used in infrapopliteal
anastomoses.6 Recently, there has
been a resurgence of reports show
ing excellent results with the nonreversed in-situ saphenous vein.7
However, some investigators8 have
noted the unsuitability of the saphe
nous vein in 3% to 21% of patients.
Szilagyi and colleagues9 have dem
onstrated that the quality of the
vein, determined by its diameter,
presence of varices, fibrotic valves
and diffuse sclerosis, has correlated
well with long-term patency. In
many patients, the saphenous vein
is absent due to previous surgery.
Reports10-11 show that a PTFE
graft may function as well as the
saphenous vein when the distal
anastomosis lies above the knee.
Christenson and colleagues12
found a significantly higher cumu
lative patency rate when the distal
anastomosis of a PTFE graft was
placed above the knee than below.
Their findings corresponded with
earlier reports by Kidson and asso
ciates13 and Raithel and Groitl.14
Some15 have recommended the
use of PTFE in preference to the
autologous vein graft in the abovethe-knee situation, arguing that
this preserves the saphenous vein
for treatment of distal occlusive
disease which might subsequently
develop. Since the requirements for
autologous saphenous vein assume
greater importance as smaller ca
libre vessels are reached, the argu
ment for its preservation for use in
bypassing to the level of the tibial
vessels seems rational, but we are
not yet ready to adopt this policy.
In our series, indications for
using the PTFE graft were absence
of the saphenous vein or insuffi
cient diameter of the vein. More
over, the distal anastomosis was
always performed above the knee.
VOL. 32, NO. 1, JANUARY 1989
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Our data confirm the observation of
other investigators that PTFE may
safely be used for above-knee femoropopliteal bypass with the expecta
tion of results equivalent to those
achieved with saphenous vein. Al
though experience with the syn
thetic graft has increased, both
early thrombosis and late graft oc
clusion continue to pose serious
problems. Anastomotic neointimal
hyperplasia and progression of the
disease are mainly responsible for
late failure. There is increasing evi
dence that antiplatelet treatment
can lessen the thrombogenicity of
the graft .16 It is also well known
that PTFE bypasses are unique in
that thrombectomy alone can some
times restore long-term patency
after early thrombosis.17
Only longer follow-up and ran
domized patient selection will deter
mine whether PTFE is superior to
autogenous saphenous vein for
lower extremity bypass.18 In cases
of severe ischemia and in the rarer
cases of disabling claudication,
when the distal anastomosis can be
performed above the knee, saphe
nous vein should be the first choice.
However, if the vein is not available,
PTFE seems to be a durable and
dependable long-term alternative.
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Adrenal Myelolipomatous Nodules
Mimicking Adrenal Neoplasms: Report of
Three Cases
D.V. Bautista, MD;* M. Asch, MD;f K. Kovacs, MD, PhD, FRCPC, FCAP, FRCPath;*
D. Murray, MB, BS, FRCPath*
The authors describe three cases of adrenal myelolipoma. In the first two, unilateral
adrenal masses, assumed to represent adrenal neoplasms, were found during
urologic examination; the correct diagnosis was made by frozen-section examination
during operation. The third case involved bilateral adrenal lesions diagnosed at
autopsy in a patient suspected to have metastatic cancer. Histologic,
immunohistochemical and electron microscopic studies revealed polyclonal lesions
composed of hematopoietic cells and fat cells. Radiologic recognition and fine-needle
biopsy of these lesions are important to avoid unnecessary surgery in asymptomatic
cases. Since the lesions cannot be regarded as true neoplasms, the authors suggest
that the name myelolipoma should be replaced by the term myelolipomatous nodule.

Les auteurs decrivent trois cas de myelolipomes surrenaliens. Dans les deux
premiers cas, une masse surrenalienne u n ilateral prise pour un cancer de la
surrenale fut decouverte a l’examen urologique; le diagnostic exact fut pose a
l’examen des coupes en congelation. Le troisieme cas comprenait des lesions
surrenaliennes bilaterales qui furent diagnostiquees a l’autopsie chez un patient
soupconne d’etre atteint d’un cancer metastatique. Les examens histologiques,
immunohistochimiques, ainsi que la microscopie electronique, revelerent des lesions
polydonales composees d’elements hematopoietiques et de cellules adipeuses.
L ’identification radiologique et la ponction-biopsie a l’aiguille fine de ces lesions
sont de premiere importance si Ton veut eviter une chirurgie inutile dans les cas
asymptomatiques. Puisque ces lesions ne peuvent pas etre considerees comme de
veritables neoplasies, les auteurs suggerent de remplacer le vocable de myelolipome
par celui de nodule myelolipomateux.

myelolipomas, rare le
A drenal
sions unassociated with hor

mone production, are composed of
hematopoietic cells and fat cells
resembling bone marrow. They
were first described by Gierke in

19051 and were named “myelolipo
mas” by Oberling in 1929.2
These lesions are usually found
incidentally or at autopsy in 0.08%3
to 0.2%4 of cases. The first case of
surgically removed myelolipoma
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was reported by Dyckman and
Freedman5 in 1957. Subsequently,
several other cases of myelolipomas
have been described.6-8 Ultrasonog
raphy and, especially, computed to
mography are helpful in identifying
a fat-containing mass, suggesting
the diagnosis, but are not patho
gnomonic of myelolipoma.9
We present two patients who had
myelolipomas removed surgically
and in whom the preoperative diag
nosis was adrenal neoplasm; in a
third patient, bilateral adrenal mye
lolipomas suspected to be metasta
tic cancer were found at autopsy.
Case Reports
Case 1

A 55-year-old obese woman was
admitted for investigation of a left
suprarenal mass, discovered during
evaluation of recurrent urinary tract
infection. She complained of de
creased energy and a weight gain of
4.5 kg over the past 3 months.
Symptoms of feeling hot and
sweaty, suggesting a pheochromocytoma, were attributed to
menopause. In the past she had
been involved in a motor vehicle
accident and had sustained verte
bral fractures and hepatic and sple
nic lacerations necessitating sple
nectomy. She was being treated for
long-standing hypertension and hyVOL. 32, NO. 1, JANUARY 1989
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pothyroidism. On examination she
was in no distress, her blood pres
sure was 130/90 mm Hg and optic
fundi showed grade II hypertensive
changes.
Blood cell count, electrolyte val
ues, renal and liver function test
results and serum calcium and
phosphorus levels were all normal.
Thyroid function tests on thyroxine
supplementation gave normal re
sults. Intravenous pyelography re
vealed a large left intra- or suprare
nal lesion, which was shown on
ultrasonography to be a solid adre
nal mass measuring 5 X 6 cm. This
was confirmed by computed tomog
raphy. Angiography showed the
mass to be avascular. An adrenal
pheochromocytoma was suspected,
although catecholamine and vanillylmandelic acid values in a 24-hour
urine specimen were normal. Elec
tive left adrenalectomy was per
formed and examination of a fro
zen-section led to the diagnosis of
myelolipoma.
Case 2
A 58-year-old moderately obese
man was admitted for investigation
of a right adrenal mass discovered
by ultrasonography during exami
nation for long-standing hyperten
sion. He was asymptomatic and his
blood pressure was 170/100 mm
Hg. No abnormality was found on
physical examination.
Blood cell count, electrolyte val
ues, renal and liver function test
results and serum calcium and mag
nesium levels were normal. Cate
cholamine and vanillylmandelic acid
levels in a 24-hour urine specimen
were normal. Levels of testosterone,
androstenedione, dehydroepiandrosterone sulfate, adrenocorticotropic
hormone (ACTH), cortisol and
17-ketosteroids were within the
normal range. A chest x-ray film
showed a moderately enlarged heart
and the electrocardiographic find52
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ings were consistent with an old
anterior myocardial infarction. Ul
trasonography revealed an echogenic right suprarenal mass measuring
6.5 X 7.2 cm, which was shown by
computed tomography (Fig. 1) to be
attached to the adrenal gland. It
had a low CT number of —60 to
—70, suggestive of a fat-containing
lesion. There was also suggestion
of a mass of similar attenuation 1.5
cm in diameter associated with the
left adrenal gland. A nonfunction
ing adrenocortical adenoma was
suspected. Elective resection of the
mass and right adrenal gland was
performed and the diagnosis of
myelolipoma was made by frozensection examination.

mass suggestive of a pancreatic
pseudocyst, enlargement of both
adrenal glands to about 3.5 cm with
attenuation values suggestive of
soft-tissue and retroperitoneal lymphadenopathy. These findings sug
gested metastatic carcinoma, with
lung or pancreas as possible pri
mary sites.
The patient’s respiratory failure
progressed and he died. At autopsy,
bilateral adrenal myelolipomas were
found. Death was attributed to a
pancreatic pseudocyst, extending to
the thoracic cavity with serofibri
nous pericarditis and massive bila
teral pleural effusions causing the
respiratory failure.

Case 3

Examination of the Specimens

A 56-year-old man was admitted
with pneumonia due to Haemo
philus sp. Relevant history included
alcohol abuse complicated by pan
creatitis, liver disease, a perforated
ulcer 21 years previously requiring
gastrectomy and vagotomy, hyper
tension and, more recently, open
reduction and internal fixation for a
fractured humerus, complicated by
osteomyelitis. On physical examina
tion he was afebrile and had a blood
pressure of 120/80 mm Hg. Find
ings on chest examination were
consistent with the diagnosis of
pneumonia.
Laboratory investigation revealed
leukocytosis (leukocyte count 29.6
X 109/L), hyponatremia (114
mmol/L), hypocalcemia (1.74
mmol/L), normal serum amylase
(75 U/L), hypoproteinemia (total
protein 40 g/L) and hypoalbuminemia (albumin 19 g/L). Ul
trasonography was technically poor
and revealed no abnormality. A
chest x-ray film demonstrated bilat
eral pleural effusions, consolidation
of the left lung and a normal-sized
heart. A computed tomogram re
vealed bilateral pleural effusions, a

For light microscopy, tissue sam
ples were fixed in 10% formalin and
embedded in paraffin. Sections 4 to
6 /xm thick were stained with hema
toxylin and eosin, Gordon-Sweet
silver and Giemsa methods. For
immunohistochemical analysis, the
avidin-biotin-peroxidase complex
(ABC) technique1011 was used. Sec
tions were stained for Factor VIII,
lysozyme, leukocyte common anti
gen, immunoglobulins and light
chains. For electron microscopy,
small pieces of tissue were fixed in
2.5% glutaraldehyde, osmicated,
dehydrated in graded alcohol, pro
cessed through propylene oxide and
embedded in an Epon-Araldite mix-
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ture. Semithin sections were stained
with toluidine blue, and appropriate
areas were selected for ultrastructural study. Ultrathin sections were
stained with uranyl acetate and lead
citrate and investigated with a Phi
lips-410 LS electron microscope.
Gross Findings

The specimen from case 1 con
sisted of an adrenal gland and at
tached fat weighing 97.5 g and
measuring 7 X 7 X 4 cm. The cut
surface was hemorrhagic, firm and
brown with areas of yellow, fatty
tissue.
In case 2 the specimen consisted
of an adrenal gland with an at-

tached, encapsulated, soft mass
weighing 103 g and measuring 8.5
X 5.5 X 4 cm. The attached mass
was round, red-yellow and mea
sured 7 X 4.5 X 4 cm. The cut
surface was dark red with yellow,
fatty areas. Incorporated in the cap
sule were foci of attenuated adrenal
cortex.
The right adrenal gland in case 3
weighed 8.5 g. Attached to the
lower pole was an encapsulated,
soft mass measuring 2.5 X 5.5 X
7.5 cm. The left adrenal gland
weighed 12.5 g and also had an
encapsulated, soft mass, measuring
4 X 3 X 1.5 cm, attached to its
lower pole (Fig. 2). The cut surfaces
were hemorrhagic and red-brown.
Histologic Findings

FIG. 2. Encapsulated soft mass ( 4 X 3
X 1.5 cm) attached to lower pole of left
adrenal gland.
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Each lesion consisted of hemato
poietic cells and fat cells in variable
amounts (Fig. 3). Areas of residual
zona fasciculata and zona glomerulosa cells were seen under the adre
nal capsule. Scattered foci of zona
fasciculata and zona reticularis cells
were noted throughout the lesions.
In case 1, the lesion was located
within the cortex, expanding it.

'v .

Adipose tissue was predominant. In
case 2, the lesion was a discrete,
encapsulated mass which was
slightly more cellular than in case
1. Both lesions in case 3 were
discrete, encapsulated masses and
were more cellular than the lesions
in the other two patients. They
showed extensive hemorrhage and
hemosiderin deposit.
The composition of the hemato
poietic cells was identical in all
three cases. Megakaryocytes were
prominent. Scattered collections of
lymphocytes and cells of the erythroid series were seen. Myeloid
elements in which the Giemsa stain
demonstrated cytoplasmic granules
were present in various phases of
development. The Gordon-Sweet
silver stain revealed a delicate reticulin framework and occasional
small vascular channels. No calcifi
cation was present.
Immunohistochemical Findings

Staining for Factor VIII was posi
tive in megakaryocytes and endo
thelial cells lining vascular chan
nels. Immunoreactivity for lysozyme
was seen in monocytes, neutrophils
and their precursors (Fig. 4). Immunostaining was especially strong
in patients 1 and 3. Staining for
leukocyte common antigen was dif
fusely positive in all cases. Staining
for immunoglobulins IgG, IgA and
IgM and light chains showed focal
positivity in the lesions, indicating
the presence of plasma cells.

**/<■
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Electron Microscopic Findings
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FIG. 3. Hematopoietic and fat cells
with adjacent residual adrenal cortex
(hematoxylin and eosin, original mag
nification X 100).

FIG. 4. Immunohistochemical stain for
lysozyme showing immunoreactivity in
monocytes, neutrophils and their pre
cursors (ABC stain, original magnifica
tion X 250).

Case 3 was not studied because
of postmortem autolysis. The adre
nal cortical cells in case 2 showed
typical ultrastructural features of
steroid-producing cells with abun
dant cytoplasm containing numer
ous lipid droplets, smooth endoplas
mic reticulum membranes, parallel
VOL. 32. NO. 1. JANUARY 1989
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arrays of rough endoplasmic reticu
lum, many mitochondria exhibiting
characteristic cristae and occasional
electron-dense granules.
Electron microscopy of the le
sions gave findings consistent with
those of light microscopy (Figs. 5
and 6). Cells representing all three
hematopoietic lines were observed.
Irregularly shaped erythrocytes
were seen within vascular channels
as well as within cellular areas
which also contained megakaryo
cytes, lymphocytes and granulo
cytes in various stages of matura
tion. Megakaryocytes with large,
multilobed nuclei and abundant cy
toplasm were identified. Lympho
cytes were recognized by small,
round nuclei with indented chroma
tin, microvilli and sparse organelles.
Neutrophils, basophils and eosino
phils were identified by their char
acteristic nuclei and cytoplasmic
granules. Endothelial cells, fat cells,
fibroblasts and interspersed colla
gen bundles were also seen.

Discussion
Adrenal myelolipomas are endocrinologically nonfunctioning. Our
light microscopic, immunohistochemical and electron microscopic
studies showed that they are com
posed of hematopoietic cells and fat
cells resembling bone marrow.
The size of myelolipomas varies
from microscopic to 8 cm diameter,
and giant myelolipomas have been
reported.12' 14 The clinical presenta
tion and morphologic features have
previously been described by Del
Gaudio and Solidoro.6 As in our
three patients, most of the previ
ously described lesions were discov
ered incidentally during gastrointes
tinal or urologic examination. Most
patients were middle-aged; the
youngest reported was a 12-yearold girl with bilateral adrenocorti
cal hyperplasia and hypertension.15
54
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Many clinical associations have
been noted, including obesity, hy
pertension, chronic systemic dis
ease (e.g., malignant disease, car
diovascular disease, osteomyelitis,
pyelonephritis), serious burns and
endocrinopathies.16
The pathogenesis of myelolipo
mas is unclear. Most3-12 agree that
they are derived from undifferentiat
ed stromal cells within the adrenal
cortex which undergo myeloid
metaplasia and proliferate to form a
tumour-like mass. Alternatively,
myeloid metaplasia may develop
within pre-existing adrenocortical
nodules. Collections of myeloid cells
and fat cells have been described in
the adrenal gland, in nonfunction
ing adrenal nodules and in associa
tion with adrenocortical nodular hy
perplasia, such as in Cushing’s dis
ease.817 Boudreaux and colleagues12
reported a sequential proliferative
process resulting in the formation
of a myelolipoma in a hyperplastic
adrenal cortex. As with myelolipo
mas, these accumulations are asso
ciated with increasing age and have
also been seen in patients with
elevated blood ACTH levels and
those under stress. They are rare in

children and have not been noted in
healthy young patients who have
died suddenly. Their polyclonal
character, emphasized by our immunohistochemical and electron mi
croscopic studies, indicates that
myelolipoma is a misnomer since
this implies a neoplasm. We sug
gest that the term myelolipoma be
replaced with that of myelolipomatous nodule, which is more consis
tent with the nature of the lesion.
The stimulus causing prolifera
tion of hematopoietic and fat cells
remains enigmatic. The hypothesis
of Olsson and colleagues3 that tis
sue necrosis is the basic stimulus, is
supported by the finding of myelolipomatous change in adrenal glands
of patients dying from severe burns.
Tumour necrosis and fat necrosis in
obese patients, especially those with
hypertension, may also stimulate
cell proliferation. A review of 10
patients by Ayyat and associates18
showed associations with tissue ne
crosis. Two cases, one of a myeloli
poma associated with 17-hydroxy
lase deficiency19 and another with
Cushing’s disease,20 suggest that
hormonal dysfunction may play an
etiologic role in the development of

FIG. 5. Ultrastructure of adrenal corti
cal cells showing abundant cytoplasm
and lipid droplets (uranyl acetate and
lead citrate stain, original magnifica
tion X 2400).

FIG. 6. Ultrastructure of lesions show
ing endothelial cell, erythrocytes, two
granulocyte precursors and small lym
phocyte (uranyl acetate and lead citrate
stain, original magnification X 2400).
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the lesion. Selye and Stone21 pro
duced myelolipomatous changes in
adrenal cortices of rats injected
with necrotic tumour extracts,
testosterone and thyroxine, and
proposed that tissue necrosis in the
presence of ACTH is important in
the pathogenesis of this disease.
Boudreaux and colleagues12 empha
sized the etiologic role of humoral
agents released during tissue necro
sis, increased ACTH secretion and
androgenic stimulation.
In this series, patients 1 and 2
were middle-aged, obese and suf
fered from hypertension. Our first
patient had a history of hypothy
roidism and was receiving thyrox
ine. She also had a history of
trauma to the same side as the
adrenal lesion. Endocrinologic in
vestigations were normal in this
case and in case 2, and the involved
adrenal gland in each case con
tained no other lesions. Case 3 was
a middle-aged man with chronic
pancreatitis and a history of hyper
tension and osteomyelitis.
Local tissue necrosis combined
with thyroxine may have been re
sponsible for the development of
the myelolipoma in case 1. In case
3, extensive tissue necrosis associ
ated with stress-induced elevated
ACTH levels may have contributed
to the development of bilateral le
sions. Fat necrosis associated with
obesity and hypertension, as de
scribed previously,3 may have
played a role in case 2; however, no
endocrinologic disturbance was
demonstrated. The common factor
appears to be tissue necrosis; the
role of hormones may be to aug
ment or modify the effect of the
necrosis. Selye and Stone21 pro
duced myeloid tissue in the adrenal
glands of rats injected with crude
anterior pituitary extracts rich in
ACTH. With the addition of testos
terone, myeloid and adipose tissue
developed. Thyroxine had a syner
gistic effect.

As with previously reported
cases,6 adrenal neoplasms were sus
pected and surgical excision was
performed to establish the diagno
sis. Radiologic investigations may
reveal a radiolucent mass with dis
placement of the kidney and there
may be associated areas of calcifica
tion.622 When fatty components
predominate, ultrasonography typi
cally shows an echogenic mass;6
similarly, computed tomography
will demonstrate a fat-containing
tumour.23 These appearances vary
depending on the proportion of fat
to myelogenous components. If
nonfatty components predominate,
heterogeneous atypical images will
result.6 Angiography reveals an
avascular lesion. Radiologic recog
nition is important since surgical
excision is not necessary for small,
asymptomatic lesions.6 These pa
tients must be followed radiologically. Fine-needle aspiration guided by
computed tomography may be used
to diagnose this lesion620-23 when
the differentiation from malignant
disease is difficult.
We thank Debbie Lietz, May Wong and
the Medical Photography Department
of St. Michael’s Hospital for their assis
tance.
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T h e Risk of Occult Invasive Breast
Cancer After Excisional Biopsy Showing
In-Situ Ductal Carcinoma of Comedo
Pattern
P.D.J. Hardman, MB, ChB, FRCR;* A. Worth, MD, FRCPC;t U. Lee*
Between Jan. 1,1985 and Aug. 31,1987, 62 in-situ ductal carcinomas with a
predominantly comedo pattern were identified in 61 patients in British Columbia
from excisional biopsy of a palpable or mammographically demonstrable lesion of a
breast. The biopsies were intended to remove the lesion completely. Fifty-seven
(92%) of the 61 patients required wide re-excision or total mastectomy, usually
within a month of the initial biopsy. Occult invasive disease was demonstrated in 14
of the re-excision specimens (24.5%) and residual in-situ carcinoma was present in a
further 24 (42.1%), giving an overall rate of residual disease of 66.6%.
Axillary lymph nodes were sampled in 54 cases. Metastases were found in two
cases (3.7%) and each was associated with occult infiltrating ductal carcinoma in the
breast. This suggests that in-situ ductal carcinoma having a predominant comedo
pattern may be more widespread and associated with a higher incidence of invasive
ductal carcinoma than is generally believed.

En Colombie-Britannique, du le r janvier 1985 au 31 aout 1987, 62 cas de cancer in
situ des canaux galactophores de type comedon ont ete identifies chez 61 patientes a
partir de la biopsie-exerese d’une tumeur mammaire palpable et visible a la
mammographie. Les biopsies visaient a eliminer les tumeurs completement.
Cinquante-sept (92%) des 61 patientes ont necessity une re-excision plus large ou
une mastectomie totale, habituellement moins d’un mois apres la biopsie initiale. Un
cancer invasif occulte fut demontre dans 14 prelevements de re-excision (24.5%) et
un carcinome in situ residuel etait present chez 24 autres (42.1%), pour un taux
global de cancer residuel de 66.6%.
Des prelevements de ganglions axillaires furent pris dans 54 cas. Dans deux cas,
des metastases etaient presentes et, chaque fois, elles etaient reliees a un cancer
invasif occulte des canaux galactophores. Ces donnees indiquent que les carcinomes
in situ des canaux galactophores de type comedon sont possiblement plus repandus
et associes a une incidence plus elevee de cancers invasifs qu’on l’imagine
generalement.

From the *Division o f Radiation Oncology and fD ivision o f Pathology, Cancer Control Agency
o f British Columbia, Vancouver, BC
f Medical student, University o f British Columbia, Vancouver
Accepted fo r publication Apr. 29, 1988
Reprint requests to: Dr. A. Worth, Division o f Pathology. Cancer Control Agency o f British
Columbia, 600 West 10th Ave., Vancouver, BC V5Z 4E6
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creening programs designed to
identify carcinoma of the breast
at an early stage will result in the
diagnosis of more preinvasive duc
tal carcinomas. When intraductal
carcinoma has been identified by
biopsy, management decisions must
be based upon the likelihood of
occult invasive carcinoma being
present and on the future risk of
invasive disease in the same breast.
Intraductal carcinoma can be
classified morphologically into crib
riform, comedo, papillary, solid and
clinging forms,1 the cribriform and
comedo groups being the most
common. It has been stated2 that
there is little value in distinguishing
between these variants. The inci
dence of occult invasive ductal car
cinoma following repeat biopsy or
total mastectomy has been reported
to range from 6% to 21%.3-6 Fur
thermore, it is known that approxi
mately 1% of patients with intraduc
tal carcinoma and no evidence of
infiltration on microscopy have ipsilateral axillary lymph-node metasta
ses.7
Thymidine-labelling studies have
suggested that the morphologic
subgroups of intraductal carcinoma
have significantly different cell ki
netics.8 It is interesting that comedocarcinoma has a relatively high
rate of proliferation and apparently
a greater malignant potential than

S
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cribriform-papillary intraductal car
cinoma.
At the Cancer Control Agency of
British Columbia, patients with
comedocarcinoma are believed to be
at higher risk of harbouring occult
invasive disease than those with
other forms of intraductal carcino
ma. To demonstrate conclusively a
real difference in the incidence of
occult invasion between the mor
phologic subgroups of in-situ carci
noma would require the simulta
neous comparison by a small group
of tumour pathologists of all sub
groups of in-situ carcinoma seen in
a given period. Before embarking
upon such a study we considered it
necessary to examine the incidence
of occult invasive ductal carcinoma
found in a subsequent wider exci
sion specimen after the initial biop
sy diagnosis of in-situ ductal carci
noma of predominant comedo pat
tern. We considered a comparative
study of all variants justified only if
the incidence of occult invasive car
cinoma for in-situ comedocarcinoma
was higher than generally accepted.
In this paper we describe our expe
rience.

Patients and Methods
Available records in the cancer
registry showed that in British Co
lumbia between Jan. 1, 1985 and
Aug. 31, 1987, 4476 patients were
found to have invasive or preinvasive breast cancer. Of this number,
3137 (70%) were referred to the
Cancer Control Agency of British
Columbia from hospitals through
out the province. At this institution
all available histopathology sections
are reviewed by a small number of
reference tumour pathologists
whenever a new patient is seen.
During the study period, 55 pa
tients were referred to the agency
having a diagnosis of in-situ ductal
carcinoma of the breast of predomi

nant comedo pattern (50% or more
of the observed disease) following
excisional biopsy. Patients with metastases or Paget’s disease of the
nipple were excluded.
Six patients with in-situ comedo
carcinoma, not referred to the agen
cy, were identified from the cancer
registry. For each, histopathology
sections were available and were
reviewed. They met our criteria and
were included in the study.
Thus, 61 patients with in-situ
comedocarcinoma of the breast
were eligible for further study. In
all, the biopsy was undertaken to
remove all disease present. If a
mammographically detected lesion
was removed using fine-wire localiz
ing techniques, a postoperative
mammogram was obtained to con
firm that all detectable disease had
been removed. One patient under
went simultaneous biopsy of each
breast and was found to have bilat
eral comedocarcinoma. This patient
was considered as two separate
cases, giving a total of 62 biopsies
(cases); this represents 1.4% of all
cases of invasive and preinvasive
breast cancer known to have oc
curred in British Columbia during
the study period.
From a review of the clinical
records, the following information
was extracted: age at diagnosis,
mode of presentation, palpability of
the lesion and mammographic Find
ings.
The initial biopsy specimens were
re-examined before entering the pa
tients into the study. A diagnosis of
in-situ ductal carcinoma of predomi
nant comedo pattern was confirmed
if 50% or more of the in-situ carci
noma was associated with central
necrosis. Specimens with evidence
of stromal invasion were excluded.
Completeness of excision was based
on resection margins; the extent of
observed disease was not quantified.
If it was thought that the dis
eased tissue was not completely

excised, the patient underwent ei
ther wide local re-excision or total
mastectomy. Irrespective of the ini
tial surgical procedure, low-level ax
illary node dissection was per
formed. Any subsequent excision
specimens were reviewed and the
following features recorded: evi
dence of invasive disease, the pres
ence of residual disease (disease in
the same quadrant as the excisional
biopsy), the presence of multifocal
disease (disease in a different quad
rant), an assessment of the excision
margins, evidence of axillary node
metastases and the number of axil
lary nodes harvested.

Findings
The mean age of the 61 patients
at presentation was 53.6 years
(range from 28 to 80 years). The
presenting features were a breast
lump in 31 cases (50%), mammo
graphic abnormalities in 25 (40%)
and nipple discharge in 6 (10%).

Treatment Method
Because of doubt concerning the
adequacy of the original excision,
41 total mastectomies and 16 wide
local re-excisions were performed.
Infiltrating carcinoma was found in
four of the latter necessitating total
mastectomy in three; the fourth had
radical radiotherapy to the breast.
The definitive surgical procedures
performed, therefore, were 44 total
mastectomies and 13 wide local
re-excisions. The five remaining
cases for which the patient did not
undergo further surgical treatment
after the initial biopsy were exclud
ed from the remainder of the study.
In 55 (89%) cases sampling of the
axillary lymph nodes provided tis
sue suitable for staging. Of the 57
carcinomas for which the patient
required re-excision or total mastecVOL. 32, NO. 1, JANUARY 1989
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tomy, the surgery was performed
within 1 month of the initial excisional biopsy in 47 (82%). In seven
(12%) cases the second operation
was performed within 2 months and
in three (5%) more than 2 months
from the time of the original biopsy.
One patient underwent further
surgery only when recurrent disease
at the original biopsy site and in the
ipsilateral axilla became clinically
apparent 11 months after the inci
sional biopsy. The re-excision re
vealed infiltrating carcinoma in the
breast and axillary lymph nodes. It
is impossible to determine whether
occult invasive disease was present
at the time of the original biopsy,
but it was considered likely so the
patient was classified accordingly.

Pathological Features of the
Biopsy Specimen
All the excisional biopsy speci
mens were confirmed as showing
in-situ comedocarcinoma, without
evidence of stromal invasion. The
excision margins could not be eval
uated in 34 cases. In 21 specimens
the in-situ ductal carcinoma in
volved the excision margin so the
lesions were deemed to have been
incompletely excised. Seven speci
mens had excision margins clear of
disease.

Pathological Features of the
Wide Excision or Mastectomy
Specimen
In the 44 total mastectomy and

13 wide excision specimens, no re
sidual or multifocal in-situ ductal
carcinoma was evident in 19
(33.3%) cases. Residual in-situ duc
tal carcinoma was found in the
same quadrant as the biopsy site in
24 (42.1%), and in 14 other cases
(24.5%) infiltrating ductal carcino
ma was found at the biopsy site
together with in-situ ductal carcino
ma. There was, therefore, residual
ductal carcinoma within the breast
after the original biopsy in 38 cases
(66 .6%).

The histologic findings in these
specimens were compared with the
clinical presenting features (Table
I). Patients presenting with nipple
discharge appeared at highest risk
for subsequent residual (33%) or
infiltrating (50%) carcinoma.
Multifocal in-situ ductal carcino
ma was observed in 12 (27%) of the
44 total mastectomy specimens. All
cases of multifocal in-situ ductal
carcinoma in the initial biopsy spec
imen were associated with residual
in-situ or infiltrating ductal carcino
ma in the wider excision specimen
also.

Axillary Lymph-Node
Involvement
The number of nodes harvested
was specified in 47 of the 55 cases;
a mean of 9.2 nodes were obtained
from each patient (range from 1 to
30). Excluding the patient in whom
re-excision and axillary node dissec
tion were delayed until she present
ed with recurrent disease, there

Table I - Histologic Findings of Mastectomy or Re-excision Specimen Compared With Clinical
Presentation
Presenting features, no. (%)
Mammographic Nipple
abnormalities discharge

Histologic findings

Lump

No. residual carcinoma, n = 19
Residual in-situ carcinoma, n = 24
Infiltrating carcinoma, n = 14

10(34)
13 (45)
6 (21)

8(36)
9 (41)
5 (23)

1 (16)
2 (33)
3 (50)

Totals

29

22

6
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were two cases of axillary node
metastases in the 54 patients who
underwent axillary node dissection
within 1 month of excisional biop
sy. All cases of axillary node metas
tases were associated with occult
invasive carcinoma in the re-excision specimen.

Discussion
We believe that this is the first
report on the incidence of occult
invasive breast cancer after an ini
tial diagnosis of in-situ ductal carci
noma of predominant comedo pat
tern. Residual in-situ carcinoma was
present in 42.1% of the re-excision
specimens and infiltrating carcino
ma was present in a further 24.5%
of the study population, for a total
incidence of residual disease of
66.6%. When no attempt is made to
stratify the disease into morpholog
ic subgroups, the incidence of oc
cult invasive carcinoma is higher
than the generally quoted range of
6% to 21%.
There was no demonstrable dif
ference in the pathological findings,
whether the patient presented with
a palpable breast lump or with a
mammographic abnormality. The
association between nipple dis
charge and infiltrating carcinoma is
probably due to random variation in
a small subgroup. Otherwise, clini
cal presentation was of no value in
predicting the subsequent need for
mastectomy or re-excision.
Rosen and colleagues3 reported a
series of 129 excisional biopsies
from 121 patients having a frozenor paraffin-section diagnosis of noninvasive breast cancer. Of this
group, 103 required total mastecto
my, and occult invasive cancer was
subsequently diagnosed in 6%.
Carter and Smith4 reported a se
ries of 38 patients shown to have
intraductal carcinoma on biopsy; 7
(18%) had invasive carcinoma in the
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subsequent mastectomy specimen.
Thirty-six patients underwent defin
itive surgery within 1 month of the
biopsy, but the remaining two had a
treatment interval of 20 months and
63 months, raising the possibility
that the invasive disease developed
after the original biopsy.
Lagios and associates5 reported a
series of 80 breast biopsies, the
specimens of which were found to
contain in-situ ductal carcinoma; in
53 cases the breast was subsequent
ly resected. Occult invasive cancer
was seen in 21% of the resected
breasts and multicentric disease in
32%. One lymph-node metastasis
(2%) was found. This report sug
gests that the size of the original
lesion was an important predictive
factor for the presence of both
occult invasion and multicentric
foci of disease in the resected
breast.
Fentiman and associates6 exam
ined 82 mastectomy specimens,
which were previously shown to
contain in-situ ductal carcinoma.
Overall, 13 breasts (16%) contained
invasive disease and no case of
axillary node metastasis was ob
served. It is of interest that the
results were tabulated with specific
reference to the morphologic sub
group of in-situ disease. The data
clearly showed that in-situ disease
of comedo pattern made up 25% of
the original biopsy specimens and
yet accounted for 46% of the occult
invasive cancers. This result is not
statistically significant but does
suggest that in-situ comedocarcinoma is associated with a higher
incidence of occult infiltrating carci
noma.
Until recently, total mastectomy
was accepted as the treatment of
choice for in-situ ductal carcinoma
because most patients treated in
this way were cured of their disease.
However, in the case of small infil
trating breast cancers, local exci
sion and radical radiotherapy have

produced results comparable to
those of the various forms of radical
mastectomy.910 This has led to the
paradox that women with infiltrat
ing carcinoma may be treated by
breast-conserving techniques, but
those who present with in-situ duc
tal carcinoma undergo total mastec
tomy. It has been suggested911"16
that conservative breast techniques
be evaluated in the management of
in-situ ductal carcinoma. Clearly,
each case should be judged on its
suitability for breast conservation.
The criteria that are usually used
are familiar, from application in the
management of infiltrating ductal
carcinoma (i.e., breasts are easy to
examine, follow-up must be reliable
and resection margins clear of dis
ease). However, in this series,
66.6% of patients with in-situ comedocarcinoma had residual disease in
the re-excision specimen and 24.5%
of them had occult infiltrating car
cinoma. In all cases, the surgeon
performing the excisional biopsy at
tempted to remove all diseased tis
sue, yet in two-thirds of patients the
diseased tissue was only partially
excised. We suggest that in-situ
comedocarcinoma may be a mor
phologic variant of in-situ carcino
ma in which the disease is suffi
ciently widespread and likely to be
associated with occult invasive car
cinoma that either a very wide local
excision or total mastectomy is
necessary. If wide local excision is
to be considered as a treatment
option, it is recommended that all
excised specimens be carefully
marked to facilitate pathological as
sessment of the excision margins
and that if the lesion was detected
mammographically, the findings on
a postoperative mammogram
should be within normal limits. Ide
ally, this should be performed about
1 month postoperatively when the
reactive changes secondary to sur
gery have subsided. Any patient
treated conservatively should be fol

lowed up closely with regular physi
cal examination and screening
mammography.

Conclusions
There is no evidence to suggest
that in-situ comedocarcinoma car
ries a worse prognosis than other
forms of in-situ ductal carcinoma.
However, it appears to be more
widespread and associated with a
higher incidence of occult invasive
carcinoma than has previously been
accepted. This observation is con
sistent with the hypothesis that
in-situ comedocarcinoma is a more
kinetically active variant of intra
ductal disease and may progress to
invasive disease over a shorter time.
When considering conservative
procedures for this type of breast
cancer, the surgeon should bear in
mind that residual in-situ or inva
sive ductal carcinoma in close prox
imity to the excision biopsy cavity
was found in 66.6% of breasts re
quiring re-excision in this series.
The pathologist should take great
care when assessing the excision
margins before concluding that
conservative breast surgery is ade
quate. If the adequacy of excision of
an in-situ ductal carcinoma of pre
dominant comedo pattern is in
doubt, then further surgery, either
wide local excision or total mastec
tomy combined with low-level node
dissection is advised.
We thank Colleen Mackie for clerical
assistance and Patricia Thomas for help
preparing the manuscript.
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BOOK REVIEWS

THE CLINICAL MANAGEMENT OF
THE RENAL TRANSPLANT RECIPI
ENT WITH CYCLOSPORINE. Edited
by Ronald M. Ferguson and Bruce G.
Sommer. Grune & Stratton, Orlando,
Fla.; W.B. Saunders Company Canada
Limited, Toronto, 1986. $88.25. ISBN
0-8089-1823-0.

This monograph is an interesting and
comprehensive review of the many as
pects of renal transplantation associated
with cyclosporine therapy. Every con
ceivable treatment of the kidney trans
plant is covered in this book and it
provides convincing evidence that cy
closporine has been a major advance in
the management of transplant rejection.
However, the criteria used for monitor
ing a patient being treated with cyclos
porine, the best time to start the drug
and the duration of treatment are still
controversial. The field is advancing so
rapidly that with the advent of the
monoclonal antibody immunoassay
technique the methods for measuring
cyclosporine levels are probably outdat
ed. Therefore, many of the figures and
levels quoted in this monograph will
probably no longer apply. In spite of
60
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this, this book conveys the importance
of careful monitoring of cyclosporine
levels in the first few months after
transplantation and that a critical deci
sion must be made regarding the main
tenance level of cyclosporine required to
prevent rejection but avoid nephrotox
icity.
After reading this monograph I was
not quite sure which regimen is pre
ferred initially to prevent kidney rejec
tion — ALG and prednisone followed by
cyclosporine, or cyclosporine both preoperatively and intraoperatively. Excel
lent results can be obtained from the
use of both regimens. No doubt better
assay techniques will help answer this
question.
Although the use of cyclosporine
represents a major advance in the pre
vention of rejection, important factors
such as the technical skill of the sur
geon, short ischemic times of the donor
kidneys and good matches between
donor and recipient are still of great
importance in the success of transplan
tation programs.
This book makes excellent reading
for physicians associated with renal
transplantation. At the same time it will

be of interest to other physicians who
use cyclosporine.
E.Z. Rabin, MD, FRCPC, PhD
Division o f Nephrology,
Ottawa Civic Hospital,
1053 Carling Ave.,
Ottawa, Ont.
K1Y4E9

HAIR TRANSPLANTATION. 2nd edi
tion. Edited by Walter P. Unger and
Rolf E.A. Nordstrom. 768 pp. Illust.
Marcel Dekker, Inc., New York, 1988.
$125.00 (US). ISBN 0-8247-7724-7.

Drs. Unger and Nordstrom have provid
ed an excellent reference work to state
of the art hair transplantation. This
greatly expanded second edition in
volves many authors, each an expert in
his field. In addition, most authors
include the contributions of other trans
plant surgeons. This, along with
thoughtful editorial comments, gives
the text excellent balance.
The major strength of this book is
continued on page 64
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Management of Gallstone Ileus
Roderick G. Syme, MD, FRCSC
A recent case of recurrent gallstone ileus prompted a retrospective review of 14
cases of the disease seen at St. Joseph’s Hospital, Hamilton, between 1970 and
1986. The condition is uncommon and usually occurs in elderly women who have a
history of gallbladder disease and concomitant medical illness. Twelve patients
underwent surgery; 1 who had a “ one-stage” enterolithotomy, cholecystectomy and
repair of fistula died postoperatively. Nine patients who had enterolithotomy alone
experienced notable morbidity; they included three who had recurrent biliary tract
problems, all of which were managed successfully. The author concludes that
enterolithotomy alone should be the standard procedure for gallstone ileus.
Cholecystectomy and repair of cholecyst-enteric fistula should be done later only if
there are continuing or recurrent symptoms.

problems10-16 have prompted some8'17-22 to recommend “ one-stage”
enterolithotom y, cholecystectom y
and repair o f cholecyst-enteric fis
tula. A recent case o f recurrent
gallstone ileus after enterolithotomy
prompted a review o f our 17-year
experience with gallstone ileus.

Case Report
A l’occasion de la recidive d’un ileus cause par des calculs biliaires, on a procede a
l’etude retrospective de 14 cas similaires qui ont ete vus entre 1970 et 1986 a
l’hopital St-Joseph de Hamilton. Cette affection est peu frequente et survient
habituellement chez des femmes agees qui ont des antecedents de calculs biliaires et
une maiadie coexistante. Douze malades furent operes; 1 patiente qui subit une
intervention “ en un temps” comprenant enterolithotomie, cholecystectomie et
reparation de fistule, mourut apres l’operation. Neuf patientes qui avaient subi une
enterolithotomie seule, presentment une morbidite marquee dont trois cas de
recidive des problemes biliaires, complications qui purent toutes etre reglees.
L’auteur conclut que l’enterolithotomie seule doit etre consideree comme l’intervention standard dans les cas d’ileus calculeux. La cholecystectomie et la reparation des
fistules cholecysto-enteriques doivent etre differees et pratiquees seulement s’il y a
persistance ou recidive des symptomes.

allstone ileus (mechanical ob
struction of the gastrointesti
nal tract by one or more gallstones
in the bowel lumen) was first de
scribed by Bartholini in 1654.1 In
1890, Courvoisier2 reported 131
cases of gallstone ileus, with a
death rate of 44% from the 125
related operations. Although the
condition is rare, causing only 1%
to 3% of all intestinal obstruc

G

tions,3-5 gallstone ileus is reported
to be the cause o f nonstrangulating
obstruction in 24% o f patients over
65 years o f age.6-9 Despite improve
ments in surgical technique and
postoperative care, both morbidity
and mortality from the disease re
main high.8 Reports of recurrent
gallstone ileus, cholangitis, carcino
ma o f the gallbladder and other
postenterolithotomy biliary tract

From the Department o f Surgery, St. Joseph's Hospital, McMaster University. Hamilton, Ont.
Accepted fo r publication June 13, 1988
Reprint requests to: Dr. R. Syme, Department o f Surgery, McMaster University, 1200 Main St.
W, Hamilton, Ont. L8N 3Z5

A 75-year-old obese woman com 
plained o f vomiting, crampy upper
abdominal pain and distension and
no bowel movement for 72 hours.
Her medical history included appen
dectomy, inguinal herniorrhaphy,
hypertension and arthritis. On ex
amination, she was afebrile, nonicteric and in mild distress. Bowel
sounds were present and there was
minimal tenderness with guarding
in the left lower quadrant o f the
abdomen. Plain abdominal x-ray
films (Fig. 1) demonstrated air in
the biliary tree and dilated loops of
bowel containing a gallstone.
At laparotomy, a gallstone 2.5
cm in diameter was removed from
the terminal ileum. No other stones
were palpated, and an inflammatory
mass in the right upper quadrant
was not interfered with. The patient
did well and was discharged home 2
weeks later on a full diet.
Six days after discharge, she re
turned to hospital with a 12-hour
history o f vomiting and abdominal
pain. Repeat plain abdominal x-ray
films (Fig. 2) demonstrated dilated
loops o f bowel containing another
gallstone. Careful review o f her pre
vious abdominal films (Fig. 1) reVOL. 32, NO. 1, JANUARY 1989
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vealed the outline of a stone in the
gallbladder.
At repeat laparotomy, a gallstone
4.5 cm in diameter was removed
from the upper jejunum and the
nonresolving inflammatory mass in
the right upper quadrant was not
disturbed. When the two stones
were placed together (Fig. 3), they
formed a cast of the gallbladder, a
picture similar to that published by
Raiford17 25 years ago. The patient
had a minor wound infection after
the second operation but was well
at follow-up 18 months later.

FIG. 1. Abdominal film, first admis
sion, showing obstructed loops of bow
el, air in biliary tree (small black
arrows), gallstone causing obstruction
(white arrow) and second gallstone in
gallbladder (large black arrow).

Our Experience
The medical records of 14 pa
tients (13 women, 1 man) who had
a diagnosis of gallstone ileus and
were seen at St. Joseph’s Hospital,
Hamilton, between January 1970
and December 1986 were reviewed.
Demographic characteristics, clini
cal presentation, laboratory and ra
diology reports as well as operative
findings, procedure and outcome
were abstracted for analysis.
The patients ranged in age from
58 to 97 years (mean 75.7 years).
Six (42.8%) had a history of gall
bladder disease and seven had con
comitant medical disease (diabetes
mellitus five, hypertension three,
heart disease two, airway disease
one). Although all patients had pain
and vomiting and in over 70% there
was abdominal tenderness, the his
tory and physical findings were
nonspecific. The commonest bio
chemical abnormality, leukocytosis,
was evident in only eight cases.
Delay in presentation was common;
it ranged from 0.5 to 7.0 days
(mean 4.2 days) from the onset of
symptoms.
Plain x-ray films of the abdomen
were obtained and records were
assessed in all cases for the pres
ence of Rigler’s23 four signs of
gallstone ileus (Table I). A correct
radiologic diagnosis was made preoperatively in 64.2% of patients.
Two patients did not undergo

surgery. A 97-year-old woman who
was moribund on admission, de
clined surgery and died within 48
hours; the second had severe respi
ratory disease and the obstruction
resolved with the passage of a stone
per rectum. Of the 12 patients who
underwent surgery, 9 had enterolithotomy alone and 1 had an enterolithotomy, cholecystectomy and
repair of the fistula (“one-stage”
procedure). The two remaining pa
tients had clinical and radiologic
findings of gallstone ileus, but at
laparotomy, no stone was evident.
In one, the gallbladder was removed
and the fistula repaired; in the other
the fistula was not taken down.
Stones were found in the termi
nal ileum in six patients and in the
jejunum in four. Their diameter
ranged from 2.5 to 7.0 cm (mean
4.2 cm). Two patients had more
than one stone and 11 had an
inflammatory mass in the right
upper quadrant at laparotomy.
There were two deaths (14.2%);
the 97-year-old woman already
mentioned and the patient who un
derwent the “one-stage” procedure.
The latter, a 79-year-old woman,
had intra-abdominal sepsis requir
ing repeat laparotomy for drainage
of abscesses. Despite aggressive
treatment including zipper installa
tion for peritoneal toilet, she ac
quired the adult respiratory distress
syndrome followed by multisystem
organ failure and died 1 month
postoperatively.
The most common complication
was wound infection, which oc
curred in six patients, only one of
whom had received antibiotics preT a b le 1. R ig le r’s R a d io lo g ic S ig n s of
G a lls to n e Ile u s
Sign

FIG. 2. Abdominal film, second admis
sion shows bowel obstruction with sec
ond gallstone (arrow).
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FIG. 3. Two gallstones together form
ing cast of gallbladder.

A ir in th e b ilia ry tre e
B ow e l o b s tru c tio n
S to n e vis u a liz e d
C hange in p o s itio n
o f a p re v io u s ly
o b s e rv e d sto n e

No. o l p a tie n ts (% )
9 (6 4 .3 )
1 4 (1 0 0 )
3 ( 2 1 .4 )
2 ( 1 4 .3 )

i

i

GALLSTONE ILEUS

operatively. Of the nine patients
who underwent enterolithotomy
alone, only two were problem-free
postoperatively. Five had wound in
fections, which led in one case to
dehiscence and in another to late
incisional hernia. Three of this
group had recurrent biliary tract
problems: one had a common-bileduct stone managed successfully by
endoscopic retrograde cholangi
opancreatography and sphincteroto
my; one had recurrent biliary colic
managed by cholecystectomy, ex
ploration of the common bile duct
and repair of the cholecyst-enteric
fistula 3 months after enterolithoto
my; and one (our case report) had
recurrent gallstone ileus managed
with repeat enterolithotomy.

Discussion
This study, consistent with other
published series,24-29 shows that
gallstone ileus is an uncommon
disease of elderly women, approxi
mately half of whom have a history
of gallbladder disease. There is
often a delay of several days in
seeking medical attention and they
frequently have concomitant medi
cal conditions complicating man
agement. Unfortunately, history,
physical findings and laboratory
data are of little help in diagnosis.
Radiologic criteria, as put forward
by Rigler,23 allowed us to make a
correct preoperative diagnosis of
gallstone ileus in 64.2% of patients,
which compares favourably with the
less than 50% reported in most
other series.222527
Most gallstones entering the in
testine are small enough to be
passed uneventfully. As in other
series,24-29 we found no stone smal
ler than 2.5 cm in diameter causing
obstruction of the bowel. In over
90% of our patients operated on (11
of 12), an inflammatory mass was
noted in the right upper quadrant,

raising the controversial issue of
appropriate management: enteroli
thotomy alone or enterolithotomy
in combination with cholecystecto
my and closure of the fistula (“onestage” procedure). In our small se
ries, the one patient who underwent
the latter procedure died and anoth
er (in whom the stone appeared to
have passed) underwent cholecys
tectomy and repair of fistula with
out enterolithotomy and survived.
The nine patients who underwent
enterolithotomy alone all survived
but not without morbidity, which
included recurrent biliary tract
problems in three. Nevertheless, all
complications in the enterolithoto
my group were successfully ma
naged using standard approaches,
including endoscopy and open sur
gery. Although this series is too
small to be of statistical signifi
cance, we, as surgeons, are often
forced to make decisions based on
such reports when dealing with
conditions as uncommon as gall
stone ileus.
The “one-stage” procedure of en
terolithotomy, cholecystectomy and
repair of fistula was first suggested
by Holz30 in 1929 and later by
Fraser31 in 1954 and Welch and
associates32 in 1957, each reporting
a single case. The rationale was to
prevent recurrent gallstone ileus,
cholangitis, carcinoma of the gall
bladder and other biliary tract prob
lems, reported to occur in up to
30% of patients after enterolithoto
my alone.10-16 Between 1962 and
1975, seven more papers817-22 ap
peared, supporting the “one-stage”
procedure, but they totalled only 23
cases. In the largest of these series,
Cooperman and associates20 report
ed one death in eight patients who
underwent the “one-stage” proce
dure and no deaths (but three re
currences) in six patients who un
derwent enterolithotomy alone. Kasahara and colleagues24 reported 66
patients of whom 50 underwent

enterolithotomy alone and 16 the
“one-stage” procedure; the death
rates were 12% and 19% respective
ly. Of the patients who underwent
enterolithotomy alone, 14% had re
current biliary tract problems,
which, as in our series, were dealt
with successfully. VanLandingham
and Broders26 reported nine cases of
gallstone ileus in which the only
death, as in our series, was a pa
tient who underwent the “onestage” procedure. However, their
collected literature of 191 cases (35
“one-stage” procedures) failed to
show a statistically significant dif
ference in mortality between en
terolithotomy (11%) and “onestage” procedure (20%) (p < 0.2).
Deitz and colleagues29 carried out
four “one-stage” procedures with
no deaths and reported three deaths
amongst 18 patients who under
went enterolithotomy alone.
Proponents of the “ one-stage”
procedure stress careful patient se
lection so that only those able to
withstand the more extensive sur
gery will be considered. Given the
age of the patients, concomitant
medical illnesses and frequent delay
in presentation, few would be suit
able candidates. One must also bear
in mind that the majority of pa
tients do not have further problems
after enterolithotomy and that
those problems that do develop can
usually be dealt with later, success
fully, under more favourable condi
tions. This relatively benign course,
coupled with the often precarious
physiologic status of the elderly
patient who has acute obstruction,
argues strongly for enterolithotomy
alone as the standard of care for
gallstone ileus, with cholecystecto
my and repair of the fistula done
later and only for continuing symp
toms.
The advice and support of Drs. Ken
O’Brien, E.J. Thomas and Caroline Tallmadge are gratefully acknowledged.
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BOOK REVIEWS
continued from page 60

that it guides the reader through all the
stages of hair transplantation from the
initial interview, through harvesting
and planting of plugs, to postoperative
care and problems. I found Alt’s contri
bution on the donor site to be exhaus
tive and most useful. Also, Unger’s
excellent chapter on the recipient site
has been enlarged to include hair trans
plantation in early androgenetic alope
cia, in women, in blacks and in orien
tals. The most important recent ad
vances in hair transplantation, including
alopecia reduction, unigrafts, micro
grafts, and quarter-grafts are well re
viewed. The alternative to hair trans
plantation, flap surgery, is discussed
thoroughly.
The generous use of photographs
and diagrams enhances the reader’s
understanding of the text. The only
error I found was in Table I on page
119.
I highly recommend this textbook for
both the novice and expert hair trans
plant surgeon. Let us hope that we will
not have to wait another 9 years for the
next edition.
N. Kanigsberg, MD, FRCPC
Ste. 401,
340 McLeod St..
Ottawa, Ont.
K2P 1A4

MANAGEMENT OF ABDOMINAL
HERNIAS. H. Brendan Devlin. 222 pp.
Illust. Butterworth & Co. (Publishers)
Ltd., London, 1988. Price not stated.
ISBN 0-407-00348-7.
Brendan Devlin is a general surgeon at
Stockton-on-Tees in northeast England.
His stated intention to produce “a neat,
practical book on hernia, not an ex
haustive text” is fulfilled, although it is
not clear for which audience this book
is intended. As a result of large type,
logical British style and multiple clear
illustrations, this book is easy to read.
Although it is only 200 pages long, it
covers a large volume of material and at
a size of 23 X 28 cm it will not likely fit
into the pocket.
The book gives a brief but useful
history of hernia surgery and includes,
at the end, biographical notes on pio
neers in the field such as Bassini,
Cooper and McVay. Canadians will be
pleased to observe the credit given to
Earle Shouldice and Frank Glassow in
the development of hernia surgery. In
fact, the Shouldice repair is emphasized
throughout the book. Mr. Devlin points
out that hernia repair is poorly per
formed by many general surgeons and
that recurrence rates are unacceptably

i
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J

ORIGINAL ARTICLES

Popliteal Aneurysms: an Index of
Generalized Vascular Disease
C.Wm. Cole, MD, FRCSC; A.M. Thijssen, MD; G.G. Barber, MD, FRCSC; N.V. McPhail, MD, FRCSC;
T.K. Scobie, MD, FRCSC
A review of 59 popliteal aneurysms in 38 patients seen over 10 years revealed that
34 (58%) aneurysms were symptomatic. Symptoms included gangrene (15%),
ischemia due to thrombosis (38%) and embolism (5%). Patients with unilateral
aneurysms (45%) were a median of 7 years younger than those with bilateral lesions
(55%). The latter group had more frequent manifestations of occlusive disease,
which included previous myocardial infarction, coronary artery bypass grafting and
stroke. They also had more concomitant aneurysms, those of the abdominal aorta
and femoral and iliac arteries being the most common. Management consisted of
bypass grafting in 34 limbs and immediate amputation in 9; 16 inoperable limbs
remained viable. At last follow-up (median 32 months) or time of death, 30 of 34
grafts were patent. Four grafts occluded, one perioperatively and the others at 4, 5,
and 32 months respectively, resulting in two amputations. The cumulative patency
rate in the asymptomatic group was 94% compared with 81% in the symptomatic
group. These data illustrate that patients with popliteal aneurysms may have
associated vascular disease, the likelihood of which is increased when aneurysms are
bilateral.
La revue de 59 cas d’anevrismes poplites observes chez 38 patients au cours d’une
periode de 10 ans revele que 34 (58%) de ces anevrismes etaient symptomatiques.
Gangrene (15%), ischemie post-thrombotique (38%) et embolies (5%) faisaient partie
des symptomes. Les patients souffrant d’un anevrisme unilateral (45%) avaient un
age median de 7 ans plus jeune que ceux qui avaient des lesions bilaterales (55%).
Ce dernier groupe presentait plus frequemment des manifestations de maladies
ischemiques comprenant infarctus du myocarde anciens, pontages aortocoronariens
et accidents cerebrovasculaires. Ils avaient egalement plus souvent des anevrismes
concomitants, ceux de l’aorte abdominale et des arteres femorale et iliaque etant les
plus frequents. II y eut 34 pontages de 9 amputations immediates; 16 membres
inoperables furent conserves. Au dernier examen de surveillance (mediane de 32
mois) ou au moment du deces, 30 des 34 greffes etaient permeables. Quatre
derivations se sont bouchees, une durant la periode peroperatoire et les autres apres
respectivement 4, 5 et 32 mois, entrainant deux amputations. Le taux cumulatif de
permeabilite etait de 94% pour le groupe asymptomatique, comparativement a 81%
pour les patients symptomatiques. Ces resultats illustrent que les patients souffrant
d’anevrisme poplite peuvent avoir des vasculopathies associees avec une probability
qui croit en presence d’anevrismes bilateraux.

From the Division o f Vascular Surgery, University o f Ottawa, Ottawa, Ont.
Presented at the 9th annual meeting o f the Canadian Society fo r Vascular Surgery, held in
conjunction with the 56th annual meeting o f the Royal College o f Physicians and Surgeons o f
Canada, Winnipeg, Man., Sept. 12, 1987
Accepted for publication Aug. 12, 1988
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ith justification, popliteal an
eurysms have been termed
the “sinister harbinger of sudden
catastrophe”.1 Left untreated, the
majority will cause complications,
and in roughly one-third of pa
tients, limb amputation, usually
above the knee, will be required.2
Management of a patient with bilat
eral popliteal aneurysms, one of
which is thrombosed, presents the
surgeon with a dilemma concerning
the order of surgical treatment,
because the asymptomatic aneu
rysm may thrombose while atten
tion is focused on the other limb.
This dilemma prompted us to re
view our experience with popliteal
aneurysms to clarify our approach
to this clinical problem.

W

Patients and Methods
Most authorities1-4 accept that a
vessel diameter of more than 2 cm
is diagnostic of an aneurysm of the
popliteal artery.
Thirty-eight patients (1 woman,
37 men) with 59 popliteal artery
aneurysms were treated at the Otta
wa Civic Hospital between 1976
and 1987; the aneurysms were doc
umented by angiography or ul
trasonography in all cases.
Comparison of reported series is
difficult because of patient classifi
cation according to complications
and symptoms.1 In this study it was
not always possible to identify the
initial complaint, so patients were
classified according to the complica
tions that had developed when the
VOL. 32, NO. 1, J A N U A R Y 1989
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popliteal aneurysm was diagnosed.
A classification of asymptomatic
was applied to patients who had
only local discomfort or a popliteal
mass, the aneurysm being unrecog
nized by the patient before it was
discovered by the physician.
Follow-up was by regular clinic
visits using noninvasive Doppler
pressures and waveform analysis in
most cases. When travel or distance
was a problem the information was
acquired by telephone.

Findings
Of the 59 aneurysms, 25 were
asymptomatic; they included 1 that
had thrombosed, presumably for
some time before the patient sought
help for symptoms in the opposite
limb. Thirty-four aneurysms were
symptomatic. The symptoms or
signs included gangrene in 9, isch
emia due to thrombosis in 22 and
distal ischemic changes as a result
of emboli originating in the aneu
rysm in 3.
The cumulative graft patency
rate in asymptomatic limbs was 94%
and graft failure did not lead to
amputation. In contrast, there was
a graft patency rate of 81% in
symptomatic limbs, with two ampu
tations.
Follow-up was complete for 31
patients (50 popliteal aneurysms);
the other 7 (9 popliteal aneurysms)
were lost to follow-up after several
months.
Of the 38 patients, 17 had unilat
eral and 21 bilateral aneurysms.
Patients with unilateral aneurysms
were a median of 7 years younger
than those with bilateral aneurysms
(63 years versus 70 years). In two
patients who had unilateral aneu
rysms, another aneurysm developed
in the opposite leg, after 5 and 7
months respectively; they are in
cluded in the bilateral group. Asso
ciated occlusive vascular disease
66
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and additional aneurysms were
more common in those who had
bilateral popliteal artery aneurysms
than in those with unilateral lesions
(Table I).
Unilateral Aneurysms

Three of the 17 unilateral popli
teal artery aneurysms were throm
bosed, two patients requiring above
knee amputation; the other limb
remained viable although function
ally impaired. Eleven symptomatic
and 3 asymptomatic limbs were
suitable for bypass grafting (Table
II). Patency rates of grafts to
asymptomatic aneurysms were su
perior to those of symptomatic an
eurysms. Two grafts occluded, one
at 5 months resulting in a belowknee amputation and the other at
32 months resulting in a compro
mised but viable limb. Both grafts
were of reversed saphenous vein.
Bilateral Aneurysms

In this group of 21 patients,
treatment generally was directed
first to the symptomatic limb.
The aneurysm was asymptomatic

on one side in 12 patients and on
both sides in 6. Two asymptomatic
aneurysms, though not throm
bosed, were associated with severely
impaired circulation in the tibial
vessels and were unsuitable for by
pass grafting; neither aneurysm was
symptomatic on follow-up averag
ing 44 months. Bypass grafts were
inserted in 5 of 24 asymptomatic
limbs because the symptomatic limb
was not amenable to vascular re
construction. One of the five grafts
(saphenous vein) occluded in the
perioperative period, but did not
lead to amputation.
After surgical treatment on the
symptomatic limb, 17 opposite
asymptomatic limbs were subjected
to a period of observation. Bypass
grafting was later carried out on
10 of them; 6 remained under ob
servation for a variety of reasons
relating to the general health of the
patient or an unwillingness to un
dergo surgical repair. In one case
an asymptomatic aneurysm throm
bosed while the patient recovered
from bypass surgery for a throm
bosed aneurysm in the opposite
limb; this resulted in a below-knee
amputation of the previously
asymptomatic limb.

Table 1. Associated Vascular Occlusive Disease and Other Aneurysms

I

1

I

1

I
i

Patients, %
Associated disease/
aneurysm
Myocardial infarction
Coronary artery bypass grafting
Stroke
Abdominal aortic aneurysm
Femoral/iliac aneurysm

Unilateral
aneurysm
(n = 17)

Bilateral
aneurysms
(n = 21)

24
6
12
24
18

33
10
19
38
29

1

Table II. Cumulative Graft Patency Rates After Bypass of Popliteal Artery*
Asymptomatic
Unilateral
Bilateral
Totals
Patency, %

Symptomatic

Vein

ePTFE

Vein

ePTFE

Total patients/
total grafts

3/3
13/14

1/1

9/11
3/4

1/1

12/14
18/20

17/18
94

13/16
81

I

30/34

88

*Follow-up ranged from 3 to 112 months (median 32 months). Vein = reversed saphenous vein,
ePTFE = expanded polytetrafluoroethylene.
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Three patients had thrombosis of
both popliteal aneurysms and two
required bilateral above-knee ampu
tation; one had inoperable yet viable
limbs despite bilateral vascular im
pairment. Seven patients had an
ticoagulation therapy until elective
angiography could be done to deter
mine their suitability for surgical
treatment; 5 of the 14 limbs were
treated with bypass grafting, the
remainder were not suitable. Five of
the latter eventually required ampu
tation some months later. Graft
material was saphenous vein in four
and expanded polytetrafluoroethylene (ePTFE) in one.
Three of nine patients who died
had patent bypass grafts at the time
of death, and graft failure led to an
above-knee amputation in another
but was not a direct cause of death.

Discussion
Aneurysms occur in the popliteal
artery with a frequency that is sec
ond only to those of the abdominal
aorta, and their presence indicates
the high probability of another an
eurysm, either in the contralateral
popliteal artery or elsewhere.1' 13
This study and others (Table III)
support this observation, and the

Table III. Reported Series of Popliteal Aneurysms

|

I
>
>

►
►

pend on the severity of symptoms.
However, the surgeon should be
alert to the perilous situation the
patient may be in if the asymptom
atic aneurysm thromboses while at
tention is focused on the symptom
atic leg. When thrombosis does not
produce symptoms, surgical repair
is not indicated and when resulting
symptoms are tolerable, without
limb-threatening ischemic changes,
a short delay while the asymptomat
ic aneurysm is dealt with will not
alter the eventual outcome. Vessels
patent distal to the thrombosed an
eurysm will not be affected by a
delay of a few weeks during which
elective repair of the asymptomatic
fellow may avoid thrombosis and
amputation in more than one-third
of cases. As a consequence of our
immediate attention being focused
on the symptomatic limb in patients
with bilateral lesions, one patient
had thrombosis of the asymptomat
ic aneurysm while convalescing at
home after bypass grafting of the
thrombosed symptomatic limb.
Ischemia due to acute thrombosis
may threaten limb viability, and in
such cases immediate efforts must
be made to salvage the limb. Explo
ration of the vessel below the aneu
rysm and thrombectomy with a Fo
garty catheter may open a major

fact that bilateral aneurysms in
crease that probability. Data show
that the coronary or cerebral circu
lation is more likely to be occlud
ed in patients with bilateral lesions
and should the popliteal trifurcation
be similarly affected, it is considered
a predictor of myocardial infarction
after vascular reconstruction.14
Therefore, patients who have popli
teal aneurysms should undergo
careful cardiac and cerebrovascular
assessment. In this study, the differ
ence in median age of 7 years
between the two groups is probably
only one of several factors,1 includ
ing a strong genetic predisposition
to affect men.4
Our experience with respect to
graft patency rate is consistent with
that of other series41' 13 and reaf
firms that the results of surgical
treatment are substantially better
when undertaken before thrombosis
or embolism limits the outflow bed
distal to the aneurysm. Once the
popliteal aneurysm has thrombosed,
the need for eventual amputation
may not differ whether the limb is
suitable for bypass grafting or not.3
In patients with a thrombosed pop
liteal aneurysm and asymptomatic
disease in the other limb, manage
ment must be individualized, and
the indications for surgery will de

Series
Edmunds and associates, 1965s
Baird and associates, 19666
Crichlow and Roberts, 19667
Wychulis and associates, 19708
Bouhoutsos and Martin, 19749
Tompkins and associates, 1977'°
Inahara and Toledo, 197811
Guvendik and associates, 198012
Szilagyi and associates, 19812
Vermilion and associates, 19813
Reilly and associates, 19834
Whitehouse and associates, 19831
Anton and associates, 198613
Present series, 1987

No. of
patients
82
51
42
152
71
18
30
20
62
87
159
61
110
38

Male*
female
_
-

42:0
37:1

Associated occlusive
disease, %
Ml
32
=>30
10
21

CABG

Stroke

AAA

_

13
22
7
18
10

36
12
14
35
32
28
37
30
40
40
21
62
29
32

-

-

-

-

17:1
14:1
20:0

-

-

_

7

-

-

-

-

_

-

-

-

-

-

25

-

15:1
30:1
54:1
37:1

-

-

3
14
5

=>33
-

29

Other aneurysms, %

-

15
8

-

16

Iliac/
femoral

Bilateral
popliteal

=>15
=>10
=>12
=>50
13
33
27

32
42
36
59

-

=>39
= 55
= 23
37
32
24

-

45
47
33
40
68
35
44
61
55

= Approximate determinations based on data reported. Ml = myocardial infarction, CABG = coronary artery bypass grafting, AAA = abdominal aortic
aneurysm.
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outflow vessel9 but does not relieve
thrombosis in the capillary network.
Direct intra-arterial thrombolytic
therapy intraoperatively has had
some success15 and may be a help
ful addition to operative thrombec
tomy of distal vessels; in this situa
tion, tibial artery thrombosis is as
sociated with a 70% limb loss.16
However, reports of success are few
and uncontrolled, and there are no
long-term follow-up studies.
The rationale for an aggressive
surgical approach to asymptomatic
popliteal aneurysms lies in “the
threat of unforeseeable grave com
plications”2 associated with them.
We recommend, as others9 have,
that in patients who have bilateral
popliteal aneurysms, one throm
bosed and one asymptomatic, the
asymptomatic limb should be ma
naged first.
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SESAP V Critique
Item 218
With rare exceptions, aneurysms of the popliteal artery occur almost
exclusively among men of advanced age. Complications include throm
bosis with limb ischemia, as well as distal embolization producing the
so-called "blue toe” syndrome. The incidence of associated aneurysmal
disease, particularly contralateral popliteal aneurysms, which may be
uncalcified and asymptomatic, as well as of abdominal aortic aneurysms,
is high. Spontaneous rupture and hemorrhage is rare but may occur. All
popliteal aneurysms should be treated surgically if the patient’s
condition permits, even if they are asymptomatic, because of the high
incidence of limb loss with initial symptoms. Proximal and distal ligation
with bypassing of the aneurysm is preferred. The aneurysm may be
resected, but injury to the popliteal vein and tibial nerve is a potential
hazard.
,__,
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Complications and Functional Results
After Limb-Salvage Surgery and
Radiotherapy for Difficult Mesenchymal
Neoplasms: a Prospective Analysis
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Wide resection with adjuvant radiotherapy is generally accepted as the optimal
treatment for patients with extremity soft-tissue sarcomas. However, there is a
subset of patients with “difficult” tumours who sustain such marked loss of function
from limb-salvage procedures that amputation might offer a superior functional
alternative. To evaluate this issue, the authors prospectively designated 19 of 52
patients registered in Toronto’s Princess Margaret Hospital Prospective Sarcoma
Database in 1986 as “difficult” cases, on the basis of tumour size and anatomical
location. Complications and functional results of wide resection and adjuvant
radiotherapy were documented. The most frequent complication was related to
wound healing (8 of 19 patients). Functional analysis at 1 year follow-up
demonstrated that all 19 patients had results superior to those that would be
expected with amputation.

Une resection large avec radiotherapie adjuvante est generalement consideree etre le
traitement optimum pour les patients souffrant de sarcomes des tissus mous des
extremites. Toutefois, il existe un sous-groupe de patients porteurs de tumeurs dites
“difficiles” qui subissent une telle perte fonctionnelle a la suite d’une intervention
visant a sauvegarder le membre, que l’amputation pourrait offrir une alternative
superieure. Afin d’etudier cette question, les auteurs ont designe, de fa?on
prospective, 19 des 52 patients inscrits en 1986 au Registre prospective des
sarcomes du Princess Margaret Hospital de Toronto, comme des cas “difficiles”
d’apres la faille et l’emplacement anatomique des tumeurs. Les complications et les
resultats fonctionnels de la resection large avec radiotherapie adjuvante ont ete
evalues. La complication la plus frequente se rapportait a la cicatrisation de la plaie
(8 des 19 patients). L’analyse fonctionnelle effectuee apres 1 an de surveillance
demontre que chacun des 19 patients presente des resultats superieurs a ceux qu’on
aurait pu anticiper d’une amputation.
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urgical treatment of patients
having locally aggressive mes
enchymal tumours has improved
substantially in the past 15 years.
Enneking’s original anatom ical
studies of soft-tissue sarcoma dem
onstrated that its characteristic in
vasion of peripheral muscle resulted
in microaggregates of malignant
cells penetrating beyond the pseu
docapsule of the primary lesion.1
This meant that potentially con
taminated tissue had to be resected
if local control was to be achieved
by surgery alone. According to Enneking, this necessitated removal of
the entire limb compartment in
volved by tumour, either by radical
resection or amputation proximal to
the origin of muscles inside the
fascial compartment.1-3
Recognition that high-dose radia
tion can eliminate microscopic
spread of soft-tissue sarcoma has
modified the surgical management
of this disease. Several studies have
demonstrated that resection of the
gross tumour mass with a limited
margin of normal tissue (wide resec
tion) combined with adjuvant radio
therapy is adequate for local con
trol.4-9
Despite the obvious functional
benefits of conservative, limb-spar
ing surgery, combined treatment
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(surgery and high-dose radiothera
py) can result in considerable imme
diate local disability,910 especially
after extensive surgical dissection
because of the anatomic site or size
of the lesion. Indeed, it has been
suggested that the soft-tissue dis
ability after the combined treatment
of soft-tissue sarcoma can be so
severe that primary amputation may
have provided a superior functional
result.10
In this paper we consider the
complications and functional results
after surgery combined with the
radical radiotherapy, by prospective
ly reviewing the clinical course of
19 patients with large aggressive
mesenchymal neoplasms. Because
of tumour size or its anatomic loca
tion these patients might be consid
ered candidates for amputation.

Patients and Methods
There were 19 patients in the
study (11 men and 8 women). They
ranged in age from 20 to 70 years
(mean 45.2 years). All were fol
lowed up after operation for at least
16 months (range from 16 to 26
months).
Patient Selection

All cases of soft-tissue sarcoma
or aggressive fibromatosis, treated
by members of the University of
Toronto Sarcoma Group, are regis
tered prospectively in The Princess
Margaret Hospital Prospective Sar
coma Database. During 1986, 19 of
52 patients registered (11 men, 8
women) were characterized as hav
ing “difficult” tumours, based on
the following criteria:
• Tumour size more than 20
cm.
• Tumour extension within the
true pelvis.
• Encasement of the iliac or
common femoral vessels.
70
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• Tumour origin distal to the
knee or elbow, with involvement of
bone, muscle and skin that would
necessitate extensive tissue transfer
and skeletal reconstruction after
adequate wide resection.
• Axillary location with invasion
of the chest wall.
In the literature there are no
accepted characteristics to define a
subset of “ difficult” or virtually
unresectable lesions, but the criteria
listed encompass tumours that re
quire long, complex procedures for
limb salvage.
Pathological Analysis

The protocol for pathological ex
amination of the resected specimen,
established by the University of To
ronto Sarcoma Surgery Group, has
the following guidelines, adhered to
in all cases to determine if local
resection has been adequate:
• Preoperative evaluation of the
diagnostic biopsy and computed to
mogram by the surgical pathologist
managing the case.
• Examination of the resected
specimen in the operating room for
orientation by the surgeon and pa
thologist.
• Painting of the resection mar
gins.
• Sectioning of the tumour in
the pathology suite adjoining the
operating room.
• Oriented frozen section from
any resection margin with less than
1 cm of normal tissue covering the
pseudocapsule.
• Extensive sampling of the
margins for permanent sections to
determine whether microscopic dis
ease was present at any resection
surface.
Representative samples from the
diagnostic biopsy and resected spe
cimens were reviewed by an expe
rienced musculoskeletal patholo
gist (V.L.F.) who determined both
the histologic subtype and grade of

the tumour. The Musculo-Skeletal
Tumour Society definition of histo
logic grading was used.1
Radiotherapy

The protocol for radiotherapy at
The Princess Margaret Hospital
consists of radical treatment of 55
to 65 Gy at 10 Gy/wk, five frac
tions per week, for soft-tissue sar
coma. Treatment is either preopera
tive (40 to 50 Gy in 4 to 5 weeks
before surgery, with any remaining
dose administered postoperatively
using a shrinking-field technique)
or wholly postoperative after wound
healing is complete. Aggressive fi
bromatosis is generally treated with
a total dose of 55 Gy. Part of the
circumference of the limb should be
excluded to reduce the risk of encir
cling fibrosis and distal edema.
Postoperative Complications

Soft-tissue complications were
defined as necrosis of the wound
edge, dehiscence or drainage that
required dressings for longer than 7
days. Wound drainage was cultured
and isolation of the same organism
on more than one sample was ac
cepted as evidence of infection. Vas
cular, neurologic and skeletal com
plications were also included in this
review.
Function

A detailed functional analysis rat
ing (modified from that of the Mus
culo-Skeletal Tumour Society1) was
determined prospectively, before
surgery and at follow-up 3, 6, 12
and 18 months after. For the pur
pose of this presentation, only the
ambulatory status of patients with
lower extremity tumours and the
presence of pain persisting more
than 3 months after the completion
of treatment will be considered.

DIFFICULT MESENCHYMAL NEOPLASMS

Results
Pathologic Features and Treatment

t

l

Sixteen patients presented with
high-grade sarcomas: malignant fi
brous histiocytoma in 9, synovial
sarcoma in 2, liposarcoma in 2,
fibrosarcoma in 1, soft-tissue chon
drosarcoma in 1 and a chondrosar
coma originating in bone with mas
sive soft-tissue extension in 1.
Three patients had aggressive fi
bromatosis that had recurred locally
at least twice before the described
operative procedure. Ten patients
presented with extensive thigh sar
comas; 3 of them required intraop
erative vascular resection and re
construction. Three patients had
pelvic sarcomas and four distal tu
mours involving bone, muscle and
skin that required composite resec
tion and reconstruction using skele
tal stabilization and microvascular
free tissue transfer. Two patients
who had axillary tumours required
composite en-bloc resection of the
chest wall.
Of the 19 patients, 11 had previ
ously undergone incomplete tu
mour resection. In each case gross
tumour remained at the end of the
procedure. Six of these had resec
tion and irradiation at the time of
local recurrence; the other five
underwent further resection imme
diately and received radiotherapy.
The operative procedures were
long and complex; those for thigh
tumours averaged 5.8 hours, for
pelvic tumours 8.2 hours, for distal
extremity lesions 4.2 hours and for
axillary lesions 8.2 hours.
Three patients had undergone
radical radiotherapy for residual
gross disease more than 1 year
before definitive management. Eight
patients received preoperative radio
therapy (40 to 50 Gy) with a post
operative boost to 55 to 65 Gy. Six
patients underwent postoperative
radiotherapy only.

Complications

Eight of 13 patients with thigh
or pelvic sarcomas suffered major
wound complications that required
secondary procedures. In two, small
areas (less than 5 X 5 cm) of skin
necrosis developed but healed rapid
ly after split-thickness skin graft
ing. Three patients had larger areas
of necrosis (greater than 10 X 10
cm) that required debridement and
grafting; of these, wounds were
healed in two 3 months and in the
third 9 months after surgery. The
patient with delayed healing had
chemotherapy postoperatively for a
lung metastasis.
Three patients with thigh and
pelvic sarcomas required vascula
rized tissue transfer for extensive
wound dehiscence which developed
after vascular reconstruction in
two.
None of the patients who had
axillary or distal extremity tumours
managed by primary reconstruction
with free tissue transfer suffered
wound complications.
The timing of radiotherapy and
surgery did not seem to affect the
incidence of wound complications;
6 of 13 patients who had preopera
tive radiotherapy suffered wound
complications compared with 2 of 6
patients who had postoperative ra
diotherapy.
All wound complications were
treated immediately and aggressive
ly.
Vascular complications occurred
in five patients. One who had a
large thigh tumour, sustained
thrombosis of the superficial femo
ral artery immediately after resec
tion of the lesion; thrombectomy
was successful. Two patients who
underwent vascular resection and
reconstruction suffered major
wound dehiscence which required
debridement and vascularized tissue
transfer for limb salvage. Chronic
arterial insufficiency was not en

countered. Two patients now suffer
from chronic venous insufficiency
and wear compression hose while
walking.
Six patients had neurologic com
plications postoperatively. Three
had complete, permanent, motor le
sions of the sciatic nerve, requiring
the use of an ankle-foot orthosis.
Two required a cane when walking.
Three other patients had substantial
loss of the femoral nerve during
anterior thigh resections. Two of
these required a drop lock knee
brace for stability while walking and
the third learned to walk with a
knee recurvatum gait.
Three patients who underwent
bone resection during tumour re
moval later suffered pathologic frac
tures in the area. Two required
reoperation and internal fixation;
the third fracture healed in a cast.
Function and Follow-up

All but one patient, who had a
pathologic fracture of the tibia, had
stopped the regular use of narcotic
analgesics within 3 months of sur
gery. Two who had pelvic resection
required codeine when active and
two (one who underwent thigh re
section and the other a distal ex
tremity resection) required anti
inflammatory medications regularly.
The others, including the patient
with a pathologic fracture, required
no analgesics at 1 year.
All of the 16 patients who had
lower extremity lesions were fully
ambulatory within 6 months. Eight
of the 10 patients who had resec
tion of a thigh sarcoma were com
munity ambulators and required no
walking aids; two required a cane.
Because the abductor musculature
had been resected, two of three
patients who had pelvic tumours
excised required two canes for
walking; the third walked without
aids.
It should be remembered that
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alternative procedures in these pa
tients would have been hemipelvectomy or hip disarticulation. Adults
rarely accomodate to prostheses
after such amputations and general
ly use either a wheelchair or two
crutches for walking.14 All patients
who had distal lower extremity tu
mours resected were able to walk
without aids.
Of three patients treated for
upper extremity tumours, two re
turned to work that would have
been impossible after amputation —
a chef and a welder. The third who
had a soft-tissue sarcoma of the
axilla had insufficient active shoul
der movement to resume work as a
hairdresser but since her elbow and
hand function was virtually normal
she retrained as a secretary.
No patients had local recurrence.
Relapse occurred at distant sites in
six patients (five with thigh tu
mours). Two died of metastatic dis
ease. At the time of writing one was
alive with extensive metastases and
three had undergone resection of
the metastases and were disease
free.

Discussion
The goal of treatment in soft-tis
sue sarcoma is to provide local
control of the lesion yet maintain
function. Over the past 25 years,
treatment has progressed from sim
ple excision with a 60% to 70%
local relapse rate1112 to radical re
section,1-3 to conservative surgery
with high-dose adjuvant radiothera
py.3 Several studies4-9 have demon
strated that a combination of sur
gery and radiation has eliminated
local disease in more than 90% of
patients treated. Data from our in
stitution suggest that the most im
portant factor in determining local
control is the adequacy of the local
resection.13
If it is accepted that conservative
72
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resection combined with radiation
offers a reasonable chance of local
tumour control in soft-tissue sarco
ma, then associated complications
and residual function become im
portant secondary considerations.
There is no point in saving the limb
if the patient is left with chronic
pain, a draining wound or a useless
extremity. The high early postoper
ative complication rate with com
bined treatment has been cited as a
reason for performing primary am
putation.10 In this review, we have
attempted to identify, prospectively,
patients with difficult soft-tissue
sarcomas who would have such
severe complications and poor func
tion that limb salvage should be
avoided and amputation proposed
as primary management.
Our patients in this study repre
sent the most difficult subset of
soft-tissue sarcomas, those most
prone to postoperative complica
tions, of which a delay in wound
healing was the most common. In
deed, wound complications were
found in 8 of 13 patients with lower
extremity or pelvic tumours. This is
not surprising, since adequate tu
mour resection required that large
skin flaps be lifted off the deep
fascia, interrupting the myocutaneous vessels that provide skin vas
cularity.14 Added insults are the
effects of radiation on skin heal
ing15 and dermal vascularity.16-17
However, the high incidence of softtissue complications did not detract
from the eventual functional results
obtained in this study. All patients
had healed wounds at 1-year follow
up.
Neurovascular involvement was
not a contraindication to limb sal
vage. Although patients requiring
vascular reconstruction frequently
underwent a secondary procedure
for wound complications, the end
result was a functional limb in each
case. It should also be noted that
resection of the femoral or sciatic

nerve, sometimes necessary for wide
resection, was compatible with rea
sonable ambulatory function.
The results of this review suggest
that almost all soft-tissue sarcomas
can be managed by limb-salvage
techniques with reasonable func
tional outcome. In our current con
secutive series of 86 patients with
the disease, the only amputation
performed was for a tumour involv
ing the entire brachial plexes. This
aggressive approach to limb salvage
has also been reported by Karakousis and associates,4 with similar rea
sonable functional results.
It should be emphasized that,
before referral, 11 of the 19 pa
tients in this series had undergone
one or more inadequate surgical
procedures which markedly in
creased the difficulty of definitive
surgery. We suggest that before
operating on a subfascial mass, the
surgeon should:
• Carry out local and systemic
staging studies and discuss com
bined management of the case with
a radiation oncologist skilled in sar
coma management before perform
ing a biopsy.
• Determine a strategy to en
sure adequate wide resection.
• Consider appropriate tech
niques for soft-tissue or skeletal
reconstruction.
• Ensure that pathology facili
ties suitable for both the interpreta
tion of biopsy and assessment of
resection margins are available.
If these criteria cannot be met,
we recommend that the patient be
referred to a multidisciplinary man
agement team before the first surgi
cal procedure is done.
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BOOK R E V IE W S
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high in many centres. The success rate
depends more on the operator than the
technique, and he sets out to improve
the techniques and results.
The 20 chapters cover all aspects of
hernia repair. Anatomy of the abdomi
nal wall and epidemiology and etiology
of hernias are covered well. There is a
good section on outpatient management
and on general principles of hernia
repair. The coverage of suture and
mesh materials is good. There is a short
section on anesthesia. Although the
author favours the Shouldice technique,
he and his patients prefer general anes
thesia, and this would likely reflect the
Canadian experience. However, tech
niques of local anesthesia are well de
scribed. The chapters on groin and
umbilical hernias in children and on the
differential diagnosis of groin lumps are
useful and practical.
The section on inguinal hernias in
adults covers the topic well and again
emphasizes the Shouldice repair. The
McVay repair is described more briefly
and the use of Marlex mesh is also
summarized. Older studies of hernia
repair are analysed to show that follow
up was usually poor and yet complete
information is essential for determining
true recurrence rates. Results in many
large centres are often poor, especially

when operation is carried out by inexpe
rienced surgeons. There is a short but
useful section on the truss. Repair of
femoral, umbilical, epigastric and inci
sional hernias is well described. A num
ber of rare hernias are also considered
and there are short chapters on Spigeli
an hernia and parastomal hernia. In a
chapter on extraperitoneal or preperitoneal repair with mesh, the author rec
ommends that only experienced sur
geons use this technique in cases of
very large or recurrent hernias. The list
of 679 references is exhaustive but
might be more helpful if a few key
references were highlighted.
This text does not detail the work on
hernias by Nyhus. Although the illus
trations are useful teaching aids, the
book contains too much detail for most
medical students. Residents in general
surgery would benefit from reading this
book early in their training and keeping
it for later reference. Although the
emphasis is on hernia repair, there is
much useful information on groin anat
omy, wound healing and choice of
sutures. It could also serve as a useful
review and refresher course for the
general surgeon who repairs hernias as
part of a varied pratice. The emphasis
on the Shouldice repair, on outpatient
surgery and local anesthesia is useful

for surgeons trained on a steady diet of
Bassini and McVay repairs. The impor
tance of long-term follow-up should be
noted by all who repair hernias.
One may question a few details, such
as the need for extensive shaving before
hernia repair, the use of adherent plas
tic during operation, or the avoidance
of sutures for wound closure, but over
all this is a brief, clear and logical
review of hernias.
D.M. Grace, MD, FRCSC
Division o f General Surgery,
University Hospital,
339 Windermere Rd.,
London. Ont.
N6A 5A5

TOTAL HIP ARTHROPLASTY. Rob
ert E. Booth, Jr., Richard A. Balderston, Richard H. Rothman. 310 pp.
Illust. W.B. Saunders Company, Phila
delphia, 1988. $ 1 0 8 .0 0 . ISBN 0-03013328-9.
"Total Hip Arthroplasty” is a delight to
read. It is concise and informative.
continued on page 79
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Surgical Treatment of Fungal Mycetoma
R. Visvanathan, BM, BCh, FRCS(Ire), FRCS, FRCS(Edin), FWACS, FICS
Chemotherapy for chronic fungal infections is often ineffective, and the associated
delay in surgical treatment may result in radical procedures being performed to
effect a cure. The author describes four patients with chronic fungal lesions, three
involving a foot and one the abdominal wall, all of which failed to respond to
antifungal chemotherapy. The lesions were excised, using procedures aimed at
preserving function. Infection recurred in two patients during a 9-month follow-up.
The author concludes that surgical therapy should be instituted early in the disease
to forestall spread to deeper structures and preserve functional integrity of the
affected parts.

La chimiotherapie des infections fongiques chroniques s’avere souvent inefficace, et
il en resulte un retard de chirurgie pouvant conduire a effectuer des interventions
radicales dans le but d’obtenir la guerison. L’auteur decrit quatre patients souffrant
d’infections fongiques chroniques, du pied dans trois cas et de la paroi abdominale
dans un, chez qui la chimiotherapie antifongique avait echoue. Les lesions furent
excisees par une technique visant la preservation fonctionnelle. Au cours d’une
periode de surveillance de 9 mois, il y eut recidive infectieuse chez deux patients.
L’auteur conclut a la necessity d’operer tot dans revolution de la maladie si l’on veut
empecher sa dissemination a des structures plus profondes et conserver l’integrite
fonctionnelle des organes touches.

hronic fungal infections of the
skin and subcutaneous tissue
respond poorly to antifungal che
motherapy. In most instances, the
lesions progress during such treat
ment and operative intervention is
delayed with the result that radical
surgical measures are often neces
sary to achieve a cure. This is a
report on four patients with fungal
mycetoma (eumycetoma) in whom
surgical therapy aimed at conserv
ing function was undertaken when
chemotherapy was found to be inef
fective.

C

his hemoglobin (78 g /L ) and serum
albumin (29 g /L ) levels. Multiple
tissue biopsies revealed mycelial ele
ments suggestive of Madurella
mycetomi in a granulomatous in
flammatory process with leukocytic
cellular aggregations and giant
cells. There was no indication of
malignancy. He had no bowel symp
toms and barium x-ray studies of
both the small and large bowel were
normal. The following treatment

Case Reports
Case 1
A 27-year-old farm labourer was
admitted to hospital with an 8-year
history of progressive, relatively
painless ulceration over his abdomi
nal wall. There were fleshy, conflu
ent, ulcerating lesions with multiple
sinuses and plaque-like thickening
of the subcutaneous tissue extend
ing over the affected area (Fig. 1).
Loss of serosanguineous fluid from
the ulcerated surface reflected on

From the Department o f Surgery, University Teaching Hospital, Maiduguri. Borno State. Nigeria
Accepted for publication July 5, 1988
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FIG. 1. Case 1. Anterior and right
lateral view of abdominal lesion. Previ
ous biopsy scars are visible on flank.

1

FUNGAL MYCETOMA

was begun: a 6-week course of
procaine penicillin G 600 000 units
and streptomycin sulfate 1 g intra
muscularly daily; a 6-month course
of Bactrim, two tablets orally twice
a day (one tablet contains 80 mg
trimethroprim and 400 mg sulfame
thoxazole); dapsone 100 mg/d,
7 which was reduced to 50 m g/d
after 2 months, and griseofulvin 1
g /d which also was reduced after 2
months to 750 m g/d.

FIG. 2. Case 2. Anterior and lateral
views of right foot showing nodular
recurrence 5 weeks after excisional
surgery and skin grafting.

t

The anemia was corrected and
his nutritional state improved dur
ing 3 months in hospital, but there
was no visible response to the che
motherapy regimen at the end of 6
months.
Under general anesthesia the ul
cerated surface and subcutaneous
tissue were removed en bloc from
the anterior rectus sheaths and
uninvolved external oblique aponeu
roses. The denuded area was cov
ered with meshed autologous skin
grafts harvested from both thighs.
He was discharged home 4 weeks
after operation with satisfactory

healing of the grafted areas. Within
9 weeks of his discharge three
isolated recurrences in the form of
small nodules appeared on his right
flank and hypogastrium. These
were widely excised and he has
remained free of further infection
during a 9-month follow-up.
Case 2
A 34-year-old man presented with
a 4-year history of progressive ul
ceration of the skin over the front
of his right foot and ankle. The
area involved was approximately 90
cm2 with swelling, induration, ulcer
ation and discharging sinuses af
fecting the skin and subcutaneous
tissue. Tissue biopsies revealed hyphae consistent with M. mycetomi.
There was no bony involvement and
he had satisfactory extension of his
toes. A 4-week course of daily intra
muscular injections of procaine
penicillin G and streptomycin was
instituted and a 4-month course of
oral dapsone, Bactrim and griseo
fulvin in dosages similar to those in
case 1. He failed to respond to this
regimen, so the lesion was excised
using an Esmarch bandage to re
duce blood loss. Dissection was car
ried down to the tendo-osseous
plane and the diseased tissue re
moved en bloc, preserving the ex
tensor tendons. After adequate
granulation, the residual area was
covered with split-thickness autolo
gous skin grafts. A nodular recur
rence seen 5 weeks later was ex
cised with 1 cm skin clearance (Fig.
2). A second recurrence occurring
after 3 weeks was similarly excised.
No further recurrence was observed
during the first 6 months of follow
up.
Case 3

FIG. 3. Case 3. Tumour-like mycotic
lesion in right foot (top) and resulting
defect following its removal (bottom).

A man in his early twenties was
admitted with a 3-year history of
VOL. 32, NO. 1, JANUARY 1989
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painless swelling of his right fore
foot and discharging sinuses in the
clefts on either side of his third toe,
which was also very swollen (Fig.
3). Because previous broad-spec
trum chemotherapy had had no
effect, an Esmarch bandage was
applied and the mass removed en
bloc with the third metatarsal bone
and the involved toe (Fig. 3). The
reconstructed foot healed well. The
surgical specimen was a granuloma
tous inflammatory mass with leuko
cytic cell infiltrate and sinus tracts
similar to those seen in the two
previous patients. However, no fun
gus was isolated from the specimen.
The patient remained recurrencefree 9 months later.

Case 4
A 23-year-old man presented with
a 3-year history of an ulcerating
swelling on his right foot, similar
to, but less extensive than, the
lesion in patient 2; it covered an
area of 55 cm2 on its dorsal and
lateral aspects. Dark fungal parti
cles were seen in the discharge and
M. mycetomi was isolated. He was
started on an initial 4-week course
of intramuscular procaine penicillin
G and streptomycin and a 4-month
course of dapsone, Bactrim and
griseofulvin, orally, in dosages simi
lar to the first two patients. There
was again no response to treatment.
The lesion was excised and the
denuded area grafted. The patient
was free of recurrence for 6 months
after operation.

Discussion
The causative agent of a chronic
fungal lesion may elude detection.1
Previous chemotherapy or an over
growth of secondary invaders may
suppress the proliferation of fungal
elements. The morphologic picture
76
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of granulomatous changes with in
flammatory and giant cells, along
with the characteristic clinical pic
ture, usually suggests a fungal
cause.
The poor response of fungal my
cetoma (eumycetoma) to chemo
therapy has led to the recommenda
tion of surgical measures.23 The
timing of surgery, either in con
junction with or after drug ther
apy, has yet to be clarified, though
some guidelines have been drawn
up.4 Broad-spectrum antimicrobial
agents in conjunction with antifun
gal therapy are aimed at reducing
the secondary invading organisms,
though their effect was not dramat
ic in the patients studied. The an
tifungal agents dapsone and griseo
fulvin have some effect on eumyce
toma.5-7
Newer agents, clotrimazole and
ketoconazole, have been shown to
be more effective and their toxic
effects are being evaluated.7-9 Keto
conazole in combination with sur
gery has been used to treat fungal
mycetoma and has given encourag
ing results.10 The effectiveness of
these agents in reducing postopera
tive recurrence is, however, unde
termined. Until their effectiveness
and safety are established, surgery
for fungal mycetoma should be car
ried out as soon as the diagnosis is
made.
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Correction

On page 415 of the November 1988
issue, in the paper “Unusual gastric
foreign body: a case report” by
W.M. Kuzon, Jr., C.A. McFadyen
and F.L. Moffat, there are two lines
missing from the bottom of the
middle column as follows: “and
oversewing of the ulcer seemed jus
tified. It could be argued that”. The
two sentences involved should read,
“Therefore, removal of the mass
with partial thickness excision and
oversewing of the ulcer seemed jus
tified. It could be argued that, since
this was a gastric foreign body, a
more aggressive attempt to dislodge
and remove the components of the
mass endoscopically should have
been attempted first.” We apologize
to Dr. Kuzon and his colleagues and
to our readers for this error.
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Anteromedial (Perineal) Dislocation of the
Hip: a Case Report
J.C. Burrell, MD, FRCSC;* J.K. Lipinski, MD, FRCPC, FRCR(Lond)t
Anteromedial (perineal) dislocation of the hip is rare. The authors describe the case
of a 13-year-old girl whose femoral head was dislocated into the vagina as a result of
a motor vehicle accident. The hip could not be reduced by traction but was pushed
through the vagina with moderate ease. When the patient was placed in the
lithotomy position, the hip redislocated and further reduction was required. The
vagina and soft tissues were repaired and the hip joint was irrigated and closed over
a drain. Antibiotics were given for 10 days. The girl recovered completely.

La dislocation anteromediane de la hanche est rare. Les auteurs decrivent un cas
chez une fillette de 13 ans dont la tete du femur avait perfore le vagin lors d’un
accident d’automobile. La hanche ne put etre replacee par traction, mais elle fut
poussee a travers le vagin avec relativement de facilite. Quand la patiente fut placee
en position de lithotomie, la hanche se disloqua de nouveau et la luxation dut encore
etre reduite. On repara le vagin et les tissus mous, et la hanche fut refermee apres la
pose d’un drain. Des antibiotiques furent administres pendant 10 jours. La guerison
fut totale.

multiple injuries including a right
brachial plexus palsy, fractures of
the mandible and the right first rib
and a closed head injury resulting
in a decreased level of conscious
ness.
The left leg was abducted and
externally rotated at the hip. Swell
ing and bruising were evident above
the perineum on the left side and
the skin was tense and discoloured
(Fig. 1). There was moderate bleed
ing from the vagina. The examining
physician interpreted this finding as
indicating a fracture of the pelvis.

A

nterior dislocation of the hip is
uncommon; when it occurs,
the femoral head usually lies in the
periarticular position. We report a
rare case of traumatic anteromedial
dislocation of the hip in which the
femoral head punctured the vaginal
wall.

Case Report

A 13-year-old girl was seen 8
hours after she had been involved in
a motor vehicle accident. She had
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On retraction of the labia (Fig. 2),
however, the femoral articular sur
face was clearly seen with the ligamentum teres protruding through
the introitus. A pelvic x-ray film
confirmed the anteromedial position
of the femoral head (Fig. 3).
Initial resuscitation was carried
out in the emergency department.
In the operating room under gener
al anesthesia, the presenting ligamentum teres and the attached
fragment of bone were excised. No
amount of traction would reduce
the hip; however, a moderate push
on the femoral head through the
tear in the vagina reduced the head
quite easily. Stability of the hip was
good in all positions except abduc
tion and external rotation. When
the patient was placed in the lithot
omy position to repair the vagina
the hip redislocated. After further
reduction, the leg was held in inter
nal rotation which kept the joint
reduced.
The soft tissues of the vagina and
rectum were repaired and the pa
tient was prepared and draped for
an anterior approach to the hip
joint. The joint was irrigated thor
oughly and then closed over a
drain. In addition to cefazolin,
which was started in the emergency
department, tobramycin and met
ronidazole were given in appropri
ate dosage for age and weight. The
antibiotic therapy was continued for
10 days. The drain was removed 4
days after operation.
VOL. 32, NO. 1, JANUAR Y 1989
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The immediate postreduction
films showed a near-anatomic posi
tion of the greater trochanter and
an acceptable position of the lesser
trochanter fragment. Films obtained
2 weeks after injury showed heal

FIG. 1. Bruising and discolouration of
left aspect of perineum.

ing, callus formation and periosteal
reaction, and the hip was in a
normal location (Fig. 4).
When the girl was last seen, 6
months after her accident, she had
a full range of movement of the hip

FIG. 2. Femoral head and ligamentum
teres are evident at introitus.

and a normal gait. Radiologically,
there were no signs of avascular
necrosis.

Discussion
Dislocations of the femoral head
are classified as posterior, anterior
and central; the posterior type is
the most common, accounting for
85% of dislocations.1 Anterior dislo
cations are usually pubic or inferior.
We could find only one other report
of a perineal dislocation.2 For such
a displacement the mechanism
would have to be external rotation
and flexion, associated with a medi
al blow to the femur. The avulsions
of the lesser and greater trochan
ters and disruptions of the soft
tissues are an obvious association.
In our case, the joint was open
and because of the vaginal and
rectal disruptions, contamination
was likely. Furthermore, separate
drainage was considered indicated
as a precautionary measure. One
complication of these dislocations is
avascular necrosis, which occurs
much less frequently (less than
10%) than in posterior dislocations.3
The avascular necrosis may not be
apparent for up to 24 months, so a
long follow-up is necessary for
these patients.
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BOOK REVIEWS
continued from page 73

The book reflects the bias of the
authors who are followers of the Charnley school of hip arthroplasty. For ex
ample, they still recommend the trans
trochanteric approach for this proce
dure even though it is almost obsolete
in North America. The series on which
they base their conclusions is small,
comprising only about 600 cases, but
the follow-up is long and thorough.
The authors have no experience with
bipolar prostheses and freely admit it.
The section on hip revision is somewhat
dated and mentions little of the serious
problems currently being experienced in
the revision of noncemented implants
and the bone loss encountered in ar
throplasties being revised for the third
or fourth time. Similarly, the section on
noncemented hips reflects little of the
recent advances in this field such as
modular hip stems; comment is made
on obsolete implants such as the origi
nal Lord prosthesis which Lord himself
abandoned 3 to 4 years ago. This
section also contains a few errors. The
screw cup shown on page 269 is an

Anderson cup on the x-ray film, but the
illustration is of a Richards cup. Also, a
number of chapters were obviously writ
ten some time ago. A 2-day admission
before hip surgery is recommended. In
Canada, a 1-day admission is more
usual and the advent of diagnostic
related groupings (DRGs) has made
same-day admission common in the
United States.
Apart from these criticisms, I found
this one of the best surgical texts I have
seen. It is well written, lavishly illustrat
ed and clearly thought out. The authors
are to be congratulated. The section on
radiologic patterns of osteoarthritis,
which contains a thorough survey of
the literature and the complications and
results achieved in hip replacements for
rare conditions such as Gaucher's dis
ease and osteopetrosis, is of particular
value.
The chapter on the patient/surgeon
interview should be mandatory reading
for all undergraduates and surgical resi
dents. Indeed, this chapter could, with
advantage, be reprinted separately and

circulated to all surgeons. The subject
is a harsh and uncomfortable one for
both the surgeon and the patient. The
patient must be viewed in a global sense
not simply as an arthritic hip. We
surgeons are not gods and without the
patient’s cooperation we can only do so
much. As the authors of this book put
it “denying hip replacement to an unde
pendable, poorly motivated substance
abuser is not an uncharitable act but
rather an act of good judgement pre
venting him from years of potential
complications that would leave him
more disabled in the future”. Those of
us who must carry out revision on such
patients know well the truth of this
statement.
I heartily recommend this book for
all surgeons who practise hip replace
ment.
Hugh U. Cameron. MB, ChB, FRCSC
Ste. 318,
43 Wellesley St. E.
Toronto, Ont.
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Opportunity
For Surgeon!!!
Academic Surgical
Oncologist

►

*

The University of Calgary Faculty of Medicine invites
applications for a full time appointment in the Department
of Surgery. Located at the Foothills Hospital and reporting
to the Division Chief of Surgical Oncology, the incumbent
will be part of a team developing an integrated cancer
program at the site. Research will be a major focus of
this position. Extensive funding opportunities exist at
the local and provincial levels for basic research initia
tives. Rank and salary are commensurate with experience
and qualifications. The starting date is negotiable.
In accordance with Canadian immigration requirements,
priority will be given to Canadian citizens and perma
nent residents of Canada.
The University of Calgary is committed to employment
equity.
Qualified applicants are invited to forward a curriculum
vitae by February 28, 1989 to:

t

Dr. W. J. Temple
Chief, Division of Surgical Oncology
Department of Surgery
The University of Calgary
1403 - 29 Street N.W.
Calgary, Alberta T2N 2T9

S89-05

We are seeking a second General Surgeon to
meet the health care needs of this rapidly
expanding and vital young community. State
of the art technology and a full range of
diagnostic and procedural services are features
of this fully accredited 300-bed hospital with
I50 beds currently open with good availability.
We b o a s t an excellent referral base and
anaesthetic support combined with six O.R.
th e a t re s o ffe rin g flexible sc h ed ul e s and
minimal waiting time. Fort McMurray offers
superb recreational, cultural, and educational
facilities. Income potential is well abov e
average. Call today for more information:

The President
Fort McMurray Regional Hospital
Fort McMurray, Alberta T9H 1P2
Phone (403)791-6161

Fort McMurray
Regional
Hospital
S89-04

►
►
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As a further service to its readers the Canadian Journal o f Surgery is pleased to accept suitable classified advertisements. The deadline is 1
month before issue date. Regular classified rates (for each insertion): $45.00 for the first 40 words or less, additional words 600 each (additional
$17.00 for frame). Special Display under 100 words, 2Vt in. X 2 in., $110.00. $6.00 charge (first insertion only) for CJS box numbers Display
rates available on request.
Copy should be mailed to the Canadian Journal o f Surgery, PO Box 8650, Ottawa, Ontario K1G 0G8.

HEAD. DIVISION OF ORTHOPEDICS: ON St. Michael's Hospital, a 700-bed active treat
ment teaching hospital, fully affiliated with the
University of Toronto, with a busy trauma
service, invites applications for the position of
Head, Division of Orthopedics. Located in
downtown Toronto, the hospital is in close
proximity to the University of Toronto and
other major teaching and research activities.
Essential requirements for the position include a
clear commitment to patient care, demonstrat
ed clinical and managerial expertise and proven
leadership in teaching and research. Applicants
must have certification by the Royal College of
Physicians and Surgeons of Canada or equiva
lent. The successful candidate will be jointly
appointed to the Department of Surgery in the
Faculty of Medicine at the University of Toron
to. In accordance with Canadian immigration
requirements, this advertisement is directed to
Canadian citizens and permanent residents.
Please apply w ith curriculum vitae by Feb. 28,
1989 to: Dr. John C. Platt, vice president,
Medical Affairs, St. Michael's Hospital, 30
Bond St., Toronto, ON M5B 1W 8. Tel: (416)
8 6 4 -5 0 4 1 .
-S89-07

ADVERTISERS’ INDEX

Canadian Association of General
Surgeons
35

D E P A R T M E N T O F S U R G ER Y
Victoria Hospital, London, Ontario, a major tertiary
care institution affiliated with the University of
Western Ontario, is now accepting applications for
Chief of the Department of Surgery.
Applications, accompanied by a current curiculum
vitae and the names of three referees, should be
sent to:
Dr. G. S. Bartlett
Vice President, Medical Services
Victoria Hospital
375 South Street
London, ON N6A 4G5

Applications will close February 17,1989.
S-89-03

UNIVERSITY CHAIRMAN, DIVISION OF
NEUROSURGERY: ON — Required for Univer
sity of Toronto as of July 1, 1989. The Head of
the Division of Neurosurgery at the University of
Toronto is responsible for the academic pro
grams of five hospital divisions, including un
dergraduate and postgraduate education re
sponsibilities, and coordination of research.
Candidates will be expected to have a reputa
tion for clinical excellence, as well as accom
plishment in the areas of teaching and research
and leadership experience. In accordance with
Canadian immigration requirements, this adver
tisement is directed primarily to Canadian citi
zens or permanent residents. Applicants should
send a letter and accompanying curriculum
vitae to: Dr. B. Langer, R.S. McLaughlin,
professor and chairman. Department of Sur
gery, University of Toronto, The Banting
Institute. 100 College St., Toronto, ON M5G
1 L5-

GENERAL SURGEON: SK — An opportunity
exists for a general surgeon to join in busy
practice of general surgery, university centre,
western Canada. Please send CV to: Box 726,
Canadian Journal of Surgery, PO Box 8650,
Ottawa, ON K1G 0G8.
-S89-01

GENERAL PRACTITIONER/ANESTHETIST:
AB - Required by a well established 15-doctor
group. Laboratory and x-ray facilities in clinic.
Accredited 120-bed active treatment hospital in
community of 12 000 and servicing the region
al needs of 30 000 people. Camrose is a
beautiful place to live; close, but not too close
to Edmonton, with university accredited, active
recreational, sports and cultural programs. Con
tact: Mr. T. C. Ofrim, administrator. Smith
Clinic, 4825-51 St., Camrose, AB T4V 1R9.
Tel: (403) 6 7 2 -2424.
-S 89-08

BIOGRAPHY: — Material for biography of the
late Professor J. C. B. Grant required. Personal
memoirs, anecdotes, photographs, welcome.
Information treated with discretion and material
returned promptly. Reply to: Dr. Clayton Rob
inson, 808 - 750 West Broadway, Vancou
ver, BC V5Z 1H7.
- S 88-39

HAND SURGERY FELLOWSHIP: ON Available, starting July 1, 1989. For infor
mation contact: The office of Dr. J. H.
Roth, (FRCSC), 345 Westminster Ave.,
London, ON N6C 4V3 Tel: (519)
4 3 9 -0 7 0 1 .
-S 88-40
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CLINICAL FELLOW
IN NEUROSURGERY
Corporate
22
Fibyrax
18, Inside Back Cover

Applications are invited for the position of clinical fellow in
neurosurgery, Memorial University of Newfoundland. The post
becomes vacant March 1, 1989 and is for a period of 1 year
(renewable). The Provincial Neurosurgery Unit is based at the Health
Sciences Centre. Previous experience in neurosurqery is reauired
Salary - $42 960.

Merck Sharp & Dohme Canada

In accordance with Canadian Immigration requirements, priority
will be given to Canadian citizens and permanent residents. Closinq
date for this advertisement is January 31,1989.
For further information contact:

Lederle
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Dr. E.S. Wright, Chairman
Discipline of Surgery
Memorial University
Health Sciences Centre
St. John’s, NF
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for fibre laxatives

Convenience they want with
efficacy they need
Fibyrax® provides a mixture of 4 natural-source fibres
chosen for maximum bulk and water-retention properties.
Fibyrax® Tablets increase fecal bulk to stimulate
peristalsis and bind water in the colon to keep stools
soft for easy passage.
Fibyrax® treats constipation gently and by
natural means, avoiding the discomfort often
associated with irritant-type laxatives.
And the tablets are more convenient to
use, less trouble to take than powdered fibre
laxatives.
Fibyrax® Tablets contain no sodium,
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All natural-source fibre from citrus fruits
for hypertensives, diabetics and obese
and bran
patients.

Fibl|HU< Tablets

►
CONSUMER HEALTH PRODUCTS ® Registered trade mark
Toronto. M ontreal

For prescribing information see page 18
►

|

paab

| |

|

polyglyconate monofilament absorbable suture

w

The multi-faceted
absorbable suture
appearing in
Plastic and
General surgery
theatres
everywhere. For a
personal
presentation call
your D + G
Representative
today.

Cyanamid Canada Inc.
88 McNabb Street
Markham, Ontario L3R 6E6
(416) 470-3600

©Registered trademark

